id	sid	tid	token	lemma	pos
ajlm-1645	1	1	abstract	abstract	ADJ
ajlm-1645	1	2	introduction	introduction	NOUN
ajlm-1645	1	3	methods	method	NOUN
ajlm-1645	1	4	results	result	VERB
ajlm-1645	1	5	discussion	discussion	NOUN
ajlm-1645	1	6	acknowledgements	acknowledgement	NOUN
ajlm-1645	1	7	references	reference	NOUN
ajlm-1645	1	8	about	about	ADP
ajlm-1645	1	9	the	the	DET
ajlm-1645	1	10	author(s	author(s	PROPN
ajlm-1645	1	11	)	)	PUNCT
ajlm-1645	1	12	erica	erica	PROPN
ajlm-1645	1	13	-	-	PUNCT
ajlm-1645	1	14	mari	mari	PROPN
ajlm-1645	1	15	nell	nell	PROPN
ajlm-1645	1	16	division	division	NOUN
ajlm-1645	1	17	of	of	ADP
ajlm-1645	1	18	haematological	haematological	ADJ
ajlm-1645	1	19	pathology	pathology	NOUN
ajlm-1645	1	20	,	,	PUNCT
ajlm-1645	1	21	department	department	PROPN
ajlm-1645	1	22	of	of	ADP
ajlm-1645	1	23	pathology	pathology	PROPN
ajlm-1645	1	24	,	,	PUNCT
ajlm-1645	1	25	faculty	faculty	NOUN
ajlm-1645	1	26	of	of	ADP
ajlm-1645	1	27	medicine	medicine	NOUN
ajlm-1645	1	28	and	and	CCONJ
ajlm-1645	1	29	health	health	NOUN
ajlm-1645	1	30	sciences	sciences	PROPN
ajlm-1645	1	31	,	,	PUNCT
ajlm-1645	1	32	stellenbosch	stellenbosch	PROPN
ajlm-1645	1	33	university	university	PROPN
ajlm-1645	1	34	,	,	PUNCT
ajlm-1645	1	35	cape	cape	NOUN
ajlm-1645	1	36	town	town	NOUN
ajlm-1645	1	37	,	,	PUNCT
ajlm-1645	1	38	south	south	PROPN
ajlm-1645	1	39	africa	africa	PROPN
ajlm-1645	1	40	national	national	PROPN
ajlm-1645	1	41	health	health	PROPN
ajlm-1645	1	42	laboratory	laboratory	PROPN
ajlm-1645	1	43	service	service	PROPN
ajlm-1645	1	44	,	,	PUNCT
ajlm-1645	1	45	tygerberg	tygerberg	PROPN
ajlm-1645	1	46	hospital	hospital	NOUN
ajlm-1645	1	47	,	,	PUNCT
ajlm-1645	1	48	cape	cape	NOUN
ajlm-1645	1	49	town	town	NOUN
ajlm-1645	1	50	,	,	PUNCT
ajlm-1645	1	51	south	south	PROPN
ajlm-1645	1	52	africa	africa	PROPN
ajlm-1645	1	53	zivanai	zivanai	PROPN
ajlm-1645	1	54	c.	c.	PROPN
ajlm-1645	1	55	chapanduka	chapanduka	PROPN
ajlm-1645	1	56	division	division	NOUN
ajlm-1645	1	57	of	of	ADP
ajlm-1645	1	58	haematological	haematological	ADJ
ajlm-1645	1	59	pathology	pathology	NOUN
ajlm-1645	1	60	,	,	PUNCT
ajlm-1645	1	61	department	department	PROPN
ajlm-1645	1	62	of	of	ADP
ajlm-1645	1	63	pathology	pathology	PROPN
ajlm-1645	1	64	,	,	PUNCT
ajlm-1645	1	65	faculty	faculty	NOUN
ajlm-1645	1	66	of	of	ADP
ajlm-1645	1	67	medicine	medicine	NOUN
ajlm-1645	1	68	and	and	CCONJ
ajlm-1645	1	69	health	health	NOUN
ajlm-1645	1	70	sciences	sciences	PROPN
ajlm-1645	1	71	,	,	PUNCT
ajlm-1645	1	72	stellenbosch	stellenbosch	PROPN
ajlm-1645	1	73	university	university	PROPN
ajlm-1645	1	74	,	,	PUNCT
ajlm-1645	1	75	cape	cape	NOUN
ajlm-1645	1	76	town	town	NOUN
ajlm-1645	1	77	,	,	PUNCT
ajlm-1645	1	78	south	south	PROPN
ajlm-1645	1	79	africa	africa	PROPN
ajlm-1645	1	80	national	national	PROPN
ajlm-1645	1	81	health	health	PROPN
ajlm-1645	1	82	laboratory	laboratory	PROPN
ajlm-1645	1	83	service	service	PROPN
ajlm-1645	1	84	,	,	PUNCT
ajlm-1645	1	85	tygerberg	tygerberg	PROPN
ajlm-1645	1	86	hospital	hospital	NOUN
ajlm-1645	1	87	,	,	PUNCT
ajlm-1645	1	88	cape	cape	NOUN
ajlm-1645	1	89	town	town	NOUN
ajlm-1645	1	90	,	,	PUNCT
ajlm-1645	1	91	south	south	PROPN
ajlm-1645	1	92	africa	africa	PROPN
ajlm-1645	1	93	citation	citation	PROPN
ajlm-1645	1	94	nell	nell	PROPN
ajlm-1645	1	95	e	e	PROPN
ajlm-1645	1	96	,	,	PUNCT
ajlm-1645	1	97	chapanduka	chapanduka	PROPN
ajlm-1645	1	98	zc	zc	NOUN
ajlm-1645	1	99	.	.	PROPN
ajlm-1645	1	100	aetiology	aetiology	NOUN
ajlm-1645	1	101	of	of	ADP
ajlm-1645	1	102	pancytopenia	pancytopenia	NOUN
ajlm-1645	1	103	:	:	PUNCT
ajlm-1645	1	104	experience	experience	NOUN
ajlm-1645	1	105	of	of	ADP
ajlm-1645	1	106	a	a	DET
ajlm-1645	1	107	south	south	ADJ
ajlm-1645	1	108	african	african	ADJ
ajlm-1645	1	109	tertiary	tertiary	ADJ
ajlm-1645	1	110	academic	academic	ADJ
ajlm-1645	1	111	centre	centre	NOUN
ajlm-1645	1	112	.	.	PUNCT
ajlm-1645	2	1	afr	afr	PROPN
ajlm-1645	2	2	j	j	PROPN
ajlm-1645	2	3	lab	lab	PROPN
ajlm-1645	2	4	med	med	PROPN
ajlm-1645	2	5	.	.	PUNCT
ajlm-1645	3	1	2022;11(1	2022;11(1	NUM
ajlm-1645	3	2	)	)	PUNCT
ajlm-1645	4	1	,	,	PUNCT
ajlm-1645	4	2	a1645	a1645	PROPN
ajlm-1645	4	3	.	.	PUNCT
ajlm-1645	5	1	https://doi.org/10.4102/ajlm.v11i1.1645	https://doi.org/10.4102/ajlm.v11i1.1645	X
ajlm-1645	5	2	original	original	ADJ
ajlm-1645	5	3	research	research	NOUN
ajlm-1645	5	4	aetiology	aetiology	NOUN
ajlm-1645	5	5	of	of	ADP
ajlm-1645	5	6	pancytopenia	pancytopenia	NOUN
ajlm-1645	5	7	:	:	PUNCT
ajlm-1645	5	8	experience	experience	NOUN
ajlm-1645	5	9	of	of	ADP
ajlm-1645	5	10	a	a	DET
ajlm-1645	5	11	south	south	ADJ
ajlm-1645	5	12	african	african	ADJ
ajlm-1645	5	13	tertiary	tertiary	ADJ
ajlm-1645	5	14	academic	academic	PROPN
ajlm-1645	5	15	centre	centre	NOUN
ajlm-1645	5	16	erica	erica	PROPN
ajlm-1645	5	17	-	-	PUNCT
ajlm-1645	5	18	mari	mari	PROPN
ajlm-1645	5	19	nell	nell	PROPN
ajlm-1645	5	20	,	,	PUNCT
ajlm-1645	5	21	zivanai	zivanai	PROPN
ajlm-1645	5	22	c.	c.	PROPN
ajlm-1645	5	23	chapanduka	chapanduka	PROPN
ajlm-1645	5	24	received	receive	VERB
ajlm-1645	5	25	:	:	PUNCT
ajlm-1645	5	26	10	10	NUM
ajlm-1645	5	27	june	june	PROPN
ajlm-1645	5	28	2021	2021	NUM
ajlm-1645	5	29	;	;	PUNCT
ajlm-1645	5	30	accepted	accept	VERB
ajlm-1645	5	31	:	:	PUNCT
ajlm-1645	5	32	18	18	NUM
ajlm-1645	5	33	feb	feb	NOUN
ajlm-1645	5	34	.	.	PROPN
ajlm-1645	5	35	2022	2022	NUM
ajlm-1645	5	36	;	;	PUNCT
ajlm-1645	5	37	published	publish	VERB
ajlm-1645	5	38	:	:	PUNCT
ajlm-1645	5	39	31	31	NUM
ajlm-1645	5	40	may	may	AUX
ajlm-1645	5	41	2022	2022	NUM
ajlm-1645	5	42	copyright	copyright	NOUN
ajlm-1645	5	43	:	:	PUNCT
ajlm-1645	5	44	©	©	PROPN
ajlm-1645	5	45	2022	2022	NUM
ajlm-1645	5	46	.	.	PUNCT
ajlm-1645	6	1	the	the	DET
ajlm-1645	6	2	author(s	author(s	PROPN
ajlm-1645	6	3	)	)	PUNCT
ajlm-1645	6	4	.	.	PUNCT
ajlm-1645	7	1	licensee	licensee	NOUN
ajlm-1645	7	2	:	:	PUNCT
ajlm-1645	7	3	aosis	aosis	NOUN
ajlm-1645	7	4	.	.	PUNCT
ajlm-1645	8	1	this	this	PRON
ajlm-1645	8	2	is	be	AUX
ajlm-1645	8	3	an	an	DET
ajlm-1645	8	4	open	open	ADJ
ajlm-1645	8	5	access	access	NOUN
ajlm-1645	8	6	article	article	NOUN
ajlm-1645	8	7	distributed	distribute	VERB
ajlm-1645	8	8	under	under	ADP
ajlm-1645	8	9	the	the	DET
ajlm-1645	8	10	terms	term	NOUN
ajlm-1645	8	11	of	of	ADP
ajlm-1645	8	12	the	the	DET
ajlm-1645	8	13	creative	creative	ADJ
ajlm-1645	8	14	commons	common	NOUN
ajlm-1645	8	15	attribution	attribution	NOUN
ajlm-1645	8	16	license	license	NOUN
ajlm-1645	8	17	,	,	PUNCT
ajlm-1645	8	18	which	which	PRON
ajlm-1645	8	19	permits	permit	VERB
ajlm-1645	8	20	unrestricted	unrestricted	ADJ
ajlm-1645	8	21	use	use	NOUN
ajlm-1645	8	22	,	,	PUNCT
ajlm-1645	8	23	distribution	distribution	NOUN
ajlm-1645	8	24	,	,	PUNCT
ajlm-1645	8	25	and	and	CCONJ
ajlm-1645	8	26	reproduction	reproduction	NOUN
ajlm-1645	8	27	in	in	ADP
ajlm-1645	8	28	any	any	DET
ajlm-1645	8	29	medium	medium	NOUN
ajlm-1645	8	30	,	,	PUNCT
ajlm-1645	8	31	provided	provide	VERB
ajlm-1645	8	32	the	the	DET
ajlm-1645	8	33	original	original	ADJ
ajlm-1645	8	34	work	work	NOUN
ajlm-1645	8	35	is	be	AUX
ajlm-1645	8	36	properly	properly	ADV
ajlm-1645	8	37	cited	cite	VERB
ajlm-1645	8	38	.	.	PUNCT
ajlm-1645	9	1	abstract	abstract	ADJ
ajlm-1645	9	2	background	background	NOUN
ajlm-1645	9	3	:	:	PUNCT
ajlm-1645	9	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	9	5	is	be	AUX
ajlm-1645	9	6	a	a	DET
ajlm-1645	9	7	manifestation	manifestation	NOUN
ajlm-1645	9	8	of	of	ADP
ajlm-1645	9	9	numerous	numerous	ADJ
ajlm-1645	9	10	disease	disease	NOUN
ajlm-1645	9	11	entities	entity	NOUN
ajlm-1645	9	12	.	.	PUNCT
ajlm-1645	10	1	the	the	DET
ajlm-1645	10	2	causes	cause	NOUN
ajlm-1645	10	3	of	of	ADP
ajlm-1645	10	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	10	5	differ	differ	VERB
ajlm-1645	10	6	with	with	ADP
ajlm-1645	10	7	geographic	geographic	ADJ
ajlm-1645	10	8	region	region	NOUN
ajlm-1645	10	9	,	,	PUNCT
ajlm-1645	10	10	socio	socio	NOUN
ajlm-1645	10	11	-	-	PUNCT
ajlm-1645	10	12	economic	economic	ADJ
ajlm-1645	10	13	factors	factor	NOUN
ajlm-1645	10	14	and	and	CCONJ
ajlm-1645	10	15	hiv	hiv	PROPN
ajlm-1645	10	16	prevalence	prevalence	NOUN
ajlm-1645	10	17	.	.	PUNCT
ajlm-1645	11	1	awareness	awareness	NOUN
ajlm-1645	11	2	of	of	ADP
ajlm-1645	11	3	the	the	DET
ajlm-1645	11	4	common	common	ADJ
ajlm-1645	11	5	causes	cause	NOUN
ajlm-1645	11	6	of	of	ADP
ajlm-1645	11	7	pancytopenia	pancytopenia	NOUN
ajlm-1645	11	8	may	may	AUX
ajlm-1645	11	9	aid	aid	VERB
ajlm-1645	11	10	timely	timely	ADJ
ajlm-1645	11	11	diagnosis	diagnosis	NOUN
ajlm-1645	11	12	.	.	PUNCT
ajlm-1645	12	1	objective	objective	NOUN
ajlm-1645	12	2	:	:	PUNCT
ajlm-1645	12	3	this	this	DET
ajlm-1645	12	4	study	study	NOUN
ajlm-1645	12	5	aimed	aim	VERB
ajlm-1645	12	6	to	to	PART
ajlm-1645	12	7	determine	determine	VERB
ajlm-1645	12	8	the	the	DET
ajlm-1645	12	9	aetiology	aetiology	NOUN
ajlm-1645	12	10	of	of	ADP
ajlm-1645	12	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	12	12	in	in	ADP
ajlm-1645	12	13	a	a	DET
ajlm-1645	12	14	south	south	ADJ
ajlm-1645	12	15	african	african	ADJ
ajlm-1645	12	16	population	population	NOUN
ajlm-1645	12	17	.	.	PUNCT
ajlm-1645	13	1	methods	method	NOUN
ajlm-1645	13	2	:	:	PUNCT
ajlm-1645	13	3	a	a	DET
ajlm-1645	13	4	retrospective	retrospective	ADJ
ajlm-1645	13	5	observational	observational	ADJ
ajlm-1645	13	6	study	study	NOUN
ajlm-1645	13	7	of	of	ADP
ajlm-1645	13	8	adult	adult	NOUN
ajlm-1645	13	9	patients	patient	NOUN
ajlm-1645	13	10	presenting	present	VERB
ajlm-1645	13	11	with	with	ADP
ajlm-1645	13	12	pancytopenia	pancytopenia	NOUN
ajlm-1645	13	13	at	at	ADP
ajlm-1645	13	14	tygerberg	tygerberg	PROPN
ajlm-1645	13	15	academic	academic	ADJ
ajlm-1645	13	16	hospital	hospital	NOUN
ajlm-1645	13	17	,	,	PUNCT
ajlm-1645	13	18	south	south	PROPN
ajlm-1645	13	19	africa	africa	PROPN
ajlm-1645	13	20	,	,	PUNCT
ajlm-1645	13	21	from	from	ADP
ajlm-1645	13	22	january	january	PROPN
ajlm-1645	13	23	2016	2016	NUM
ajlm-1645	13	24	to	to	ADP
ajlm-1645	13	25	december	december	PROPN
ajlm-1645	13	26	2017	2017	NUM
ajlm-1645	13	27	was	be	AUX
ajlm-1645	13	28	performed	perform	VERB
ajlm-1645	13	29	.	.	PUNCT
ajlm-1645	14	1	data	datum	NOUN
ajlm-1645	14	2	on	on	ADP
ajlm-1645	14	3	pancytopenia	pancytopenia	NOUN
ajlm-1645	14	4	cases	case	NOUN
ajlm-1645	14	5	were	be	AUX
ajlm-1645	14	6	obtained	obtain	VERB
ajlm-1645	14	7	from	from	ADP
ajlm-1645	14	8	the	the	DET
ajlm-1645	14	9	laboratory	laboratory	NOUN
ajlm-1645	14	10	information	information	NOUN
ajlm-1645	14	11	system	system	NOUN
ajlm-1645	14	12	and	and	CCONJ
ajlm-1645	14	13	utilised	utilise	VERB
ajlm-1645	14	14	to	to	PART
ajlm-1645	14	15	determine	determine	VERB
ajlm-1645	14	16	the	the	DET
ajlm-1645	14	17	causes	cause	NOUN
ajlm-1645	14	18	of	of	ADP
ajlm-1645	14	19	pancytopenia	pancytopenia	NOUN
ajlm-1645	14	20	.	.	PUNCT
ajlm-1645	15	1	results	result	NOUN
ajlm-1645	15	2	:	:	PUNCT
ajlm-1645	15	3	a	a	DET
ajlm-1645	15	4	total	total	NOUN
ajlm-1645	15	5	of	of	ADP
ajlm-1645	15	6	673	673	NUM
ajlm-1645	15	7	cases	case	NOUN
ajlm-1645	15	8	of	of	ADP
ajlm-1645	15	9	pancytopenia	pancytopenia	NOUN
ajlm-1645	15	10	were	be	AUX
ajlm-1645	15	11	identified	identify	VERB
ajlm-1645	15	12	.	.	PUNCT
ajlm-1645	16	1	the	the	DET
ajlm-1645	16	2	most	most	ADV
ajlm-1645	16	3	common	common	ADJ
ajlm-1645	16	4	causes	cause	NOUN
ajlm-1645	16	5	of	of	ADP
ajlm-1645	16	6	pancytopenia	pancytopenia	NOUN
ajlm-1645	16	7	were	be	AUX
ajlm-1645	16	8	chemoradiation	chemoradiation	NOUN
ajlm-1645	16	9	therapy	therapy	NOUN
ajlm-1645	16	10	(	(	PUNCT
ajlm-1645	16	11	25	25	NUM
ajlm-1645	16	12	%	%	NOUN
ajlm-1645	16	13	)	)	PUNCT
ajlm-1645	16	14	,	,	PUNCT
ajlm-1645	16	15	sepsis	sepsis	NOUN
ajlm-1645	16	16	(	(	PUNCT
ajlm-1645	16	17	18	18	NUM
ajlm-1645	16	18	%	%	NOUN
ajlm-1645	16	19	)	)	PUNCT
ajlm-1645	16	20	,	,	PUNCT
ajlm-1645	16	21	haematological	haematological	ADJ
ajlm-1645	16	22	malignancy	malignancy	NOUN
ajlm-1645	16	23	(	(	PUNCT
ajlm-1645	16	24	9	9	NUM
ajlm-1645	16	25	%	%	NOUN
ajlm-1645	16	26	)	)	PUNCT
ajlm-1645	16	27	,	,	PUNCT
ajlm-1645	16	28	advanced	advanced	PROPN
ajlm-1645	16	29	hiv	hiv	PROPN
ajlm-1645	16	30	(	(	PUNCT
ajlm-1645	16	31	7	7	NUM
ajlm-1645	16	32	%	%	NOUN
ajlm-1645	16	33	)	)	PUNCT
ajlm-1645	16	34	,	,	PUNCT
ajlm-1645	16	35	and	and	CCONJ
ajlm-1645	16	36	megaloblastic	megaloblastic	ADJ
ajlm-1645	16	37	anaemia	anaemia	NOUN
ajlm-1645	16	38	(	(	PUNCT
ajlm-1645	16	39	6	6	NUM
ajlm-1645	16	40	%	%	NOUN
ajlm-1645	16	41	)	)	PUNCT
ajlm-1645	16	42	.	.	PUNCT
ajlm-1645	17	1	the	the	DET
ajlm-1645	17	2	diagnostic	diagnostic	ADJ
ajlm-1645	17	3	yield	yield	NOUN
ajlm-1645	17	4	of	of	ADP
ajlm-1645	17	5	bone	bone	NOUN
ajlm-1645	17	6	marrow	marrow	NOUN
ajlm-1645	17	7	examinations	examination	NOUN
ajlm-1645	17	8	(	(	PUNCT
ajlm-1645	17	9	bme	bme	NOUN
ajlm-1645	17	10	)	)	PUNCT
ajlm-1645	17	11	was	be	AUX
ajlm-1645	17	12	57	57	NUM
ajlm-1645	17	13	%	%	NOUN
ajlm-1645	17	14	(	(	PUNCT
ajlm-1645	17	15	n	n	NOUN
ajlm-1645	17	16	=	=	SYM
ajlm-1645	17	17	52/91	52/91	NUM
ajlm-1645	17	18	)	)	PUNCT
ajlm-1645	17	19	.	.	PUNCT
ajlm-1645	18	1	the	the	DET
ajlm-1645	18	2	aetiology	aetiology	NOUN
ajlm-1645	18	3	of	of	ADP
ajlm-1645	18	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	18	5	differed	differ	VERB
ajlm-1645	18	6	according	accord	VERB
ajlm-1645	18	7	to	to	ADP
ajlm-1645	18	8	age	age	NOUN
ajlm-1645	18	9	,	,	PUNCT
ajlm-1645	18	10	with	with	ADP
ajlm-1645	18	11	malignancy	malignancy	NOUN
ajlm-1645	18	12	being	be	AUX
ajlm-1645	18	13	a	a	DET
ajlm-1645	18	14	more	more	ADV
ajlm-1645	18	15	common	common	ADJ
ajlm-1645	18	16	cause	cause	NOUN
ajlm-1645	18	17	of	of	ADP
ajlm-1645	18	18	pancytopenia	pancytopenia	NOUN
ajlm-1645	18	19	among	among	ADP
ajlm-1645	18	20	the	the	DET
ajlm-1645	18	21	elderly	elderly	ADJ
ajlm-1645	18	22	.	.	PUNCT
ajlm-1645	19	1	conclusion	conclusion	NOUN
ajlm-1645	19	2	:	:	PUNCT
ajlm-1645	19	3	several	several	ADJ
ajlm-1645	19	4	easily	easily	ADV
ajlm-1645	19	5	recognisable	recognisable	ADJ
ajlm-1645	19	6	and	and	CCONJ
ajlm-1645	19	7	treatable	treatable	ADJ
ajlm-1645	19	8	conditions	condition	NOUN
ajlm-1645	19	9	can	can	AUX
ajlm-1645	19	10	manifest	manifest	VERB
ajlm-1645	19	11	as	as	ADP
ajlm-1645	19	12	pancytopenia	pancytopenia	NOUN
ajlm-1645	19	13	.	.	PUNCT
ajlm-1645	20	1	prompt	prompt	ADJ
ajlm-1645	20	2	management	management	NOUN
ajlm-1645	20	3	of	of	ADP
ajlm-1645	20	4	such	such	ADJ
ajlm-1645	20	5	conditions	condition	NOUN
ajlm-1645	20	6	,	,	PUNCT
ajlm-1645	20	7	notably	notably	ADV
ajlm-1645	20	8	sepsis	sepsis	NOUN
ajlm-1645	20	9	and	and	CCONJ
ajlm-1645	20	10	megaloblastic	megaloblastic	ADJ
ajlm-1645	20	11	anaemia	anaemia	NOUN
ajlm-1645	20	12	,	,	PUNCT
ajlm-1645	20	13	can	can	AUX
ajlm-1645	20	14	result	result	VERB
ajlm-1645	20	15	in	in	ADP
ajlm-1645	20	16	the	the	DET
ajlm-1645	20	17	resolution	resolution	NOUN
ajlm-1645	20	18	of	of	ADP
ajlm-1645	20	19	the	the	DET
ajlm-1645	20	20	cytopenias	cytopenia	NOUN
ajlm-1645	20	21	and	and	CCONJ
ajlm-1645	20	22	negate	negate	VERB
ajlm-1645	20	23	the	the	DET
ajlm-1645	20	24	need	need	NOUN
ajlm-1645	20	25	for	for	ADP
ajlm-1645	20	26	a	a	DET
ajlm-1645	20	27	bme	bme	NOUN
ajlm-1645	20	28	.	.	PUNCT
ajlm-1645	21	1	however	however	ADV
ajlm-1645	21	2	,	,	PUNCT
ajlm-1645	21	3	haematological	haematological	ADJ
ajlm-1645	21	4	malignancy	malignancy	NOUN
ajlm-1645	21	5	and	and	CCONJ
ajlm-1645	21	6	unexplained	unexplained	ADJ
ajlm-1645	21	7	pancytopenia	pancytopenia	NOUN
ajlm-1645	21	8	strongly	strongly	ADV
ajlm-1645	21	9	rely	rely	VERB
ajlm-1645	21	10	on	on	ADP
ajlm-1645	21	11	a	a	DET
ajlm-1645	21	12	bme	bme	NOUN
ajlm-1645	21	13	to	to	PART
ajlm-1645	21	14	establish	establish	VERB
ajlm-1645	21	15	a	a	DET
ajlm-1645	21	16	diagnosis	diagnosis	NOUN
ajlm-1645	21	17	.	.	PUNCT
ajlm-1645	22	1	pancytopenia	pancytopenia	NOUN
ajlm-1645	22	2	investigations	investigation	NOUN
ajlm-1645	22	3	,	,	PUNCT
ajlm-1645	22	4	when	when	SCONJ
ajlm-1645	22	5	guided	guide	VERB
ajlm-1645	22	6	by	by	ADP
ajlm-1645	22	7	appropriate	appropriate	ADJ
ajlm-1645	22	8	clinic	clinic	NOUN
ajlm-1645	22	9	-	-	PUNCT
ajlm-1645	22	10	laboratory	laboratory	NOUN
ajlm-1645	22	11	findings	finding	NOUN
ajlm-1645	22	12	,	,	PUNCT
ajlm-1645	22	13	can	can	AUX
ajlm-1645	22	14	promptly	promptly	ADV
ajlm-1645	22	15	identify	identify	VERB
ajlm-1645	22	16	the	the	DET
ajlm-1645	22	17	underlying	underlie	VERB
ajlm-1645	22	18	aetiology	aetiology	NOUN
ajlm-1645	22	19	,	,	PUNCT
ajlm-1645	22	20	while	while	SCONJ
ajlm-1645	22	21	also	also	ADV
ajlm-1645	22	22	identifying	identify	VERB
ajlm-1645	22	23	cases	case	NOUN
ajlm-1645	22	24	where	where	SCONJ
ajlm-1645	22	25	an	an	DET
ajlm-1645	22	26	expedited	expedite	VERB
ajlm-1645	22	27	bme	bme	NOUN
ajlm-1645	22	28	is	be	AUX
ajlm-1645	22	29	required	require	VERB
ajlm-1645	22	30	.	.	PUNCT
ajlm-1645	23	1	this	this	PRON
ajlm-1645	23	2	is	be	AUX
ajlm-1645	23	3	valuable	valuable	ADJ
ajlm-1645	23	4	in	in	ADP
ajlm-1645	23	5	resource	resource	NOUN
ajlm-1645	23	6	-	-	PUNCT
ajlm-1645	23	7	conscious	conscious	ADJ
ajlm-1645	23	8	medicine	medicine	NOUN
ajlm-1645	23	9	.	.	PUNCT
ajlm-1645	24	1	keywords	keyword	NOUN
ajlm-1645	24	2	:	:	PUNCT
ajlm-1645	24	3	pancytopenia	pancytopenia	NOUN
ajlm-1645	24	4	;	;	PUNCT
ajlm-1645	24	5	sepsis	sepsis	NOUN
ajlm-1645	24	6	;	;	PUNCT
ajlm-1645	24	7	hiv	hiv	PROPN
ajlm-1645	24	8	;	;	PUNCT
ajlm-1645	24	9	haematological	haematological	ADJ
ajlm-1645	24	10	malignancy	malignancy	NOUN
ajlm-1645	24	11	;	;	PUNCT
ajlm-1645	24	12	nutritional	nutritional	ADJ
ajlm-1645	24	13	deficiency	deficiency	NOUN
ajlm-1645	24	14	;	;	PUNCT
ajlm-1645	24	15	megaloblastic	megaloblastic	ADJ
ajlm-1645	24	16	anaemia	anaemia	NOUN
ajlm-1645	24	17	;	;	PUNCT
ajlm-1645	24	18	aging	age	VERB
ajlm-1645	24	19	.	.	PUNCT
ajlm-1645	25	1	introduction	introduction	NOUN
ajlm-1645	25	2	the	the	DET
ajlm-1645	25	3	term	term	NOUN
ajlm-1645	25	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	25	5	is	be	AUX
ajlm-1645	25	6	used	use	VERB
ajlm-1645	25	7	to	to	PART
ajlm-1645	25	8	describe	describe	VERB
ajlm-1645	25	9	a	a	DET
ajlm-1645	25	10	reduction	reduction	NOUN
ajlm-1645	25	11	in	in	ADP
ajlm-1645	25	12	all	all	DET
ajlm-1645	25	13	three	three	NUM
ajlm-1645	25	14	haematopoietic	haematopoietic	ADJ
ajlm-1645	25	15	cell	cell	NOUN
ajlm-1645	25	16	lines	line	NOUN
ajlm-1645	25	17	in	in	ADP
ajlm-1645	25	18	the	the	DET
ajlm-1645	25	19	peripheral	peripheral	ADJ
ajlm-1645	25	20	blood	blood	NOUN
ajlm-1645	25	21	,	,	PUNCT
ajlm-1645	25	22	namely	namely	ADV
ajlm-1645	25	23	erythrocytes	erythrocytes	ADJ
ajlm-1645	25	24	,	,	PUNCT
ajlm-1645	25	25	leukocytes	leukocyte	NOUN
ajlm-1645	25	26	and	and	CCONJ
ajlm-1645	25	27	platelets	platelet	NOUN
ajlm-1645	25	28	.	.	PUNCT
ajlm-1645	26	1	pancytopenia	pancytopenia	NOUN
ajlm-1645	26	2	is	be	AUX
ajlm-1645	26	3	not	not	PART
ajlm-1645	26	4	a	a	DET
ajlm-1645	26	5	disease	disease	NOUN
ajlm-1645	26	6	entity	entity	NOUN
ajlm-1645	26	7	,	,	PUNCT
ajlm-1645	26	8	but	but	CCONJ
ajlm-1645	26	9	rather	rather	ADV
ajlm-1645	26	10	the	the	DET
ajlm-1645	26	11	manifestation	manifestation	NOUN
ajlm-1645	26	12	of	of	ADP
ajlm-1645	26	13	several	several	ADJ
ajlm-1645	26	14	diseases	disease	NOUN
ajlm-1645	26	15	and	and	CCONJ
ajlm-1645	26	16	signifies	signify	VERB
ajlm-1645	26	17	the	the	DET
ajlm-1645	26	18	need	need	NOUN
ajlm-1645	26	19	for	for	ADP
ajlm-1645	26	20	investigation	investigation	NOUN
ajlm-1645	26	21	.	.	PUNCT
ajlm-1645	27	1	chemotherapy	chemotherapy	NOUN
ajlm-1645	27	2	and	and	CCONJ
ajlm-1645	27	3	radiation	radiation	NOUN
ajlm-1645	27	4	therapy	therapy	NOUN
ajlm-1645	27	5	are	be	AUX
ajlm-1645	27	6	predictable	predictable	ADJ
ajlm-1645	27	7	causes	cause	NOUN
ajlm-1645	27	8	of	of	ADP
ajlm-1645	27	9	pancytopenia.1	pancytopenia.1	NOUN
ajlm-1645	27	10	the	the	DET
ajlm-1645	27	11	occurrence	occurrence	NOUN
ajlm-1645	27	12	of	of	ADP
ajlm-1645	27	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	27	14	in	in	ADP
ajlm-1645	27	15	the	the	DET
ajlm-1645	27	16	absence	absence	NOUN
ajlm-1645	27	17	of	of	ADP
ajlm-1645	27	18	chemotherapy	chemotherapy	NOUN
ajlm-1645	27	19	or	or	CCONJ
ajlm-1645	27	20	radiation	radiation	NOUN
ajlm-1645	27	21	therapy	therapy	NOUN
ajlm-1645	27	22	is	be	AUX
ajlm-1645	27	23	a	a	DET
ajlm-1645	27	24	common	common	ADJ
ajlm-1645	27	25	diagnostic	diagnostic	ADJ
ajlm-1645	27	26	dilemma	dilemma	NOUN
ajlm-1645	27	27	and	and	CCONJ
ajlm-1645	27	28	a	a	DET
ajlm-1645	27	29	bone	bone	NOUN
ajlm-1645	27	30	marrow	marrow	NOUN
ajlm-1645	27	31	examination	examination	NOUN
ajlm-1645	27	32	(	(	PUNCT
ajlm-1645	27	33	bme	bme	NOUN
ajlm-1645	27	34	)	)	PUNCT
ajlm-1645	27	35	is	be	AUX
ajlm-1645	27	36	recommended	recommend	VERB
ajlm-1645	27	37	if	if	SCONJ
ajlm-1645	27	38	the	the	DET
ajlm-1645	27	39	cause	cause	NOUN
ajlm-1645	27	40	of	of	ADP
ajlm-1645	27	41	pancytopenia	pancytopenia	NOUN
ajlm-1645	27	42	can	can	AUX
ajlm-1645	27	43	not	not	PART
ajlm-1645	27	44	be	be	AUX
ajlm-1645	27	45	otherwise	otherwise	ADV
ajlm-1645	27	46	ascertained	ascertain	VERB
ajlm-1645	27	47	.	.	PUNCT
ajlm-1645	28	1	pancytopenia	pancytopenia	PROPN
ajlm-1645	28	2	can	can	AUX
ajlm-1645	28	3	also	also	ADV
ajlm-1645	28	4	be	be	AUX
ajlm-1645	28	5	caused	cause	VERB
ajlm-1645	28	6	by	by	ADP
ajlm-1645	28	7	central	central	ADJ
ajlm-1645	28	8	inadequate	inadequate	ADJ
ajlm-1645	28	9	production	production	NOUN
ajlm-1645	28	10	or	or	CCONJ
ajlm-1645	28	11	peripheral	peripheral	ADJ
ajlm-1645	28	12	destruction	destruction	NOUN
ajlm-1645	28	13	/	/	SYM
ajlm-1645	28	14	sequestration,1	sequestration,1	NOUN
ajlm-1645	28	15	and	and	CCONJ
ajlm-1645	28	16	the	the	DET
ajlm-1645	28	17	incidence	incidence	NOUN
ajlm-1645	28	18	of	of	ADP
ajlm-1645	28	19	the	the	DET
ajlm-1645	28	20	various	various	ADJ
ajlm-1645	28	21	causes	cause	NOUN
ajlm-1645	28	22	of	of	ADP
ajlm-1645	28	23	pancytopenia	pancytopenia	NOUN
ajlm-1645	28	24	differs	differ	NOUN
ajlm-1645	28	25	based	base	VERB
ajlm-1645	28	26	on	on	ADP
ajlm-1645	28	27	geographic	geographic	ADJ
ajlm-1645	28	28	,	,	PUNCT
ajlm-1645	28	29	socio	socio	NOUN
ajlm-1645	28	30	-	-	PUNCT
ajlm-1645	28	31	economic	economic	ADJ
ajlm-1645	28	32	,	,	PUNCT
ajlm-1645	28	33	dietary	dietary	ADJ
ajlm-1645	28	34	and	and	CCONJ
ajlm-1645	28	35	other	other	ADJ
ajlm-1645	28	36	factors	factor	NOUN
ajlm-1645	28	37	.	.	PUNCT
ajlm-1645	29	1	in	in	ADP
ajlm-1645	29	2	india	india	PROPN
ajlm-1645	29	3	,	,	PUNCT
ajlm-1645	29	4	numerous	numerous	ADJ
ajlm-1645	29	5	studies	study	NOUN
ajlm-1645	29	6	have	have	AUX
ajlm-1645	29	7	highlighted	highlight	VERB
ajlm-1645	29	8	megaloblastic	megaloblastic	ADJ
ajlm-1645	29	9	anaemia	anaemia	NOUN
ajlm-1645	29	10	and	and	CCONJ
ajlm-1645	29	11	aplastic	aplastic	ADJ
ajlm-1645	29	12	anaemia	anaemia	NOUN
ajlm-1645	29	13	as	as	ADP
ajlm-1645	29	14	the	the	DET
ajlm-1645	29	15	commonly	commonly	ADV
ajlm-1645	29	16	encountered	encounter	VERB
ajlm-1645	29	17	causes	cause	NOUN
ajlm-1645	29	18	of	of	ADP
ajlm-1645	29	19	pancytopenia.2,3,4,5,6,7,8,9,10,11,12,13,14,15	pancytopenia.2,3,4,5,6,7,8,9,10,11,12,13,14,15	ADJ
ajlm-1645	29	20	studies	study	NOUN
ajlm-1645	29	21	from	from	ADP
ajlm-1645	29	22	neighbouring	neighbouring	ADJ
ajlm-1645	29	23	countries	country	NOUN
ajlm-1645	29	24	,	,	PUNCT
ajlm-1645	29	25	including	include	VERB
ajlm-1645	29	26	pakistan,16,17,18,19,20	pakistan,16,17,18,19,20	NUM
ajlm-1645	29	27	bangladesh21,22	bangladesh21,22	NOUN
ajlm-1645	29	28	and	and	CCONJ
ajlm-1645	29	29	nepal,23,24,25	nepal,23,24,25	PROPN
ajlm-1645	29	30	show	show	VERB
ajlm-1645	29	31	similar	similar	ADJ
ajlm-1645	29	32	findings	finding	NOUN
ajlm-1645	29	33	.	.	PUNCT
ajlm-1645	30	1	climate	climate	NOUN
ajlm-1645	30	2	also	also	ADV
ajlm-1645	30	3	affects	affect	VERB
ajlm-1645	30	4	the	the	DET
ajlm-1645	30	5	aetiology	aetiology	NOUN
ajlm-1645	30	6	of	of	ADP
ajlm-1645	30	7	pancytopenia	pancytopenia	NOUN
ajlm-1645	30	8	by	by	ADP
ajlm-1645	30	9	affecting	affect	VERB
ajlm-1645	30	10	disease	disease	NOUN
ajlm-1645	30	11	transmission.26	transmission.26	NOUN
ajlm-1645	30	12	as	as	ADP
ajlm-1645	30	13	such	such	ADJ
ajlm-1645	30	14	,	,	PUNCT
ajlm-1645	30	15	malaria	malaria	NOUN
ajlm-1645	30	16	,	,	PUNCT
ajlm-1645	30	17	which	which	PRON
ajlm-1645	30	18	is	be	AUX
ajlm-1645	30	19	endemic	endemic	ADJ
ajlm-1645	30	20	in	in	ADP
ajlm-1645	30	21	bangladesh	bangladesh	NOUN
ajlm-1645	30	22	,	,	PUNCT
ajlm-1645	30	23	was	be	AUX
ajlm-1645	30	24	found	find	VERB
ajlm-1645	30	25	to	to	PART
ajlm-1645	30	26	be	be	AUX
ajlm-1645	30	27	the	the	DET
ajlm-1645	30	28	most	most	ADV
ajlm-1645	30	29	common	common	ADJ
ajlm-1645	30	30	cause	cause	NOUN
ajlm-1645	30	31	of	of	ADP
ajlm-1645	30	32	pancytopenia	pancytopenia	NOUN
ajlm-1645	30	33	in	in	ADP
ajlm-1645	30	34	a	a	DET
ajlm-1645	30	35	bangladeshi	bangladeshi	ADJ
ajlm-1645	30	36	study.22	study.22	NOUN
ajlm-1645	30	37	in	in	ADP
ajlm-1645	30	38	high	high	ADJ
ajlm-1645	30	39	-	-	PUNCT
ajlm-1645	30	40	income	income	NOUN
ajlm-1645	30	41	countries	country	NOUN
ajlm-1645	30	42	,	,	PUNCT
ajlm-1645	30	43	however	however	ADV
ajlm-1645	30	44	,	,	PUNCT
ajlm-1645	30	45	the	the	DET
ajlm-1645	30	46	disease	disease	NOUN
ajlm-1645	30	47	profile	profile	NOUN
ajlm-1645	30	48	is	be	AUX
ajlm-1645	30	49	quite	quite	ADV
ajlm-1645	30	50	different	different	ADJ
ajlm-1645	30	51	.	.	PUNCT
ajlm-1645	31	1	studies	study	NOUN
ajlm-1645	31	2	done	do	VERB
ajlm-1645	31	3	in	in	ADP
ajlm-1645	31	4	france	france	PROPN
ajlm-1645	31	5	,	,	PUNCT
ajlm-1645	31	6	sweden	sweden	PROPN
ajlm-1645	31	7	,	,	PUNCT
ajlm-1645	31	8	south	south	PROPN
ajlm-1645	31	9	korea	korea	PROPN
ajlm-1645	31	10	,	,	PUNCT
ajlm-1645	31	11	oman	oman	PROPN
ajlm-1645	31	12	and	and	CCONJ
ajlm-1645	31	13	the	the	DET
ajlm-1645	31	14	united	united	PROPN
ajlm-1645	31	15	states	states	PROPN
ajlm-1645	31	16	demonstrate	demonstrate	VERB
ajlm-1645	31	17	that	that	SCONJ
ajlm-1645	31	18	haematological	haematological	ADJ
ajlm-1645	31	19	malignancies	malignancy	NOUN
ajlm-1645	31	20	(	(	PUNCT
ajlm-1645	31	21	hms	hms	PROPN
ajlm-1645	31	22	)	)	PUNCT
ajlm-1645	31	23	are	be	AUX
ajlm-1645	31	24	the	the	DET
ajlm-1645	31	25	most	most	ADV
ajlm-1645	31	26	common	common	ADJ
ajlm-1645	31	27	cause	cause	NOUN
ajlm-1645	31	28	of	of	ADP
ajlm-1645	31	29	pancytopenia.27,28,29,30,31,32	pancytopenia.27,28,29,30,31,32	PROPN
ajlm-1645	31	30	a	a	DET
ajlm-1645	31	31	study	study	NOUN
ajlm-1645	31	32	in	in	ADP
ajlm-1645	31	33	mexico	mexico	PROPN
ajlm-1645	31	34	revealed	reveal	VERB
ajlm-1645	31	35	a	a	DET
ajlm-1645	31	36	mix	mix	NOUN
ajlm-1645	31	37	of	of	ADP
ajlm-1645	31	38	hm	hm	INTJ
ajlm-1645	31	39	and	and	CCONJ
ajlm-1645	31	40	megaloblastic	megaloblastic	ADJ
ajlm-1645	31	41	anaemia	anaemia	NOUN
ajlm-1645	31	42	as	as	ADP
ajlm-1645	31	43	the	the	DET
ajlm-1645	31	44	most	most	ADV
ajlm-1645	31	45	common	common	ADJ
ajlm-1645	31	46	causes,33	causes,33	NOUN
ajlm-1645	31	47	demonstrating	demonstrate	VERB
ajlm-1645	31	48	the	the	DET
ajlm-1645	31	49	role	role	NOUN
ajlm-1645	31	50	that	that	PRON
ajlm-1645	31	51	socio	socio	NOUN
ajlm-1645	31	52	-	-	PUNCT
ajlm-1645	31	53	economic	economic	ADJ
ajlm-1645	31	54	status	status	NOUN
ajlm-1645	31	55	and	and	CCONJ
ajlm-1645	31	56	access	access	NOUN
ajlm-1645	31	57	to	to	ADP
ajlm-1645	31	58	healthcare	healthcare	NOUN
ajlm-1645	31	59	has	have	VERB
ajlm-1645	31	60	on	on	ADP
ajlm-1645	31	61	the	the	DET
ajlm-1645	31	62	aetiology	aetiology	NOUN
ajlm-1645	31	63	of	of	ADP
ajlm-1645	31	64	pancytopenia	pancytopenia	NOUN
ajlm-1645	31	65	.	.	PUNCT
ajlm-1645	32	1	in	in	ADP
ajlm-1645	32	2	africa	africa	PROPN
ajlm-1645	32	3	,	,	PUNCT
ajlm-1645	32	4	the	the	DET
ajlm-1645	32	5	causes	cause	NOUN
ajlm-1645	32	6	of	of	ADP
ajlm-1645	32	7	pancytopenia	pancytopenia	NOUN
ajlm-1645	32	8	follow	follow	VERB
ajlm-1645	32	9	the	the	DET
ajlm-1645	32	10	pattern	pattern	NOUN
ajlm-1645	32	11	of	of	ADP
ajlm-1645	32	12	poor	poor	ADJ
ajlm-1645	32	13	nutrition	nutrition	NOUN
ajlm-1645	32	14	and	and	CCONJ
ajlm-1645	32	15	poor	poor	ADJ
ajlm-1645	32	16	access	access	NOUN
ajlm-1645	32	17	to	to	ADP
ajlm-1645	32	18	healthcare	healthcare	PROPN
ajlm-1645	32	19	.	.	PUNCT
ajlm-1645	33	1	studies	study	NOUN
ajlm-1645	33	2	performed	perform	VERB
ajlm-1645	33	3	in	in	ADP
ajlm-1645	33	4	zimbabwe	zimbabwe	PROPN
ajlm-1645	33	5	,	,	PUNCT
ajlm-1645	33	6	djibouti	djibouti	PROPN
ajlm-1645	33	7	,	,	PUNCT
ajlm-1645	33	8	morocco	morocco	PROPN
ajlm-1645	33	9	and	and	CCONJ
ajlm-1645	33	10	tunisia	tunisia	PROPN
ajlm-1645	33	11	showed	show	VERB
ajlm-1645	33	12	that	that	SCONJ
ajlm-1645	33	13	megaloblastic	megaloblastic	ADJ
ajlm-1645	33	14	anaemia	anaemia	NOUN
ajlm-1645	33	15	was	be	AUX
ajlm-1645	33	16	the	the	DET
ajlm-1645	33	17	most	most	ADV
ajlm-1645	33	18	common	common	ADJ
ajlm-1645	33	19	cause	cause	NOUN
ajlm-1645	33	20	of	of	ADP
ajlm-1645	33	21	pancytopenia.34,35,36,37	pancytopenia.34,35,36,37	PROPN
ajlm-1645	33	22	furthermore	furthermore	ADV
ajlm-1645	33	23	,	,	PUNCT
ajlm-1645	33	24	hiv	hiv	PROPN
ajlm-1645	33	25	was	be	AUX
ajlm-1645	33	26	found	find	VERB
ajlm-1645	33	27	to	to	PART
ajlm-1645	33	28	be	be	AUX
ajlm-1645	33	29	the	the	DET
ajlm-1645	33	30	third	third	ADJ
ajlm-1645	33	31	most	most	ADV
ajlm-1645	33	32	common	common	ADJ
ajlm-1645	33	33	cause	cause	NOUN
ajlm-1645	33	34	of	of	ADP
ajlm-1645	33	35	pancytopenia	pancytopenia	NOUN
ajlm-1645	33	36	in	in	ADP
ajlm-1645	33	37	both	both	CCONJ
ajlm-1645	33	38	the	the	DET
ajlm-1645	33	39	zimbabwean	zimbabwean	ADJ
ajlm-1645	33	40	and	and	CCONJ
ajlm-1645	33	41	djiboutian	djiboutian	ADJ
ajlm-1645	33	42	studies.34,35	studies.34,35	NOUN
ajlm-1645	33	43	to	to	ADP
ajlm-1645	33	44	our	our	PRON
ajlm-1645	33	45	knowledge	knowledge	NOUN
ajlm-1645	33	46	,	,	PUNCT
ajlm-1645	33	47	a	a	DET
ajlm-1645	33	48	study	study	NOUN
ajlm-1645	33	49	by	by	ADP
ajlm-1645	33	50	retief	retief	NOUN
ajlm-1645	33	51	and	and	CCONJ
ajlm-1645	33	52	heyns	heyn	NOUN
ajlm-1645	33	53	performed	perform	VERB
ajlm-1645	33	54	in	in	ADP
ajlm-1645	33	55	bloemfontein	bloemfontein	NOUN
ajlm-1645	33	56	in	in	ADP
ajlm-1645	33	57	1976	1976	NUM
ajlm-1645	33	58	is	be	AUX
ajlm-1645	33	59	the	the	DET
ajlm-1645	33	60	only	only	ADJ
ajlm-1645	33	61	previous	previous	ADJ
ajlm-1645	33	62	study	study	NOUN
ajlm-1645	33	63	investigating	investigate	VERB
ajlm-1645	33	64	the	the	DET
ajlm-1645	33	65	aetiology	aetiology	NOUN
ajlm-1645	33	66	of	of	ADP
ajlm-1645	33	67	pancytopenia	pancytopenia	NOUN
ajlm-1645	33	68	in	in	ADP
ajlm-1645	33	69	south	south	ADJ
ajlm-1645	33	70	africa.38	africa.38	NOUN
ajlm-1645	33	71	the	the	DET
ajlm-1645	33	72	most	most	ADV
ajlm-1645	33	73	common	common	ADJ
ajlm-1645	33	74	cause	cause	NOUN
ajlm-1645	33	75	of	of	ADP
ajlm-1645	33	76	pancytopenia	pancytopenia	NOUN
ajlm-1645	33	77	as	as	SCONJ
ajlm-1645	33	78	identified	identify	VERB
ajlm-1645	33	79	in	in	ADP
ajlm-1645	33	80	that	that	DET
ajlm-1645	33	81	study	study	NOUN
ajlm-1645	33	82	was	be	AUX
ajlm-1645	33	83	bone	bone	NOUN
ajlm-1645	33	84	marrow	marrow	PROPN
ajlm-1645	33	85	aplasia	aplasia	NOUN
ajlm-1645	33	86	(	(	PUNCT
ajlm-1645	33	87	49.0	49.0	NUM
ajlm-1645	33	88	%	%	NOUN
ajlm-1645	33	89	)	)	PUNCT
ajlm-1645	33	90	,	,	PUNCT
ajlm-1645	33	91	and	and	CCONJ
ajlm-1645	33	92	over	over	SCONJ
ajlm-1645	33	93	two	two	NUM
ajlm-1645	33	94	-	-	PUNCT
ajlm-1645	33	95	thirds	third	NOUN
ajlm-1645	33	96	of	of	ADP
ajlm-1645	33	97	those	those	DET
ajlm-1645	33	98	cases	case	NOUN
ajlm-1645	33	99	were	be	AUX
ajlm-1645	33	100	attributed	attribute	VERB
ajlm-1645	33	101	to	to	ADP
ajlm-1645	33	102	radiation	radiation	NOUN
ajlm-1645	33	103	or	or	CCONJ
ajlm-1645	33	104	chemotherapy	chemotherapy	NOUN
ajlm-1645	33	105	.	.	PUNCT
ajlm-1645	34	1	infectious	infectious	ADJ
ajlm-1645	34	2	agents	agent	NOUN
ajlm-1645	34	3	(	(	PUNCT
ajlm-1645	34	4	9.7	9.7	NUM
ajlm-1645	34	5	%	%	NOUN
ajlm-1645	34	6	)	)	PUNCT
ajlm-1645	34	7	were	be	AUX
ajlm-1645	34	8	the	the	DET
ajlm-1645	34	9	second	second	ADJ
ajlm-1645	34	10	most	most	ADV
ajlm-1645	34	11	common	common	ADJ
ajlm-1645	34	12	cause	cause	NOUN
ajlm-1645	34	13	,	,	PUNCT
ajlm-1645	34	14	followed	follow	VERB
ajlm-1645	34	15	by	by	ADP
ajlm-1645	34	16	megaloblastic	megaloblastic	ADJ
ajlm-1645	34	17	anaemia	anaemia	NOUN
ajlm-1645	34	18	(	(	PUNCT
ajlm-1645	34	19	9.6	9.6	NUM
ajlm-1645	34	20	%	%	NOUN
ajlm-1645	34	21	)	)	PUNCT
ajlm-1645	34	22	.	.	PUNCT
ajlm-1645	35	1	the	the	DET
ajlm-1645	35	2	hiv	hiv	PROPN
ajlm-1645	35	3	pandemic	pandemic	PROPN
ajlm-1645	35	4	started	start	VERB
ajlm-1645	35	5	in	in	ADP
ajlm-1645	35	6	1981	1981	NUM
ajlm-1645	35	7	,	,	PUNCT
ajlm-1645	35	8	thus	thus	ADV
ajlm-1645	35	9	the	the	DET
ajlm-1645	35	10	effect	effect	NOUN
ajlm-1645	35	11	of	of	ADP
ajlm-1645	35	12	hiv	hiv	PROPN
ajlm-1645	35	13	on	on	ADP
ajlm-1645	35	14	pancytopenia	pancytopenia	NOUN
ajlm-1645	35	15	was	be	AUX
ajlm-1645	35	16	not	not	PART
ajlm-1645	35	17	seen	see	VERB
ajlm-1645	35	18	in	in	ADP
ajlm-1645	35	19	the	the	DET
ajlm-1645	35	20	retief	retief	NOUN
ajlm-1645	35	21	and	and	CCONJ
ajlm-1645	35	22	heyns	heyn	VERB
ajlm-1645	35	23	study.39	study.39	NOUN
ajlm-1645	35	24	there	there	PRON
ajlm-1645	35	25	is	be	VERB
ajlm-1645	35	26	currently	currently	ADV
ajlm-1645	35	27	a	a	DET
ajlm-1645	35	28	high	high	ADJ
ajlm-1645	35	29	burden	burden	NOUN
ajlm-1645	35	30	of	of	ADP
ajlm-1645	35	31	hiv	hiv	PROPN
ajlm-1645	35	32	infection	infection	NOUN
ajlm-1645	35	33	in	in	ADP
ajlm-1645	35	34	south	south	PROPN
ajlm-1645	35	35	africa	africa	PROPN
ajlm-1645	35	36	,	,	PUNCT
ajlm-1645	35	37	and	and	CCONJ
ajlm-1645	35	38	by	by	ADP
ajlm-1645	35	39	the	the	DET
ajlm-1645	35	40	middle	middle	NOUN
ajlm-1645	35	41	of	of	ADP
ajlm-1645	35	42	2019	2019	NUM
ajlm-1645	35	43	,	,	PUNCT
ajlm-1645	35	44	13.5	13.5	NUM
ajlm-1645	35	45	%	%	NOUN
ajlm-1645	35	46	of	of	ADP
ajlm-1645	35	47	south	south	PROPN
ajlm-1645	35	48	africans	africans	PROPN
ajlm-1645	35	49	,	,	PUNCT
ajlm-1645	35	50	that	that	PRON
ajlm-1645	35	51	is	is	ADV
ajlm-1645	35	52	7.97	7.97	NUM
ajlm-1645	35	53	million	million	NUM
ajlm-1645	35	54	people	people	NOUN
ajlm-1645	35	55	,	,	PUNCT
ajlm-1645	35	56	were	be	AUX
ajlm-1645	35	57	living	live	VERB
ajlm-1645	35	58	with	with	ADP
ajlm-1645	35	59	hiv.40	hiv.40	PROPN
ajlm-1645	35	60	cytopenias	cytopenia	NOUN
ajlm-1645	35	61	are	be	AUX
ajlm-1645	35	62	commonly	commonly	ADV
ajlm-1645	35	63	observed	observe	VERB
ajlm-1645	35	64	in	in	ADP
ajlm-1645	35	65	patients	patient	NOUN
ajlm-1645	35	66	with	with	ADP
ajlm-1645	35	67	hiv	hiv	PROPN
ajlm-1645	35	68	infection	infection	NOUN
ajlm-1645	35	69	and	and	CCONJ
ajlm-1645	35	70	are	be	AUX
ajlm-1645	35	71	often	often	ADV
ajlm-1645	35	72	multifactorial	multifactorial	ADJ
ajlm-1645	35	73	in	in	ADP
ajlm-1645	35	74	aetiology.41	aetiology.41	PROPN
ajlm-1645	35	75	while	while	SCONJ
ajlm-1645	35	76	cytopenias	cytopenia	NOUN
ajlm-1645	35	77	in	in	ADP
ajlm-1645	35	78	hiv	hiv	PROPN
ajlm-1645	35	79	are	be	AUX
ajlm-1645	35	80	common	common	ADJ
ajlm-1645	35	81	,	,	PUNCT
ajlm-1645	35	82	the	the	DET
ajlm-1645	35	83	prevalence	prevalence	NOUN
ajlm-1645	35	84	of	of	ADP
ajlm-1645	35	85	pancytopenia	pancytopenia	NOUN
ajlm-1645	35	86	in	in	ADP
ajlm-1645	35	87	hiv	hiv	PROPN
ajlm-1645	35	88	clinics	clinic	NOUN
ajlm-1645	35	89	in	in	ADP
ajlm-1645	35	90	african	african	ADJ
ajlm-1645	35	91	countries	country	NOUN
ajlm-1645	35	92	is	be	AUX
ajlm-1645	35	93	low	low	ADJ
ajlm-1645	35	94	:	:	PUNCT
ajlm-1645	35	95	0.7	0.7	NUM
ajlm-1645	35	96	%	%	NOUN
ajlm-1645	35	97	in	in	ADP
ajlm-1645	35	98	an	an	DET
ajlm-1645	35	99	ethiopian	ethiopian	ADJ
ajlm-1645	35	100	study	study	NOUN
ajlm-1645	35	101	and	and	CCONJ
ajlm-1645	35	102	0.5	0.5	NUM
ajlm-1645	35	103	%	%	NOUN
ajlm-1645	35	104	in	in	ADP
ajlm-1645	35	105	a	a	DET
ajlm-1645	35	106	ugandan	ugandan	PROPN
ajlm-1645	35	107	study.42,43	study.42,43	NOUN
ajlm-1645	35	108	the	the	DET
ajlm-1645	35	109	pancytopenia	pancytopenia	NOUN
ajlm-1645	35	110	prevalence	prevalence	NOUN
ajlm-1645	35	111	is	be	AUX
ajlm-1645	35	112	much	much	ADV
ajlm-1645	35	113	higher	high	ADJ
ajlm-1645	35	114	(	(	PUNCT
ajlm-1645	35	115	8.7	8.7	NUM
ajlm-1645	35	116	%	%	NOUN
ajlm-1645	35	117	)	)	PUNCT
ajlm-1645	35	118	in	in	ADP
ajlm-1645	35	119	hiv	hiv	PROPN
ajlm-1645	35	120	clinics	clinic	NOUN
ajlm-1645	35	121	in	in	ADP
ajlm-1645	35	122	puerto	puerto	PROPN
ajlm-1645	35	123	rico.44	rico.44	VERB
ajlm-1645	35	124	this	this	DET
ajlm-1645	35	125	study	study	NOUN
ajlm-1645	35	126	aimed	aim	VERB
ajlm-1645	35	127	to	to	PART
ajlm-1645	35	128	contribute	contribute	VERB
ajlm-1645	35	129	to	to	ADP
ajlm-1645	35	130	the	the	DET
ajlm-1645	35	131	body	body	NOUN
ajlm-1645	35	132	of	of	ADP
ajlm-1645	35	133	knowledge	knowledge	NOUN
ajlm-1645	35	134	regarding	regard	VERB
ajlm-1645	35	135	the	the	DET
ajlm-1645	35	136	aetiology	aetiology	NOUN
ajlm-1645	35	137	of	of	ADP
ajlm-1645	35	138	pancytopenia	pancytopenia	NOUN
ajlm-1645	35	139	in	in	ADP
ajlm-1645	35	140	a	a	DET
ajlm-1645	35	141	developing	develop	VERB
ajlm-1645	35	142	country	country	NOUN
ajlm-1645	35	143	with	with	ADP
ajlm-1645	35	144	a	a	DET
ajlm-1645	35	145	high	high	ADJ
ajlm-1645	35	146	burden	burden	NOUN
ajlm-1645	35	147	of	of	ADP
ajlm-1645	35	148	hiv	hiv	PROPN
ajlm-1645	35	149	and	and	CCONJ
ajlm-1645	35	150	to	to	PART
ajlm-1645	35	151	assess	assess	VERB
ajlm-1645	35	152	the	the	DET
ajlm-1645	35	153	most	most	ADV
ajlm-1645	35	154	common	common	ADJ
ajlm-1645	35	155	causes	cause	NOUN
ajlm-1645	35	156	of	of	ADP
ajlm-1645	35	157	pancytopenia	pancytopenia	NOUN
ajlm-1645	35	158	across	across	ADP
ajlm-1645	35	159	different	different	ADJ
ajlm-1645	35	160	age	age	NOUN
ajlm-1645	35	161	groups	group	NOUN
ajlm-1645	35	162	.	.	PUNCT
ajlm-1645	36	1	methods	method	NOUN
ajlm-1645	36	2	ethical	ethical	ADJ
ajlm-1645	36	3	considerations	consideration	NOUN
ajlm-1645	36	4	this	this	DET
ajlm-1645	36	5	study	study	NOUN
ajlm-1645	36	6	was	be	AUX
ajlm-1645	36	7	approved	approve	VERB
ajlm-1645	36	8	by	by	ADP
ajlm-1645	36	9	the	the	DET
ajlm-1645	36	10	human	human	PROPN
ajlm-1645	36	11	research	research	PROPN
ajlm-1645	36	12	ethics	ethic	NOUN
ajlm-1645	36	13	committee	committee	PROPN
ajlm-1645	36	14	review	review	PROPN
ajlm-1645	36	15	board	board	PROPN
ajlm-1645	36	16	of	of	ADP
ajlm-1645	36	17	stellenbosch	stellenbosch	PROPN
ajlm-1645	36	18	university	university	PROPN
ajlm-1645	36	19	(	(	PUNCT
ajlm-1645	36	20	study	study	VERB
ajlm-1645	36	21	approval	approval	NOUN
ajlm-1645	36	22	number	number	NOUN
ajlm-1645	36	23	:	:	PUNCT
ajlm-1645	36	24	s18/08/171	s18/08/171	NUM
ajlm-1645	36	25	)	)	PUNCT
ajlm-1645	36	26	and	and	CCONJ
ajlm-1645	36	27	all	all	DET
ajlm-1645	36	28	research	research	NOUN
ajlm-1645	36	29	was	be	AUX
ajlm-1645	36	30	performed	perform	VERB
ajlm-1645	36	31	in	in	ADP
ajlm-1645	36	32	accordance	accordance	NOUN
ajlm-1645	36	33	with	with	ADP
ajlm-1645	36	34	relevant	relevant	ADJ
ajlm-1645	36	35	regulations	regulation	NOUN
ajlm-1645	36	36	with	with	ADP
ajlm-1645	36	37	anonymised	anonymised	ADJ
ajlm-1645	36	38	data	datum	NOUN
ajlm-1645	36	39	.	.	PUNCT
ajlm-1645	37	1	the	the	DET
ajlm-1645	37	2	requirement	requirement	NOUN
ajlm-1645	37	3	for	for	ADP
ajlm-1645	37	4	informed	informed	ADJ
ajlm-1645	37	5	consent	consent	NOUN
ajlm-1645	37	6	was	be	AUX
ajlm-1645	37	7	waived	waive	VERB
ajlm-1645	37	8	by	by	ADP
ajlm-1645	37	9	the	the	DET
ajlm-1645	37	10	ethics	ethic	NOUN
ajlm-1645	37	11	committee	committee	NOUN
ajlm-1645	37	12	due	due	ADP
ajlm-1645	37	13	to	to	ADP
ajlm-1645	37	14	the	the	DET
ajlm-1645	37	15	retrospective	retrospective	ADJ
ajlm-1645	37	16	nature	nature	NOUN
ajlm-1645	37	17	of	of	ADP
ajlm-1645	37	18	the	the	DET
ajlm-1645	37	19	study	study	NOUN
ajlm-1645	37	20	.	.	PUNCT
ajlm-1645	38	1	setting	setting	NOUN
ajlm-1645	38	2	,	,	PUNCT
ajlm-1645	38	3	specimens	specimen	NOUN
ajlm-1645	38	4	and	and	CCONJ
ajlm-1645	38	5	defining	define	VERB
ajlm-1645	38	6	criteria	criterion	NOUN
ajlm-1645	38	7	a	a	DET
ajlm-1645	38	8	retrospective	retrospective	ADJ
ajlm-1645	38	9	cross	cross	ADJ
ajlm-1645	38	10	-	-	ADJ
ajlm-1645	38	11	sectional	sectional	ADJ
ajlm-1645	38	12	descriptive	descriptive	ADJ
ajlm-1645	38	13	study	study	NOUN
ajlm-1645	38	14	was	be	AUX
ajlm-1645	38	15	conducted	conduct	VERB
ajlm-1645	38	16	over	over	ADP
ajlm-1645	38	17	a	a	DET
ajlm-1645	38	18	two	two	NUM
ajlm-1645	38	19	-	-	PUNCT
ajlm-1645	38	20	year	year	NOUN
ajlm-1645	38	21	period	period	NOUN
ajlm-1645	38	22	.	.	PUNCT
ajlm-1645	39	1	all	all	DET
ajlm-1645	39	2	adult	adult	NOUN
ajlm-1645	39	3	patients	patient	NOUN
ajlm-1645	39	4	with	with	ADP
ajlm-1645	39	5	new	new	ADJ
ajlm-1645	39	6	-	-	PUNCT
ajlm-1645	39	7	onset	onset	ADJ
ajlm-1645	39	8	pancytopenia	pancytopenia	NOUN
ajlm-1645	39	9	who	who	PRON
ajlm-1645	39	10	were	be	AUX
ajlm-1645	39	11	treated	treat	VERB
ajlm-1645	39	12	at	at	ADP
ajlm-1645	39	13	tygerberg	tygerberg	PROPN
ajlm-1645	39	14	academic	academic	ADJ
ajlm-1645	39	15	hospital	hospital	NOUN
ajlm-1645	39	16	,	,	PUNCT
ajlm-1645	39	17	cape	cape	NOUN
ajlm-1645	39	18	town	town	NOUN
ajlm-1645	39	19	,	,	PUNCT
ajlm-1645	39	20	south	south	PROPN
ajlm-1645	39	21	africa	africa	PROPN
ajlm-1645	39	22	,	,	PUNCT
ajlm-1645	39	23	from	from	ADP
ajlm-1645	39	24	01	01	NUM
ajlm-1645	39	25	january	january	PROPN
ajlm-1645	39	26	2016	2016	NUM
ajlm-1645	39	27	to	to	ADP
ajlm-1645	39	28	31	31	NUM
ajlm-1645	39	29	december	december	PROPN
ajlm-1645	39	30	2017	2017	NUM
ajlm-1645	39	31	were	be	AUX
ajlm-1645	39	32	identified	identify	VERB
ajlm-1645	39	33	and	and	CCONJ
ajlm-1645	39	34	included	include	VERB
ajlm-1645	39	35	in	in	ADP
ajlm-1645	39	36	our	our	PRON
ajlm-1645	39	37	study	study	NOUN
ajlm-1645	39	38	.	.	PUNCT
ajlm-1645	40	1	pancytopenia	pancytopenia	PROPN
ajlm-1645	40	2	was	be	AUX
ajlm-1645	40	3	defined	define	VERB
ajlm-1645	40	4	as	as	ADP
ajlm-1645	40	5	leucocyte	leucocyte	PROPN
ajlm-1645	40	6	count	count	NOUN
ajlm-1645	40	7	<	<	X
ajlm-1645	40	8	4	4	NUM
ajlm-1645	40	9	×	×	NOUN
ajlm-1645	40	10	109	109	NUM
ajlm-1645	40	11	/	/	SYM
ajlm-1645	40	12	l	l	NOUN
ajlm-1645	40	13	,	,	PUNCT
ajlm-1645	40	14	haemoglobin	haemoglobin	NOUN
ajlm-1645	40	15	<	<	X
ajlm-1645	40	16	10	10	NUM
ajlm-1645	40	17	g	g	NOUN
ajlm-1645	40	18	/	/	SYM
ajlm-1645	40	19	dl	dl	PROPN
ajlm-1645	40	20	,	,	PUNCT
ajlm-1645	40	21	and	and	CCONJ
ajlm-1645	40	22	a	a	DET
ajlm-1645	40	23	platelet	platelet	NOUN
ajlm-1645	40	24	count	count	NOUN
ajlm-1645	40	25	<	<	X
ajlm-1645	40	26	100	100	NUM
ajlm-1645	40	27	×	×	NOUN
ajlm-1645	40	28	109	109	NUM
ajlm-1645	40	29	/	/	SYM
ajlm-1645	40	30	l.	l.	NOUN
ajlm-1645	41	1	these	these	DET
ajlm-1645	41	2	parameters	parameter	NOUN
ajlm-1645	41	3	are	be	AUX
ajlm-1645	41	4	comparable	comparable	ADJ
ajlm-1645	41	5	with	with	ADP
ajlm-1645	41	6	other	other	ADJ
ajlm-1645	41	7	studies	study	NOUN
ajlm-1645	41	8	investigating	investigate	VERB
ajlm-1645	41	9	the	the	DET
ajlm-1645	41	10	aetiology	aetiology	NOUN
ajlm-1645	41	11	of	of	ADP
ajlm-1645	41	12	pancytopenia.6,7,14,15,16,21,45,46	pancytopenia.6,7,14,15,16,21,45,46	NOUN
ajlm-1645	41	13	patients	patient	NOUN
ajlm-1645	41	14	were	be	AUX
ajlm-1645	41	15	excluded	exclude	VERB
ajlm-1645	41	16	from	from	ADP
ajlm-1645	41	17	the	the	DET
ajlm-1645	41	18	study	study	NOUN
ajlm-1645	41	19	if	if	SCONJ
ajlm-1645	41	20	they	they	PRON
ajlm-1645	41	21	received	receive	VERB
ajlm-1645	41	22	clinical	clinical	ADJ
ajlm-1645	41	23	care	care	NOUN
ajlm-1645	41	24	at	at	ADP
ajlm-1645	41	25	another	another	DET
ajlm-1645	41	26	facility	facility	NOUN
ajlm-1645	41	27	even	even	ADV
ajlm-1645	41	28	though	though	SCONJ
ajlm-1645	41	29	the	the	DET
ajlm-1645	41	30	bme	bme	NOUN
ajlm-1645	41	31	was	be	AUX
ajlm-1645	41	32	reported	report	VERB
ajlm-1645	41	33	at	at	ADP
ajlm-1645	41	34	tygerberg	tygerberg	PROPN
ajlm-1645	41	35	academic	academic	ADJ
ajlm-1645	41	36	hospital	hospital	NOUN
ajlm-1645	41	37	.	.	PUNCT
ajlm-1645	42	1	data	datum	NOUN
ajlm-1645	42	2	collection	collection	NOUN
ajlm-1645	42	3	and	and	CCONJ
ajlm-1645	42	4	interpretation	interpretation	NOUN
ajlm-1645	42	5	the	the	DET
ajlm-1645	42	6	data	datum	NOUN
ajlm-1645	42	7	were	be	AUX
ajlm-1645	42	8	obtained	obtain	VERB
ajlm-1645	42	9	from	from	ADP
ajlm-1645	42	10	the	the	DET
ajlm-1645	42	11	laboratory	laboratory	NOUN
ajlm-1645	42	12	information	information	NOUN
ajlm-1645	42	13	system	system	NOUN
ajlm-1645	42	14	(	(	PUNCT
ajlm-1645	42	15	lis	li	NOUN
ajlm-1645	42	16	)	)	PUNCT
ajlm-1645	42	17	of	of	ADP
ajlm-1645	42	18	the	the	DET
ajlm-1645	42	19	national	national	PROPN
ajlm-1645	42	20	health	health	PROPN
ajlm-1645	42	21	laboratory	laboratory	PROPN
ajlm-1645	42	22	service	service	NOUN
ajlm-1645	42	23	.	.	PUNCT
ajlm-1645	43	1	an	an	DET
ajlm-1645	43	2	lis	lis	NOUN
ajlm-1645	43	3	search	search	NOUN
ajlm-1645	43	4	was	be	AUX
ajlm-1645	43	5	conducted	conduct	VERB
ajlm-1645	43	6	to	to	PART
ajlm-1645	43	7	identify	identify	VERB
ajlm-1645	43	8	cases	case	NOUN
ajlm-1645	43	9	meeting	meet	VERB
ajlm-1645	43	10	the	the	DET
ajlm-1645	43	11	study	study	NOUN
ajlm-1645	43	12	criteria	criterion	NOUN
ajlm-1645	43	13	for	for	ADP
ajlm-1645	43	14	pancytopenia	pancytopenia	NOUN
ajlm-1645	43	15	.	.	PUNCT
ajlm-1645	44	1	the	the	DET
ajlm-1645	44	2	identified	identify	VERB
ajlm-1645	44	3	pancytopenia	pancytopenia	NOUN
ajlm-1645	44	4	cases	case	NOUN
ajlm-1645	44	5	were	be	AUX
ajlm-1645	44	6	reviewed	review	VERB
ajlm-1645	44	7	on	on	ADP
ajlm-1645	44	8	the	the	DET
ajlm-1645	44	9	national	national	PROPN
ajlm-1645	44	10	health	health	PROPN
ajlm-1645	44	11	laboratory	laboratory	PROPN
ajlm-1645	44	12	service	service	NOUN
ajlm-1645	44	13	lis	li	NOUN
ajlm-1645	44	14	to	to	PART
ajlm-1645	44	15	identify	identify	VERB
ajlm-1645	44	16	the	the	DET
ajlm-1645	44	17	cause	cause	NOUN
ajlm-1645	44	18	of	of	ADP
ajlm-1645	44	19	the	the	DET
ajlm-1645	44	20	pancytopenia	pancytopenia	NOUN
ajlm-1645	44	21	.	.	PUNCT
ajlm-1645	45	1	information	information	NOUN
ajlm-1645	45	2	retrieved	retrieve	VERB
ajlm-1645	45	3	from	from	ADP
ajlm-1645	45	4	the	the	DET
ajlm-1645	45	5	lis	li	NOUN
ajlm-1645	45	6	included	include	VERB
ajlm-1645	45	7	the	the	DET
ajlm-1645	45	8	reports	report	NOUN
ajlm-1645	45	9	of	of	ADP
ajlm-1645	45	10	peripheral	peripheral	ADJ
ajlm-1645	45	11	blood	blood	NOUN
ajlm-1645	45	12	smears	smear	NOUN
ajlm-1645	45	13	,	,	PUNCT
ajlm-1645	45	14	bmes	bme	NOUN
ajlm-1645	45	15	,	,	PUNCT
ajlm-1645	45	16	vitamin	vitamin	NOUN
ajlm-1645	45	17	b12	b12	NOUN
ajlm-1645	45	18	and	and	CCONJ
ajlm-1645	45	19	serum	serum	NOUN
ajlm-1645	45	20	folate	folate	NOUN
ajlm-1645	45	21	levels	level	NOUN
ajlm-1645	45	22	,	,	PUNCT
ajlm-1645	45	23	iron	iron	NOUN
ajlm-1645	45	24	studies	study	NOUN
ajlm-1645	45	25	,	,	PUNCT
ajlm-1645	45	26	viral	viral	ADJ
ajlm-1645	45	27	studies	study	NOUN
ajlm-1645	45	28	,	,	PUNCT
ajlm-1645	45	29	mycobacterium	mycobacterium	NOUN
ajlm-1645	45	30	tuberculosis	tuberculosis	NOUN
ajlm-1645	45	31	culture	culture	NOUN
ajlm-1645	45	32	and	and	CCONJ
ajlm-1645	45	33	genexpert	genexpert	ADJ
ajlm-1645	45	34	®	®	NOUN
ajlm-1645	45	35	tests	test	NOUN
ajlm-1645	45	36	(	(	PUNCT
ajlm-1645	45	37	cepheid	cepheid	NOUN
ajlm-1645	45	38	,	,	PUNCT
ajlm-1645	45	39	sunnyvale	sunnyvale	PROPN
ajlm-1645	45	40	,	,	PUNCT
ajlm-1645	45	41	california	california	PROPN
ajlm-1645	45	42	,	,	PUNCT
ajlm-1645	45	43	united	united	PROPN
ajlm-1645	45	44	states	states	PROPN
ajlm-1645	45	45	)	)	PUNCT
ajlm-1645	45	46	,	,	PUNCT
ajlm-1645	45	47	malaria	malaria	NOUN
ajlm-1645	45	48	rapid	rapid	ADJ
ajlm-1645	45	49	tests	test	NOUN
ajlm-1645	45	50	(	(	PUNCT
ajlm-1645	45	51	binaxnow	binaxnow	NOUN
ajlm-1645	45	52	malaria	malaria	PROPN
ajlm-1645	45	53	,	,	PUNCT
ajlm-1645	45	54	abbott	abbott	PROPN
ajlm-1645	45	55	laboratories	laboratories	PROPN
ajlm-1645	45	56	,	,	PUNCT
ajlm-1645	45	57	chicago	chicago	PROPN
ajlm-1645	45	58	,	,	PUNCT
ajlm-1645	45	59	illinois	illinois	PROPN
ajlm-1645	45	60	,	,	PUNCT
ajlm-1645	45	61	united	united	PROPN
ajlm-1645	45	62	states	states	PROPN
ajlm-1645	45	63	)	)	PUNCT
ajlm-1645	45	64	and	and	CCONJ
ajlm-1645	45	65	thick	thick	ADJ
ajlm-1645	45	66	and	and	CCONJ
ajlm-1645	45	67	thin	thin	ADJ
ajlm-1645	45	68	smears	smear	NOUN
ajlm-1645	45	69	,	,	PUNCT
ajlm-1645	45	70	autoimmune	autoimmune	ADJ
ajlm-1645	45	71	screens	screen	NOUN
ajlm-1645	45	72	,	,	PUNCT
ajlm-1645	45	73	sepsis	sepsis	NOUN
ajlm-1645	45	74	markers	marker	NOUN
ajlm-1645	45	75	,	,	PUNCT
ajlm-1645	45	76	and	and	CCONJ
ajlm-1645	45	77	blood	blood	NOUN
ajlm-1645	45	78	cultures	culture	NOUN
ajlm-1645	45	79	.	.	PUNCT
ajlm-1645	46	1	in	in	ADP
ajlm-1645	46	2	addition	addition	NOUN
ajlm-1645	46	3	,	,	PUNCT
ajlm-1645	46	4	information	information	NOUN
ajlm-1645	46	5	on	on	ADP
ajlm-1645	46	6	patient	patient	ADJ
ajlm-1645	46	7	age	age	NOUN
ajlm-1645	46	8	,	,	PUNCT
ajlm-1645	46	9	gender	gender	NOUN
ajlm-1645	46	10	,	,	PUNCT
ajlm-1645	46	11	hiv	hiv	PROPN
ajlm-1645	46	12	status	status	NOUN
ajlm-1645	46	13	,	,	PUNCT
ajlm-1645	46	14	cd4	cd4	PROPN
ajlm-1645	46	15	count	count	NOUN
ajlm-1645	46	16	,	,	PUNCT
ajlm-1645	46	17	and	and	CCONJ
ajlm-1645	46	18	hiv	hiv	PROPN
ajlm-1645	46	19	viral	viral	ADJ
ajlm-1645	46	20	load	load	NOUN
ajlm-1645	46	21	was	be	AUX
ajlm-1645	46	22	obtained	obtain	VERB
ajlm-1645	46	23	.	.	PUNCT
ajlm-1645	47	1	advanced	advanced	PROPN
ajlm-1645	47	2	hiv	hiv	PROPN
ajlm-1645	47	3	was	be	AUX
ajlm-1645	47	4	defined	define	VERB
ajlm-1645	47	5	as	as	ADP
ajlm-1645	47	6	a	a	DET
ajlm-1645	47	7	cd4	cd4	PROPN
ajlm-1645	47	8	count	count	NOUN
ajlm-1645	47	9	<	<	X
ajlm-1645	47	10	200	200	NUM
ajlm-1645	47	11	cells/µl.47,48	cells/µl.47,48	NOUN
ajlm-1645	47	12	since	since	SCONJ
ajlm-1645	47	13	the	the	DET
ajlm-1645	47	14	aetiology	aetiology	NOUN
ajlm-1645	47	15	of	of	ADP
ajlm-1645	47	16	cytopenias	cytopenia	NOUN
ajlm-1645	47	17	in	in	ADP
ajlm-1645	47	18	hiv	hiv	PROPN
ajlm-1645	47	19	is	be	AUX
ajlm-1645	47	20	multifactorial	multifactorial	ADJ
ajlm-1645	47	21	,	,	PUNCT
ajlm-1645	47	22	evidence	evidence	NOUN
ajlm-1645	47	23	of	of	ADP
ajlm-1645	47	24	contributing	contribute	VERB
ajlm-1645	47	25	factors	factor	NOUN
ajlm-1645	47	26	such	such	ADJ
ajlm-1645	47	27	as	as	ADP
ajlm-1645	47	28	folate	folate	NOUN
ajlm-1645	47	29	deficiency	deficiency	NOUN
ajlm-1645	47	30	,	,	PUNCT
ajlm-1645	47	31	opportunistic	opportunistic	ADJ
ajlm-1645	47	32	infection	infection	NOUN
ajlm-1645	47	33	or	or	CCONJ
ajlm-1645	47	34	malignancy	malignancy	NOUN
ajlm-1645	47	35	were	be	AUX
ajlm-1645	47	36	sought	seek	VERB
ajlm-1645	47	37	in	in	ADP
ajlm-1645	47	38	hiv	hiv	PROPN
ajlm-1645	47	39	-	-	PUNCT
ajlm-1645	47	40	positive	positive	ADJ
ajlm-1645	47	41	patients	patient	NOUN
ajlm-1645	47	42	.	.	PUNCT
ajlm-1645	48	1	in	in	ADP
ajlm-1645	48	2	the	the	DET
ajlm-1645	48	3	absence	absence	NOUN
ajlm-1645	48	4	of	of	ADP
ajlm-1645	48	5	any	any	DET
ajlm-1645	48	6	other	other	ADJ
ajlm-1645	48	7	cause	cause	NOUN
ajlm-1645	48	8	of	of	ADP
ajlm-1645	48	9	cytopenias	cytopenia	NOUN
ajlm-1645	48	10	,	,	PUNCT
ajlm-1645	48	11	and	and	CCONJ
ajlm-1645	48	12	if	if	SCONJ
ajlm-1645	48	13	the	the	DET
ajlm-1645	48	14	cd4	cd4	PROPN
ajlm-1645	48	15	count	count	NOUN
ajlm-1645	48	16	was	be	AUX
ajlm-1645	48	17	<	<	X
ajlm-1645	48	18	200	200	NUM
ajlm-1645	48	19	cells/µl	cells/µl	NOUN
ajlm-1645	48	20	,	,	PUNCT
ajlm-1645	48	21	the	the	DET
ajlm-1645	48	22	pancytopenia	pancytopenia	NOUN
ajlm-1645	48	23	was	be	AUX
ajlm-1645	48	24	attributed	attribute	VERB
ajlm-1645	48	25	to	to	ADP
ajlm-1645	48	26	the	the	DET
ajlm-1645	48	27	advanced	advanced	ADJ
ajlm-1645	48	28	hiv	hiv	PROPN
ajlm-1645	48	29	.	.	PUNCT
ajlm-1645	49	1	data	datum	NOUN
ajlm-1645	49	2	analysis	analysis	NOUN
ajlm-1645	49	3	statistical	statistical	ADJ
ajlm-1645	49	4	analysis	analysis	NOUN
ajlm-1645	49	5	was	be	AUX
ajlm-1645	49	6	done	do	VERB
ajlm-1645	49	7	in	in	ADP
ajlm-1645	49	8	conjunction	conjunction	NOUN
ajlm-1645	49	9	with	with	ADP
ajlm-1645	49	10	the	the	DET
ajlm-1645	49	11	biostatistics	biostatistic	NOUN
ajlm-1645	49	12	department	department	PROPN
ajlm-1645	49	13	of	of	ADP
ajlm-1645	49	14	stellenbosch	stellenbosch	PROPN
ajlm-1645	49	15	university	university	PROPN
ajlm-1645	49	16	.	.	PUNCT
ajlm-1645	50	1	percentages	percentage	NOUN
ajlm-1645	50	2	were	be	AUX
ajlm-1645	50	3	calculated	calculate	VERB
ajlm-1645	50	4	for	for	ADP
ajlm-1645	50	5	categorical	categorical	ADJ
ajlm-1645	50	6	variables	variable	NOUN
ajlm-1645	50	7	.	.	PUNCT
ajlm-1645	51	1	age	age	NOUN
ajlm-1645	51	2	was	be	AUX
ajlm-1645	51	3	presented	present	VERB
ajlm-1645	51	4	as	as	ADP
ajlm-1645	51	5	mean	mean	ADJ
ajlm-1645	51	6	and	and	CCONJ
ajlm-1645	51	7	standard	standard	ADJ
ajlm-1645	51	8	deviation	deviation	NOUN
ajlm-1645	51	9	.	.	PUNCT
ajlm-1645	52	1	non	non	ADJ
ajlm-1645	52	2	-	-	ADJ
ajlm-1645	52	3	parametric	parametric	ADJ
ajlm-1645	52	4	data	datum	NOUN
ajlm-1645	52	5	such	such	ADJ
ajlm-1645	52	6	as	as	ADP
ajlm-1645	52	7	hiv	hiv	PROPN
ajlm-1645	52	8	viral	viral	ADJ
ajlm-1645	52	9	load	load	NOUN
ajlm-1645	52	10	,	,	PUNCT
ajlm-1645	52	11	cd4	cd4	PROPN
ajlm-1645	52	12	count	count	NOUN
ajlm-1645	52	13	,	,	PUNCT
ajlm-1645	52	14	time	time	NOUN
ajlm-1645	52	15	to	to	PART
ajlm-1645	52	16	bme	bme	VERB
ajlm-1645	52	17	and	and	CCONJ
ajlm-1645	52	18	time	time	NOUN
ajlm-1645	52	19	to	to	ADP
ajlm-1645	52	20	resolution	resolution	NOUN
ajlm-1645	52	21	of	of	ADP
ajlm-1645	52	22	pancytopenia	pancytopenia	NOUN
ajlm-1645	52	23	were	be	AUX
ajlm-1645	52	24	presented	present	VERB
ajlm-1645	52	25	as	as	ADP
ajlm-1645	52	26	medians	median	NOUN
ajlm-1645	52	27	and	and	CCONJ
ajlm-1645	52	28	interquartile	interquartile	NOUN
ajlm-1645	52	29	ranges	range	NOUN
ajlm-1645	52	30	.	.	PUNCT
ajlm-1645	53	1	pearson	pearson	PROPN
ajlm-1645	53	2	’s	’s	PART
ajlm-1645	53	3	chi	chi	ADJ
ajlm-1645	53	4	-	-	PUNCT
ajlm-1645	53	5	square	square	ADJ
ajlm-1645	53	6	tests	test	NOUN
ajlm-1645	53	7	were	be	AUX
ajlm-1645	53	8	used	use	VERB
ajlm-1645	53	9	to	to	PART
ajlm-1645	53	10	assess	assess	VERB
ajlm-1645	53	11	the	the	DET
ajlm-1645	53	12	statistical	statistical	ADJ
ajlm-1645	53	13	differences	difference	NOUN
ajlm-1645	53	14	in	in	ADP
ajlm-1645	53	15	the	the	DET
ajlm-1645	53	16	frequencies	frequency	NOUN
ajlm-1645	53	17	of	of	ADP
ajlm-1645	53	18	causes	cause	NOUN
ajlm-1645	53	19	of	of	ADP
ajlm-1645	53	20	pancytopenia	pancytopenia	NOUN
ajlm-1645	53	21	between	between	ADP
ajlm-1645	53	22	the	the	DET
ajlm-1645	53	23	hiv	hiv	PROPN
ajlm-1645	53	24	-	-	PUNCT
ajlm-1645	53	25	positive	positive	ADJ
ajlm-1645	53	26	and	and	CCONJ
ajlm-1645	53	27	negative	negative	ADJ
ajlm-1645	53	28	groups	group	NOUN
ajlm-1645	53	29	,	,	PUNCT
ajlm-1645	53	30	as	as	ADV
ajlm-1645	53	31	well	well	ADV
ajlm-1645	53	32	as	as	ADP
ajlm-1645	53	33	between	between	ADP
ajlm-1645	53	34	different	different	ADJ
ajlm-1645	53	35	age	age	NOUN
ajlm-1645	53	36	groups	group	NOUN
ajlm-1645	53	37	.	.	PUNCT
ajlm-1645	54	1	the	the	DET
ajlm-1645	54	2	data	datum	NOUN
ajlm-1645	54	3	were	be	AUX
ajlm-1645	54	4	analysed	analyse	VERB
ajlm-1645	54	5	using	use	VERB
ajlm-1645	54	6	statistical	statistical	ADJ
ajlm-1645	54	7	package	package	NOUN
ajlm-1645	54	8	for	for	ADP
ajlm-1645	54	9	the	the	DET
ajlm-1645	54	10	social	social	ADJ
ajlm-1645	54	11	sciences	sciences	PROPN
ajlm-1645	54	12	version	version	NOUN
ajlm-1645	54	13	25	25	NUM
ajlm-1645	54	14	(	(	PUNCT
ajlm-1645	54	15	ibm	ibm	PROPN
ajlm-1645	54	16	corp	corp	PROPN
ajlm-1645	54	17	.	.	PROPN
ajlm-1645	54	18	,	,	PUNCT
ajlm-1645	54	19	armonk	armonk	PROPN
ajlm-1645	54	20	,	,	PUNCT
ajlm-1645	54	21	new	new	PROPN
ajlm-1645	54	22	york	york	PROPN
ajlm-1645	54	23	,	,	PUNCT
ajlm-1645	54	24	united	united	PROPN
ajlm-1645	54	25	states	states	PROPN
ajlm-1645	54	26	)	)	PUNCT
ajlm-1645	54	27	.	.	PUNCT
ajlm-1645	55	1	results	result	VERB
ajlm-1645	55	2	a	a	DET
ajlm-1645	55	3	total	total	NOUN
ajlm-1645	55	4	of	of	ADP
ajlm-1645	55	5	695	695	NUM
ajlm-1645	55	6	cases	case	NOUN
ajlm-1645	55	7	of	of	ADP
ajlm-1645	55	8	new	new	ADJ
ajlm-1645	55	9	-	-	PUNCT
ajlm-1645	55	10	onset	onset	NOUN
ajlm-1645	55	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	55	12	were	be	AUX
ajlm-1645	55	13	identified	identify	VERB
ajlm-1645	55	14	within	within	ADP
ajlm-1645	55	15	the	the	DET
ajlm-1645	55	16	two	two	NUM
ajlm-1645	55	17	-	-	PUNCT
ajlm-1645	55	18	year	year	NOUN
ajlm-1645	55	19	period	period	NOUN
ajlm-1645	55	20	.	.	PUNCT
ajlm-1645	56	1	further	further	ADJ
ajlm-1645	56	2	investigation	investigation	NOUN
ajlm-1645	56	3	showed	show	VERB
ajlm-1645	56	4	that	that	SCONJ
ajlm-1645	56	5	seven	seven	NUM
ajlm-1645	56	6	cases	case	NOUN
ajlm-1645	56	7	had	have	VERB
ajlm-1645	56	8	platelet	platelet	NOUN
ajlm-1645	56	9	clumping	clumping	NOUN
ajlm-1645	56	10	with	with	ADP
ajlm-1645	56	11	a	a	DET
ajlm-1645	56	12	subsequent	subsequent	ADJ
ajlm-1645	56	13	platelet	platelet	NOUN
ajlm-1645	56	14	count	count	NOUN
ajlm-1645	56	15	above	above	ADP
ajlm-1645	56	16	100	100	NUM
ajlm-1645	56	17	×	×	NOUN
ajlm-1645	56	18	109	109	NUM
ajlm-1645	56	19	/	/	SYM
ajlm-1645	56	20	l	l	NOUN
ajlm-1645	56	21	,	,	PUNCT
ajlm-1645	56	22	and	and	CCONJ
ajlm-1645	56	23	15	15	NUM
ajlm-1645	56	24	cases	case	NOUN
ajlm-1645	56	25	were	be	AUX
ajlm-1645	56	26	due	due	ADJ
ajlm-1645	56	27	to	to	ADP
ajlm-1645	56	28	sample	sample	NOUN
ajlm-1645	56	29	dilution	dilution	NOUN
ajlm-1645	56	30	,	,	PUNCT
ajlm-1645	56	31	having	having	AUX
ajlm-1645	56	32	been	be	AUX
ajlm-1645	56	33	collected	collect	VERB
ajlm-1645	56	34	from	from	ADP
ajlm-1645	56	35	a	a	DET
ajlm-1645	56	36	cannulated	cannulated	ADJ
ajlm-1645	56	37	infusion	infusion	NOUN
ajlm-1645	56	38	vein	vein	NOUN
ajlm-1645	56	39	.	.	PUNCT
ajlm-1645	57	1	thus	thus	ADV
ajlm-1645	57	2	the	the	DET
ajlm-1645	57	3	total	total	ADJ
ajlm-1645	57	4	number	number	NOUN
ajlm-1645	57	5	of	of	ADP
ajlm-1645	57	6	true	true	ADJ
ajlm-1645	57	7	pancytopenia	pancytopenia	NOUN
ajlm-1645	57	8	cases	case	NOUN
ajlm-1645	57	9	was	be	AUX
ajlm-1645	57	10	673	673	NUM
ajlm-1645	57	11	over	over	ADP
ajlm-1645	57	12	the	the	DET
ajlm-1645	57	13	specified	specified	ADJ
ajlm-1645	57	14	period	period	NOUN
ajlm-1645	57	15	(	(	PUNCT
ajlm-1645	57	16	figure	figure	NOUN
ajlm-1645	57	17	1	1	NUM
ajlm-1645	57	18	)	)	PUNCT
ajlm-1645	57	19	.	.	PUNCT
ajlm-1645	58	1	figure	figure	NOUN
ajlm-1645	58	2	1	1	NUM
ajlm-1645	58	3	:	:	PUNCT
ajlm-1645	58	4	flow	flow	NOUN
ajlm-1645	58	5	diagram	diagram	NOUN
ajlm-1645	58	6	of	of	ADP
ajlm-1645	58	7	case	case	NOUN
ajlm-1645	58	8	selection	selection	NOUN
ajlm-1645	58	9	and	and	CCONJ
ajlm-1645	58	10	stratification	stratification	NOUN
ajlm-1645	58	11	to	to	PART
ajlm-1645	58	12	identify	identify	VERB
ajlm-1645	58	13	the	the	DET
ajlm-1645	58	14	causes	cause	NOUN
ajlm-1645	58	15	of	of	ADP
ajlm-1645	58	16	pancytopenia	pancytopenia	NOUN
ajlm-1645	58	17	at	at	ADP
ajlm-1645	58	18	tygerberg	tygerberg	PROPN
ajlm-1645	58	19	academic	academic	ADJ
ajlm-1645	58	20	hospital	hospital	NOUN
ajlm-1645	58	21	,	,	PUNCT
ajlm-1645	58	22	cape	cape	NOUN
ajlm-1645	58	23	town	town	NOUN
ajlm-1645	58	24	,	,	PUNCT
ajlm-1645	58	25	south	south	PROPN
ajlm-1645	58	26	africa	africa	PROPN
ajlm-1645	58	27	,	,	PUNCT
ajlm-1645	58	28	from	from	ADP
ajlm-1645	58	29	january	january	PROPN
ajlm-1645	58	30	2016	2016	NUM
ajlm-1645	58	31	to	to	ADP
ajlm-1645	58	32	december	december	PROPN
ajlm-1645	58	33	2017	2017	NUM
ajlm-1645	58	34	.	.	PUNCT
ajlm-1645	59	1	true	true	ADJ
ajlm-1645	59	2	pancytopenia	pancytopenia	NOUN
ajlm-1645	59	3	was	be	AUX
ajlm-1645	59	4	confirmed	confirm	VERB
ajlm-1645	59	5	in	in	ADP
ajlm-1645	59	6	673	673	NUM
ajlm-1645	59	7	cases	case	NOUN
ajlm-1645	59	8	.	.	PUNCT
ajlm-1645	60	1	chemoradiation	chemoradiation	NOUN
ajlm-1645	60	2	therapy	therapy	NOUN
ajlm-1645	60	3	was	be	AUX
ajlm-1645	60	4	found	find	VERB
ajlm-1645	60	5	to	to	PART
ajlm-1645	60	6	be	be	AUX
ajlm-1645	60	7	the	the	DET
ajlm-1645	60	8	cause	cause	NOUN
ajlm-1645	60	9	in	in	ADP
ajlm-1645	60	10	166	166	NUM
ajlm-1645	60	11	cases	case	NOUN
ajlm-1645	60	12	,	,	PUNCT
ajlm-1645	60	13	leaving	leave	VERB
ajlm-1645	60	14	507	507	NUM
ajlm-1645	60	15	non	non	ADJ
ajlm-1645	60	16	-	-	ADJ
ajlm-1645	60	17	iatrogenic	iatrogenic	ADJ
ajlm-1645	60	18	cases	case	NOUN
ajlm-1645	60	19	with	with	ADP
ajlm-1645	60	20	unidentified	unidentified	ADJ
ajlm-1645	60	21	underlying	underlie	VERB
ajlm-1645	60	22	aetiologies	aetiology	NOUN
ajlm-1645	60	23	.	.	PUNCT
ajlm-1645	61	1	of	of	ADP
ajlm-1645	61	2	those	those	PRON
ajlm-1645	61	3	,	,	PUNCT
ajlm-1645	61	4	91	91	NUM
ajlm-1645	61	5	patients	patient	NOUN
ajlm-1645	61	6	had	have	VERB
ajlm-1645	61	7	a	a	DET
ajlm-1645	61	8	bme	bme	NOUN
ajlm-1645	61	9	and	and	CCONJ
ajlm-1645	61	10	the	the	DET
ajlm-1645	61	11	cause	cause	NOUN
ajlm-1645	61	12	of	of	ADP
ajlm-1645	61	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	61	14	was	be	AUX
ajlm-1645	61	15	identified	identify	VERB
ajlm-1645	61	16	in	in	ADP
ajlm-1645	61	17	52	52	NUM
ajlm-1645	61	18	of	of	ADP
ajlm-1645	61	19	these	these	DET
ajlm-1645	61	20	patients	patient	NOUN
ajlm-1645	61	21	.	.	PUNCT
ajlm-1645	62	1	in	in	ADP
ajlm-1645	62	2	16	16	NUM
ajlm-1645	62	3	patients	patient	NOUN
ajlm-1645	62	4	whose	whose	DET
ajlm-1645	62	5	bme	bme	NOUN
ajlm-1645	62	6	showed	show	VERB
ajlm-1645	62	7	non	non	ADJ
ajlm-1645	62	8	-	-	ADJ
ajlm-1645	62	9	specific	specific	ADJ
ajlm-1645	62	10	findings	finding	NOUN
ajlm-1645	62	11	,	,	PUNCT
ajlm-1645	62	12	a	a	DET
ajlm-1645	62	13	cause	cause	NOUN
ajlm-1645	62	14	for	for	ADP
ajlm-1645	62	15	pancytopenia	pancytopenia	NOUN
ajlm-1645	62	16	was	be	AUX
ajlm-1645	62	17	found	find	VERB
ajlm-1645	62	18	using	use	VERB
ajlm-1645	62	19	information	information	NOUN
ajlm-1645	62	20	available	available	ADJ
ajlm-1645	62	21	on	on	ADP
ajlm-1645	62	22	the	the	DET
ajlm-1645	62	23	lis	li	NOUN
ajlm-1645	62	24	.	.	PUNCT
ajlm-1645	63	1	using	use	VERB
ajlm-1645	63	2	information	information	NOUN
ajlm-1645	63	3	available	available	ADJ
ajlm-1645	63	4	on	on	ADP
ajlm-1645	63	5	the	the	DET
ajlm-1645	63	6	lis	li	NOUN
ajlm-1645	63	7	,	,	PUNCT
ajlm-1645	63	8	the	the	DET
ajlm-1645	63	9	cause	cause	NOUN
ajlm-1645	63	10	of	of	ADP
ajlm-1645	63	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	63	12	was	be	AUX
ajlm-1645	63	13	identified	identify	VERB
ajlm-1645	63	14	in	in	ADP
ajlm-1645	63	15	340	340	NUM
ajlm-1645	63	16	of	of	ADP
ajlm-1645	63	17	the	the	DET
ajlm-1645	63	18	remaining	remain	VERB
ajlm-1645	63	19	416	416	NUM
ajlm-1645	63	20	patients	patient	NOUN
ajlm-1645	63	21	who	who	PRON
ajlm-1645	63	22	did	do	AUX
ajlm-1645	63	23	not	not	PART
ajlm-1645	63	24	have	have	VERB
ajlm-1645	63	25	a	a	DET
ajlm-1645	63	26	bme	bme	NOUN
ajlm-1645	63	27	.	.	PUNCT
ajlm-1645	64	1	of	of	ADP
ajlm-1645	64	2	the	the	DET
ajlm-1645	64	3	673	673	NUM
ajlm-1645	64	4	patients	patient	NOUN
ajlm-1645	64	5	,	,	PUNCT
ajlm-1645	64	6	273	273	NUM
ajlm-1645	64	7	(	(	PUNCT
ajlm-1645	64	8	41	41	NUM
ajlm-1645	64	9	%	%	NOUN
ajlm-1645	64	10	)	)	PUNCT
ajlm-1645	64	11	were	be	AUX
ajlm-1645	64	12	male	male	ADJ
ajlm-1645	64	13	and	and	CCONJ
ajlm-1645	64	14	400	400	NUM
ajlm-1645	64	15	(	(	PUNCT
ajlm-1645	64	16	59	59	NUM
ajlm-1645	64	17	%	%	NOUN
ajlm-1645	64	18	)	)	PUNCT
ajlm-1645	65	1	were	be	AUX
ajlm-1645	65	2	female	female	ADJ
ajlm-1645	65	3	.	.	PUNCT
ajlm-1645	66	1	the	the	DET
ajlm-1645	66	2	mean	mean	ADJ
ajlm-1645	66	3	age	age	NOUN
ajlm-1645	66	4	at	at	ADP
ajlm-1645	66	5	which	which	PRON
ajlm-1645	66	6	pancytopenia	pancytopenia	NOUN
ajlm-1645	66	7	was	be	AUX
ajlm-1645	66	8	diagnosed	diagnose	VERB
ajlm-1645	66	9	was	be	AUX
ajlm-1645	66	10	44	44	NUM
ajlm-1645	66	11	±	±	NUM
ajlm-1645	66	12	15	15	NUM
ajlm-1645	66	13	years	year	NOUN
ajlm-1645	66	14	(	(	PUNCT
ajlm-1645	66	15	range	range	NOUN
ajlm-1645	66	16	:	:	PUNCT
ajlm-1645	66	17	18–87	18–87	NUM
ajlm-1645	66	18	years	year	NOUN
ajlm-1645	66	19	)	)	PUNCT
ajlm-1645	66	20	.	.	PUNCT
ajlm-1645	67	1	most	most	ADJ
ajlm-1645	67	2	common	common	ADJ
ajlm-1645	67	3	causes	cause	NOUN
ajlm-1645	67	4	of	of	ADP
ajlm-1645	67	5	pancytopenia	pancytopenia	NOUN
ajlm-1645	67	6	chemotherapy	chemotherapy	NOUN
ajlm-1645	67	7	and/or	and/or	CCONJ
ajlm-1645	67	8	radiation	radiation	NOUN
ajlm-1645	67	9	therapy	therapy	NOUN
ajlm-1645	67	10	was	be	AUX
ajlm-1645	67	11	the	the	DET
ajlm-1645	67	12	most	most	ADV
ajlm-1645	67	13	common	common	ADJ
ajlm-1645	67	14	(	(	PUNCT
ajlm-1645	67	15	25	25	NUM
ajlm-1645	67	16	%	%	NOUN
ajlm-1645	67	17	;	;	PUNCT
ajlm-1645	67	18	166/673	166/673	NUM
ajlm-1645	67	19	)	)	PUNCT
ajlm-1645	67	20	cause	cause	NOUN
ajlm-1645	67	21	of	of	ADP
ajlm-1645	67	22	pancytopenia	pancytopenia	NOUN
ajlm-1645	67	23	(	(	PUNCT
ajlm-1645	67	24	figure	figure	NOUN
ajlm-1645	67	25	2	2	NUM
ajlm-1645	67	26	)	)	PUNCT
ajlm-1645	67	27	.	.	PUNCT
ajlm-1645	68	1	the	the	DET
ajlm-1645	68	2	chemoradiation	chemoradiation	NOUN
ajlm-1645	68	3	therapy	therapy	NOUN
ajlm-1645	68	4	was	be	AUX
ajlm-1645	68	5	for	for	ADP
ajlm-1645	68	6	the	the	DET
ajlm-1645	68	7	treatment	treatment	NOUN
ajlm-1645	68	8	of	of	ADP
ajlm-1645	68	9	non	non	ADJ
ajlm-1645	68	10	-	-	ADJ
ajlm-1645	68	11	haematological	haematological	ADJ
ajlm-1645	68	12	malignancies	malignancy	NOUN
ajlm-1645	68	13	(	(	PUNCT
ajlm-1645	68	14	51	51	NUM
ajlm-1645	68	15	%	%	NOUN
ajlm-1645	68	16	;	;	PUNCT
ajlm-1645	68	17	85/166	85/166	NUM
ajlm-1645	68	18	)	)	PUNCT
ajlm-1645	68	19	and	and	CCONJ
ajlm-1645	68	20	hm	hm	INTJ
ajlm-1645	68	21	(	(	PUNCT
ajlm-1645	68	22	49	49	NUM
ajlm-1645	68	23	%	%	NOUN
ajlm-1645	68	24	;	;	PUNCT
ajlm-1645	68	25	81/166	81/166	NUM
ajlm-1645	68	26	)	)	PUNCT
ajlm-1645	68	27	(	(	PUNCT
ajlm-1645	68	28	figure	figure	NOUN
ajlm-1645	68	29	3	3	NUM
ajlm-1645	68	30	)	)	PUNCT
ajlm-1645	68	31	.	.	PUNCT
ajlm-1645	69	1	figure	figure	VERB
ajlm-1645	69	2	2	2	NUM
ajlm-1645	69	3	:	:	PUNCT
ajlm-1645	69	4	frequency	frequency	NOUN
ajlm-1645	69	5	of	of	ADP
ajlm-1645	69	6	different	different	ADJ
ajlm-1645	69	7	causes	cause	NOUN
ajlm-1645	69	8	of	of	ADP
ajlm-1645	69	9	pancytopenia	pancytopenia	NOUN
ajlm-1645	69	10	among	among	ADP
ajlm-1645	69	11	adult	adult	NOUN
ajlm-1645	69	12	patients	patient	NOUN
ajlm-1645	69	13	at	at	ADP
ajlm-1645	69	14	tygerberg	tygerberg	PROPN
ajlm-1645	69	15	academic	academic	ADJ
ajlm-1645	69	16	hospital	hospital	NOUN
ajlm-1645	69	17	,	,	PUNCT
ajlm-1645	69	18	cape	cape	NOUN
ajlm-1645	69	19	town	town	NOUN
ajlm-1645	69	20	,	,	PUNCT
ajlm-1645	69	21	south	south	PROPN
ajlm-1645	69	22	africa	africa	PROPN
ajlm-1645	69	23	,	,	PUNCT
ajlm-1645	69	24	from	from	ADP
ajlm-1645	69	25	january	january	PROPN
ajlm-1645	69	26	2016	2016	NUM
ajlm-1645	69	27	to	to	ADP
ajlm-1645	69	28	december	december	PROPN
ajlm-1645	69	29	2017	2017	NUM
ajlm-1645	69	30	.	.	PUNCT
ajlm-1645	70	1	figure	figure	VERB
ajlm-1645	70	2	3	3	NUM
ajlm-1645	70	3	:	:	PUNCT
ajlm-1645	70	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	70	5	cases	case	NOUN
ajlm-1645	70	6	at	at	ADP
ajlm-1645	70	7	tygerberg	tygerberg	PROPN
ajlm-1645	70	8	academic	academic	ADJ
ajlm-1645	70	9	hospital	hospital	NOUN
ajlm-1645	70	10	,	,	PUNCT
ajlm-1645	70	11	cape	cape	NOUN
ajlm-1645	70	12	town	town	NOUN
ajlm-1645	70	13	,	,	PUNCT
ajlm-1645	70	14	south	south	PROPN
ajlm-1645	70	15	africa	africa	PROPN
ajlm-1645	70	16	,	,	PUNCT
ajlm-1645	70	17	from	from	ADP
ajlm-1645	70	18	january	january	PROPN
ajlm-1645	70	19	2016	2016	NUM
ajlm-1645	70	20	to	to	ADP
ajlm-1645	70	21	december	december	PROPN
ajlm-1645	70	22	2017	2017	NUM
ajlm-1645	70	23	for	for	ADP
ajlm-1645	70	24	which	which	PRON
ajlm-1645	70	25	chemoradiation	chemoradiation	NOUN
ajlm-1645	70	26	therapy	therapy	NOUN
ajlm-1645	70	27	was	be	AUX
ajlm-1645	70	28	the	the	DET
ajlm-1645	70	29	cause	cause	NOUN
ajlm-1645	70	30	.	.	PUNCT
ajlm-1645	71	1	(	(	PUNCT
ajlm-1645	71	2	a	a	X
ajlm-1645	71	3	)	)	PUNCT
ajlm-1645	71	4	site	site	NOUN
ajlm-1645	71	5	of	of	ADP
ajlm-1645	71	6	nhm	nhm	PROPN
ajlm-1645	71	7	,	,	PUNCT
ajlm-1645	71	8	(	(	PUNCT
ajlm-1645	71	9	b	b	X
ajlm-1645	71	10	)	)	PUNCT
ajlm-1645	71	11	haematological	haematological	ADJ
ajlm-1645	71	12	malignancy	malignancy	NOUN
ajlm-1645	71	13	(	(	PUNCT
ajlm-1645	71	14	hm	hm	INTJ
ajlm-1645	71	15	)	)	PUNCT
ajlm-1645	71	16	subtypes	subtype	NOUN
ajlm-1645	71	17	.	.	PUNCT
ajlm-1645	72	1	the	the	DET
ajlm-1645	72	2	most	most	ADV
ajlm-1645	72	3	common	common	ADJ
ajlm-1645	72	4	causes	cause	NOUN
ajlm-1645	72	5	of	of	ADP
ajlm-1645	72	6	pancytopenia	pancytopenia	NOUN
ajlm-1645	72	7	among	among	ADP
ajlm-1645	72	8	the	the	DET
ajlm-1645	72	9	remaining	remain	VERB
ajlm-1645	72	10	507	507	NUM
ajlm-1645	72	11	(	(	PUNCT
ajlm-1645	72	12	75	75	NUM
ajlm-1645	72	13	%	%	NOUN
ajlm-1645	72	14	)	)	PUNCT
ajlm-1645	72	15	cases	case	NOUN
ajlm-1645	72	16	were	be	AUX
ajlm-1645	72	17	sepsis	sepsis	NOUN
ajlm-1645	72	18	(	(	PUNCT
ajlm-1645	72	19	18	18	NUM
ajlm-1645	72	20	%	%	NOUN
ajlm-1645	72	21	;	;	PUNCT
ajlm-1645	72	22	122/673	122/673	NUM
ajlm-1645	72	23	)	)	PUNCT
ajlm-1645	72	24	,	,	PUNCT
ajlm-1645	72	25	hm	hm	INTJ
ajlm-1645	72	26	(	(	PUNCT
ajlm-1645	72	27	9	9	NUM
ajlm-1645	72	28	%	%	NOUN
ajlm-1645	72	29	;	;	PUNCT
ajlm-1645	72	30	62/673	62/673	NUM
ajlm-1645	72	31	)	)	PUNCT
ajlm-1645	72	32	,	,	PUNCT
ajlm-1645	72	33	advanced	advance	VERB
ajlm-1645	72	34	hiv	hiv	PROPN
ajlm-1645	72	35	with	with	ADP
ajlm-1645	72	36	no	no	DET
ajlm-1645	72	37	other	other	ADJ
ajlm-1645	72	38	identifiable	identifiable	ADJ
ajlm-1645	72	39	cause	cause	NOUN
ajlm-1645	72	40	(	(	PUNCT
ajlm-1645	72	41	7	7	NUM
ajlm-1645	72	42	%	%	NOUN
ajlm-1645	72	43	;	;	PUNCT
ajlm-1645	72	44	49/673	49/673	NUM
ajlm-1645	72	45	)	)	PUNCT
ajlm-1645	72	46	and	and	CCONJ
ajlm-1645	72	47	megaloblastic	megaloblastic	ADJ
ajlm-1645	72	48	anaemia	anaemia	NOUN
ajlm-1645	72	49	(	(	PUNCT
ajlm-1645	72	50	6	6	NUM
ajlm-1645	72	51	%	%	NOUN
ajlm-1645	72	52	;	;	PUNCT
ajlm-1645	72	53	42/673	42/673	NUM
ajlm-1645	72	54	)	)	PUNCT
ajlm-1645	72	55	.	.	PUNCT
ajlm-1645	73	1	a	a	DET
ajlm-1645	73	2	cause	cause	NOUN
ajlm-1645	73	3	for	for	ADP
ajlm-1645	73	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	73	5	could	could	AUX
ajlm-1645	73	6	not	not	PART
ajlm-1645	73	7	be	be	AUX
ajlm-1645	73	8	established	establish	VERB
ajlm-1645	73	9	in	in	ADP
ajlm-1645	73	10	15	15	NUM
ajlm-1645	73	11	%	%	NOUN
ajlm-1645	73	12	(	(	PUNCT
ajlm-1645	73	13	98/673	98/673	NUM
ajlm-1645	73	14	)	)	PUNCT
ajlm-1645	73	15	of	of	ADP
ajlm-1645	73	16	cases	case	NOUN
ajlm-1645	73	17	.	.	PUNCT
ajlm-1645	74	1	haematological	haematological	ADJ
ajlm-1645	74	2	conditions	condition	NOUN
ajlm-1645	74	3	were	be	AUX
ajlm-1645	74	4	found	find	VERB
ajlm-1645	74	5	to	to	PART
ajlm-1645	74	6	be	be	AUX
ajlm-1645	74	7	common	common	ADJ
ajlm-1645	74	8	causes	cause	NOUN
ajlm-1645	74	9	of	of	ADP
ajlm-1645	74	10	pancytopenia	pancytopenia	NOUN
ajlm-1645	74	11	.	.	PUNCT
ajlm-1645	75	1	these	these	PRON
ajlm-1645	75	2	included	include	VERB
ajlm-1645	75	3	hm	hm	INTJ
ajlm-1645	75	4	(	(	PUNCT
ajlm-1645	75	5	9	9	NUM
ajlm-1645	75	6	%	%	NOUN
ajlm-1645	75	7	;	;	PUNCT
ajlm-1645	75	8	62/673	62/673	NUM
ajlm-1645	75	9	)	)	PUNCT
ajlm-1645	75	10	and	and	CCONJ
ajlm-1645	75	11	aplastic	aplastic	ADJ
ajlm-1645	75	12	anaemia	anaemia	NOUN
ajlm-1645	75	13	(	(	PUNCT
ajlm-1645	75	14	3	3	NUM
ajlm-1645	75	15	%	%	NOUN
ajlm-1645	75	16	;	;	PUNCT
ajlm-1645	75	17	20/673	20/673	NUM
ajlm-1645	75	18	)	)	PUNCT
ajlm-1645	75	19	.	.	PUNCT
ajlm-1645	76	1	six	six	NUM
ajlm-1645	76	2	of	of	ADP
ajlm-1645	76	3	the	the	DET
ajlm-1645	76	4	20	20	NUM
ajlm-1645	76	5	patients	patient	NOUN
ajlm-1645	76	6	with	with	ADP
ajlm-1645	76	7	aplastic	aplastic	ADJ
ajlm-1645	76	8	anaemia	anaemia	NOUN
ajlm-1645	76	9	had	have	VERB
ajlm-1645	76	10	a	a	DET
ajlm-1645	76	11	paroxysmal	paroxysmal	ADJ
ajlm-1645	76	12	nocturnal	nocturnal	ADJ
ajlm-1645	76	13	haematuria	haematuria	NOUN
ajlm-1645	76	14	clone	clone	NOUN
ajlm-1645	76	15	.	.	PUNCT
ajlm-1645	77	1	serum	serum	NOUN
ajlm-1645	77	2	vitamin	vitamin	NOUN
ajlm-1645	77	3	b12	b12	NOUN
ajlm-1645	77	4	,	,	PUNCT
ajlm-1645	77	5	folate	folate	NOUN
ajlm-1645	77	6	and	and	CCONJ
ajlm-1645	77	7	ferritin	ferritin	ADJ
ajlm-1645	77	8	levels	level	NOUN
ajlm-1645	77	9	were	be	AUX
ajlm-1645	77	10	measured	measure	VERB
ajlm-1645	77	11	in	in	ADP
ajlm-1645	77	12	280	280	NUM
ajlm-1645	77	13	of	of	ADP
ajlm-1645	77	14	the	the	DET
ajlm-1645	77	15	507	507	NUM
ajlm-1645	77	16	patients	patient	NOUN
ajlm-1645	77	17	with	with	ADP
ajlm-1645	77	18	non	non	ADJ
ajlm-1645	77	19	-	-	ADJ
ajlm-1645	77	20	iatrogenic	iatrogenic	ADJ
ajlm-1645	77	21	pancytopenia	pancytopenia	NOUN
ajlm-1645	77	22	.	.	PUNCT
ajlm-1645	78	1	of	of	ADP
ajlm-1645	78	2	these	these	PRON
ajlm-1645	78	3	,	,	PUNCT
ajlm-1645	78	4	12	12	NUM
ajlm-1645	78	5	%	%	NOUN
ajlm-1645	78	6	(	(	PUNCT
ajlm-1645	78	7	33/280	33/280	NUM
ajlm-1645	78	8	)	)	PUNCT
ajlm-1645	78	9	had	have	AUX
ajlm-1645	78	10	isolated	isolate	VERB
ajlm-1645	78	11	folate	folate	NOUN
ajlm-1645	78	12	deficiency	deficiency	NOUN
ajlm-1645	78	13	and	and	CCONJ
ajlm-1645	78	14	3	3	NUM
ajlm-1645	78	15	%	%	NOUN
ajlm-1645	78	16	(	(	PUNCT
ajlm-1645	78	17	9/280	9/280	NOUN
ajlm-1645	78	18	)	)	PUNCT
ajlm-1645	78	19	had	have	VERB
ajlm-1645	78	20	vitamin	vitamin	NOUN
ajlm-1645	78	21	b12	b12	NOUN
ajlm-1645	78	22	deficiency	deficiency	NOUN
ajlm-1645	78	23	.	.	PUNCT
ajlm-1645	79	1	infection	infection	NOUN
ajlm-1645	79	2	contributed	contribute	VERB
ajlm-1645	79	3	to	to	ADP
ajlm-1645	79	4	a	a	DET
ajlm-1645	79	5	considerable	considerable	ADJ
ajlm-1645	79	6	proportion	proportion	NOUN
ajlm-1645	79	7	of	of	ADP
ajlm-1645	79	8	pancytopenia	pancytopenia	NOUN
ajlm-1645	79	9	cases	case	NOUN
ajlm-1645	79	10	.	.	PUNCT
ajlm-1645	80	1	sepsis	sepsis	NOUN
ajlm-1645	80	2	was	be	AUX
ajlm-1645	80	3	the	the	DET
ajlm-1645	80	4	most	most	ADV
ajlm-1645	80	5	common	common	ADJ
ajlm-1645	80	6	non	non	ADJ
ajlm-1645	80	7	-	-	ADJ
ajlm-1645	80	8	iatrogenic	iatrogenic	ADJ
ajlm-1645	80	9	cause	cause	NOUN
ajlm-1645	80	10	of	of	ADP
ajlm-1645	80	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	80	12	.	.	PUNCT
ajlm-1645	81	1	in	in	ADP
ajlm-1645	81	2	80	80	NUM
ajlm-1645	81	3	%	%	NOUN
ajlm-1645	81	4	of	of	ADP
ajlm-1645	81	5	sepsis	sepsis	NOUN
ajlm-1645	81	6	cases	case	NOUN
ajlm-1645	81	7	(	(	PUNCT
ajlm-1645	81	8	97/122	97/122	NUM
ajlm-1645	81	9	)	)	PUNCT
ajlm-1645	81	10	,	,	PUNCT
ajlm-1645	81	11	a	a	DET
ajlm-1645	81	12	blood	blood	NOUN
ajlm-1645	81	13	culture	culture	NOUN
ajlm-1645	81	14	was	be	AUX
ajlm-1645	81	15	positive	positive	ADJ
ajlm-1645	81	16	for	for	ADP
ajlm-1645	81	17	an	an	DET
ajlm-1645	81	18	organism	organism	NOUN
ajlm-1645	81	19	.	.	PUNCT
ajlm-1645	82	1	gram	gram	NOUN
ajlm-1645	82	2	-	-	PUNCT
ajlm-1645	82	3	negative	negative	ADJ
ajlm-1645	82	4	bacteria	bacteria	NOUN
ajlm-1645	82	5	were	be	AUX
ajlm-1645	82	6	more	more	ADV
ajlm-1645	82	7	commonly	commonly	ADV
ajlm-1645	82	8	cultured	cultured	ADJ
ajlm-1645	82	9	(	(	PUNCT
ajlm-1645	82	10	61	61	NUM
ajlm-1645	82	11	%	%	NOUN
ajlm-1645	82	12	;	;	PUNCT
ajlm-1645	82	13	74/122	74/122	X
ajlm-1645	82	14	)	)	PUNCT
ajlm-1645	82	15	compared	compare	VERB
ajlm-1645	82	16	to	to	ADP
ajlm-1645	82	17	gram	gram	NOUN
ajlm-1645	82	18	-	-	PUNCT
ajlm-1645	82	19	positive	positive	ADJ
ajlm-1645	82	20	bacteria	bacteria	NOUN
ajlm-1645	82	21	(	(	PUNCT
ajlm-1645	82	22	16	16	NUM
ajlm-1645	82	23	%	%	NOUN
ajlm-1645	82	24	;	;	PUNCT
ajlm-1645	82	25	19/122	19/122	NUM
ajlm-1645	82	26	)	)	PUNCT
ajlm-1645	82	27	.	.	PUNCT
ajlm-1645	83	1	the	the	DET
ajlm-1645	83	2	remaining	remain	VERB
ajlm-1645	83	3	four	four	NUM
ajlm-1645	83	4	cultures	culture	NOUN
ajlm-1645	83	5	were	be	AUX
ajlm-1645	83	6	positive	positive	ADJ
ajlm-1645	83	7	for	for	ADP
ajlm-1645	83	8	candida	candida	NOUN
ajlm-1645	83	9	albicans	albican	NOUN
ajlm-1645	83	10	.	.	PUNCT
ajlm-1645	84	1	in	in	ADP
ajlm-1645	84	2	62	62	NUM
ajlm-1645	84	3	%	%	NOUN
ajlm-1645	84	4	(	(	PUNCT
ajlm-1645	84	5	76/122	76/122	NUM
ajlm-1645	84	6	)	)	PUNCT
ajlm-1645	84	7	of	of	ADP
ajlm-1645	84	8	sepsis	sepsis	NOUN
ajlm-1645	84	9	-	-	PUNCT
ajlm-1645	84	10	associated	associate	VERB
ajlm-1645	84	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	84	12	cases	case	NOUN
ajlm-1645	84	13	,	,	PUNCT
ajlm-1645	84	14	the	the	DET
ajlm-1645	84	15	pancytopenia	pancytopenia	NOUN
ajlm-1645	84	16	resolved	resolve	VERB
ajlm-1645	84	17	.	.	PUNCT
ajlm-1645	85	1	the	the	DET
ajlm-1645	85	2	median	median	ADJ
ajlm-1645	85	3	time	time	NOUN
ajlm-1645	85	4	to	to	ADP
ajlm-1645	85	5	resolution	resolution	NOUN
ajlm-1645	85	6	of	of	ADP
ajlm-1645	85	7	pancytopenia	pancytopenia	NOUN
ajlm-1645	85	8	was	be	AUX
ajlm-1645	85	9	2	2	NUM
ajlm-1645	85	10	days	day	NOUN
ajlm-1645	85	11	(	(	PUNCT
ajlm-1645	85	12	interquartile	interquartile	NOUN
ajlm-1645	85	13	range	range	NOUN
ajlm-1645	85	14	:	:	PUNCT
ajlm-1645	85	15	1–6	1–6	NUM
ajlm-1645	85	16	)	)	PUNCT
ajlm-1645	85	17	.	.	PUNCT
ajlm-1645	86	1	twenty	twenty	NUM
ajlm-1645	86	2	-	-	PUNCT
ajlm-1645	86	3	three	three	NUM
ajlm-1645	86	4	(	(	PUNCT
ajlm-1645	86	5	3	3	NUM
ajlm-1645	86	6	%	%	NOUN
ajlm-1645	86	7	;	;	PUNCT
ajlm-1645	86	8	23/673	23/673	NUM
ajlm-1645	86	9	)	)	PUNCT
ajlm-1645	86	10	patients	patient	NOUN
ajlm-1645	86	11	had	have	VERB
ajlm-1645	86	12	positive	positive	ADJ
ajlm-1645	86	13	mycobacterium	mycobacterium	NOUN
ajlm-1645	86	14	tuberculosis	tuberculosis	NOUN
ajlm-1645	86	15	cultures	culture	NOUN
ajlm-1645	86	16	/	/	SYM
ajlm-1645	86	17	genexpert	genexpert	PROPN
ajlm-1645	86	18	®	®	PROPN
ajlm-1645	86	19	;	;	PUNCT
ajlm-1645	86	20	the	the	DET
ajlm-1645	86	21	majority	majority	NOUN
ajlm-1645	86	22	(	(	PUNCT
ajlm-1645	86	23	19/23	19/23	NUM
ajlm-1645	86	24	)	)	PUNCT
ajlm-1645	86	25	of	of	ADP
ajlm-1645	86	26	these	these	PRON
ajlm-1645	86	27	were	be	AUX
ajlm-1645	86	28	hiv	hiv	NOUN
ajlm-1645	86	29	-	-	PUNCT
ajlm-1645	86	30	positive	positive	ADJ
ajlm-1645	86	31	patients	patient	NOUN
ajlm-1645	86	32	.	.	PUNCT
ajlm-1645	87	1	nine	nine	NUM
ajlm-1645	87	2	(	(	PUNCT
ajlm-1645	87	3	1	1	NUM
ajlm-1645	87	4	%	%	NOUN
ajlm-1645	87	5	;	;	PUNCT
ajlm-1645	87	6	9/673	9/673	NUM
ajlm-1645	87	7	)	)	PUNCT
ajlm-1645	87	8	patients	patient	NOUN
ajlm-1645	87	9	had	have	VERB
ajlm-1645	87	10	malaria	malaria	NOUN
ajlm-1645	87	11	.	.	PUNCT
ajlm-1645	88	1	description	description	NOUN
ajlm-1645	88	2	of	of	ADP
ajlm-1645	88	3	pancytopenia	pancytopenia	NOUN
ajlm-1645	88	4	in	in	ADP
ajlm-1645	88	5	patients	patient	NOUN
ajlm-1645	88	6	with	with	ADP
ajlm-1645	88	7	hiv	hiv	PROPN
ajlm-1645	88	8	of	of	ADP
ajlm-1645	88	9	the	the	DET
ajlm-1645	88	10	507	507	NUM
ajlm-1645	88	11	non	non	ADJ
ajlm-1645	88	12	-	-	ADJ
ajlm-1645	88	13	iatrogenic	iatrogenic	ADJ
ajlm-1645	88	14	pancytopenia	pancytopenia	NOUN
ajlm-1645	88	15	cases	case	NOUN
ajlm-1645	88	16	,	,	PUNCT
ajlm-1645	88	17	41	41	NUM
ajlm-1645	88	18	%	%	NOUN
ajlm-1645	88	19	(	(	PUNCT
ajlm-1645	88	20	207/507	207/507	NOUN
ajlm-1645	88	21	)	)	PUNCT
ajlm-1645	88	22	were	be	AUX
ajlm-1645	88	23	hiv	hiv	NOUN
ajlm-1645	88	24	-	-	PUNCT
ajlm-1645	88	25	positive	positive	ADJ
ajlm-1645	88	26	,	,	PUNCT
ajlm-1645	88	27	47	47	NUM
ajlm-1645	88	28	%	%	NOUN
ajlm-1645	88	29	(	(	PUNCT
ajlm-1645	88	30	236/507	236/507	NOUN
ajlm-1645	88	31	)	)	PUNCT
ajlm-1645	88	32	were	be	AUX
ajlm-1645	88	33	hiv	hiv	NOUN
ajlm-1645	88	34	-	-	PUNCT
ajlm-1645	88	35	negative	negative	ADJ
ajlm-1645	88	36	,	,	PUNCT
ajlm-1645	88	37	and	and	CCONJ
ajlm-1645	88	38	the	the	DET
ajlm-1645	88	39	hiv	hiv	PROPN
ajlm-1645	88	40	status	status	NOUN
ajlm-1645	88	41	was	be	AUX
ajlm-1645	88	42	unknown	unknown	ADJ
ajlm-1645	88	43	in	in	ADP
ajlm-1645	88	44	13	13	NUM
ajlm-1645	88	45	%	%	NOUN
ajlm-1645	88	46	(	(	PUNCT
ajlm-1645	88	47	64/507	64/507	NUM
ajlm-1645	88	48	)	)	PUNCT
ajlm-1645	88	49	.	.	PUNCT
ajlm-1645	89	1	the	the	DET
ajlm-1645	89	2	median	median	PROPN
ajlm-1645	89	3	cd4	cd4	PROPN
ajlm-1645	89	4	count	count	NOUN
ajlm-1645	89	5	was	be	AUX
ajlm-1645	89	6	94	94	NUM
ajlm-1645	89	7	cells/µl	cells/µl	NOUN
ajlm-1645	89	8	(	(	PUNCT
ajlm-1645	89	9	interquartile	interquartile	NOUN
ajlm-1645	89	10	range	range	NOUN
ajlm-1645	89	11	:	:	PUNCT
ajlm-1645	89	12	33–202	33–202	NUM
ajlm-1645	89	13	cells/µl	cells/µl	PROPN
ajlm-1645	89	14	,	,	PUNCT
ajlm-1645	89	15	n	n	NOUN
ajlm-1645	89	16	=	=	SYM
ajlm-1645	89	17	175	175	NUM
ajlm-1645	89	18	patients	patient	NOUN
ajlm-1645	89	19	tested	test	VERB
ajlm-1645	89	20	)	)	PUNCT
ajlm-1645	89	21	and	and	CCONJ
ajlm-1645	89	22	the	the	DET
ajlm-1645	89	23	median	median	ADJ
ajlm-1645	89	24	hiv	hiv	PROPN
ajlm-1645	89	25	viral	viral	ADJ
ajlm-1645	89	26	load	load	NOUN
ajlm-1645	89	27	was	be	AUX
ajlm-1645	89	28	1096	1096	NUM
ajlm-1645	89	29	copies	copy	NOUN
ajlm-1645	89	30	/	/	SYM
ajlm-1645	89	31	ml	ml	PROPN
ajlm-1645	89	32	(	(	PUNCT
ajlm-1645	89	33	interquartile	interquartile	NOUN
ajlm-1645	89	34	range	range	NOUN
ajlm-1645	89	35	lower	low	ADJ
ajlm-1645	89	36	than	than	ADP
ajlm-1645	89	37	detectable	detectable	ADJ
ajlm-1645	89	38	limit	limit	NOUN
ajlm-1645	89	39	–	–	PUNCT
ajlm-1645	89	40	91	91	NUM
ajlm-1645	89	41	560	560	NUM
ajlm-1645	89	42	copies	copy	NOUN
ajlm-1645	89	43	/	/	SYM
ajlm-1645	89	44	ml	ml	NOUN
ajlm-1645	89	45	,	,	PUNCT
ajlm-1645	89	46	n	n	NOUN
ajlm-1645	89	47	=	=	SYM
ajlm-1645	89	48	113	113	NUM
ajlm-1645	89	49	patients	patient	NOUN
ajlm-1645	89	50	tested	test	VERB
ajlm-1645	89	51	)	)	PUNCT
ajlm-1645	89	52	.	.	PUNCT
ajlm-1645	90	1	the	the	DET
ajlm-1645	90	2	viral	viral	ADJ
ajlm-1645	90	3	load	load	NOUN
ajlm-1645	90	4	was	be	AUX
ajlm-1645	90	5	undetectable	undetectable	ADJ
ajlm-1645	90	6	in	in	ADP
ajlm-1645	90	7	14	14	NUM
ajlm-1645	90	8	%	%	NOUN
ajlm-1645	90	9	(	(	PUNCT
ajlm-1645	90	10	29/207	29/207	NOUN
ajlm-1645	90	11	)	)	PUNCT
ajlm-1645	90	12	of	of	ADP
ajlm-1645	90	13	the	the	DET
ajlm-1645	90	14	hiv	hiv	NOUN
ajlm-1645	90	15	-	-	PUNCT
ajlm-1645	90	16	positive	positive	ADJ
ajlm-1645	90	17	patients	patient	NOUN
ajlm-1645	90	18	with	with	ADP
ajlm-1645	90	19	pancytopenia	pancytopenia	NOUN
ajlm-1645	90	20	,	,	PUNCT
ajlm-1645	90	21	and	and	CCONJ
ajlm-1645	90	22	advanced	advanced	ADJ
ajlm-1645	90	23	hiv	hiv	PROPN
ajlm-1645	90	24	was	be	AUX
ajlm-1645	90	25	seen	see	VERB
ajlm-1645	90	26	in	in	ADP
ajlm-1645	90	27	68	68	NUM
ajlm-1645	90	28	%	%	NOUN
ajlm-1645	90	29	(	(	PUNCT
ajlm-1645	90	30	141/207	141/207	PROPN
ajlm-1645	90	31	)	)	PUNCT
ajlm-1645	90	32	.	.	PUNCT
ajlm-1645	91	1	the	the	DET
ajlm-1645	91	2	cd4	cd4	PROPN
ajlm-1645	91	3	count	count	NOUN
ajlm-1645	91	4	was	be	AUX
ajlm-1645	91	5	not	not	PART
ajlm-1645	91	6	performed	perform	VERB
ajlm-1645	91	7	in	in	ADP
ajlm-1645	91	8	27	27	NUM
ajlm-1645	91	9	hiv	hiv	NOUN
ajlm-1645	91	10	-	-	PUNCT
ajlm-1645	91	11	positive	positive	ADJ
ajlm-1645	91	12	patients	patient	NOUN
ajlm-1645	91	13	with	with	ADP
ajlm-1645	91	14	pancytopenia	pancytopenia	NOUN
ajlm-1645	91	15	,	,	PUNCT
ajlm-1645	91	16	thus	thus	ADV
ajlm-1645	91	17	the	the	DET
ajlm-1645	91	18	proportion	proportion	NOUN
ajlm-1645	91	19	of	of	ADP
ajlm-1645	91	20	patients	patient	NOUN
ajlm-1645	91	21	with	with	ADP
ajlm-1645	91	22	advanced	advanced	ADJ
ajlm-1645	91	23	hiv	hiv	PROPN
ajlm-1645	91	24	may	may	AUX
ajlm-1645	91	25	be	be	AUX
ajlm-1645	91	26	underestimated	underestimate	VERB
ajlm-1645	91	27	.	.	PUNCT
ajlm-1645	92	1	further	further	ADJ
ajlm-1645	92	2	investigation	investigation	NOUN
ajlm-1645	92	3	in	in	ADP
ajlm-1645	92	4	patients	patient	NOUN
ajlm-1645	92	5	with	with	ADP
ajlm-1645	92	6	advanced	advanced	ADJ
ajlm-1645	92	7	hiv	hiv	PROPN
ajlm-1645	92	8	revealed	reveal	VERB
ajlm-1645	92	9	additional	additional	ADJ
ajlm-1645	92	10	contributing	contributing	NOUN
ajlm-1645	92	11	causes	cause	NOUN
ajlm-1645	92	12	of	of	ADP
ajlm-1645	92	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	92	14	,	,	PUNCT
ajlm-1645	92	15	including	include	VERB
ajlm-1645	92	16	sepsis	sepsis	NOUN
ajlm-1645	92	17	(	(	PUNCT
ajlm-1645	92	18	22	22	NUM
ajlm-1645	92	19	%	%	NOUN
ajlm-1645	92	20	;	;	PUNCT
ajlm-1645	92	21	31/141	31/141	NUM
ajlm-1645	92	22	)	)	PUNCT
ajlm-1645	92	23	,	,	PUNCT
ajlm-1645	92	24	folate	folate	NOUN
ajlm-1645	92	25	deficiency	deficiency	NOUN
ajlm-1645	92	26	(	(	PUNCT
ajlm-1645	92	27	13	13	NUM
ajlm-1645	92	28	%	%	NOUN
ajlm-1645	92	29	;	;	PUNCT
ajlm-1645	92	30	18/141	18/141	NUM
ajlm-1645	92	31	)	)	PUNCT
ajlm-1645	92	32	and	and	CCONJ
ajlm-1645	92	33	tuberculosis	tuberculosis	NOUN
ajlm-1645	92	34	(	(	PUNCT
ajlm-1645	92	35	10	10	NUM
ajlm-1645	92	36	%	%	NOUN
ajlm-1645	92	37	;	;	PUNCT
ajlm-1645	92	38	14/141	14/141	NUM
ajlm-1645	92	39	)	)	PUNCT
ajlm-1645	92	40	.	.	PUNCT
ajlm-1645	93	1	moreover	moreover	ADV
ajlm-1645	93	2	,	,	PUNCT
ajlm-1645	93	3	advanced	advanced	ADJ
ajlm-1645	93	4	hiv	hiv	PROPN
ajlm-1645	93	5	was	be	AUX
ajlm-1645	93	6	the	the	DET
ajlm-1645	93	7	only	only	ADJ
ajlm-1645	93	8	identifiable	identifiable	ADJ
ajlm-1645	93	9	cause	cause	NOUN
ajlm-1645	93	10	of	of	ADP
ajlm-1645	93	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	93	12	in	in	ADP
ajlm-1645	93	13	24	24	NUM
ajlm-1645	93	14	%	%	NOUN
ajlm-1645	93	15	(	(	PUNCT
ajlm-1645	93	16	49/207	49/207	NOUN
ajlm-1645	93	17	)	)	PUNCT
ajlm-1645	93	18	of	of	ADP
ajlm-1645	93	19	the	the	DET
ajlm-1645	93	20	hiv	hiv	NOUN
ajlm-1645	93	21	-	-	PUNCT
ajlm-1645	93	22	positive	positive	ADJ
ajlm-1645	93	23	patients	patient	NOUN
ajlm-1645	93	24	,	,	PUNCT
ajlm-1645	93	25	accounting	account	VERB
ajlm-1645	93	26	for	for	ADP
ajlm-1645	93	27	7	7	NUM
ajlm-1645	93	28	%	%	NOUN
ajlm-1645	93	29	of	of	ADP
ajlm-1645	93	30	all	all	DET
ajlm-1645	93	31	cases	case	NOUN
ajlm-1645	93	32	(	(	PUNCT
ajlm-1645	93	33	49/673	49/673	NUM
ajlm-1645	93	34	)	)	PUNCT
ajlm-1645	93	35	.	.	PUNCT
ajlm-1645	94	1	the	the	DET
ajlm-1645	94	2	aetiology	aetiology	NOUN
ajlm-1645	94	3	of	of	ADP
ajlm-1645	94	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	94	5	differed	differ	VERB
ajlm-1645	94	6	between	between	ADP
ajlm-1645	94	7	hiv	hiv	PROPN
ajlm-1645	94	8	-	-	PUNCT
ajlm-1645	94	9	positive	positive	ADJ
ajlm-1645	94	10	and	and	CCONJ
ajlm-1645	94	11	hiv	hiv	NOUN
ajlm-1645	94	12	-	-	PUNCT
ajlm-1645	94	13	negative	negative	ADJ
ajlm-1645	94	14	patients	patient	NOUN
ajlm-1645	94	15	(	(	PUNCT
ajlm-1645	94	16	figure	figure	VERB
ajlm-1645	94	17	4	4	NUM
ajlm-1645	94	18	)	)	PUNCT
ajlm-1645	94	19	.	.	PUNCT
ajlm-1645	95	1	haematological	haematological	ADJ
ajlm-1645	95	2	malignancies	malignancy	NOUN
ajlm-1645	95	3	and	and	CCONJ
ajlm-1645	95	4	aplastic	aplastic	ADJ
ajlm-1645	95	5	anaemia	anaemia	NOUN
ajlm-1645	95	6	were	be	AUX
ajlm-1645	95	7	significantly	significantly	ADV
ajlm-1645	95	8	more	more	ADV
ajlm-1645	95	9	common	common	ADJ
ajlm-1645	95	10	in	in	ADP
ajlm-1645	95	11	hiv	hiv	PROPN
ajlm-1645	95	12	-	-	PUNCT
ajlm-1645	95	13	negative	negative	ADJ
ajlm-1645	95	14	patients	patient	NOUN
ajlm-1645	95	15	(	(	PUNCT
ajlm-1645	95	16	p	p	X
ajlm-1645	95	17	<	<	X
ajlm-1645	95	18	0.0001	0.0001	NUM
ajlm-1645	95	19	)	)	PUNCT
ajlm-1645	95	20	,	,	PUNCT
ajlm-1645	95	21	while	while	SCONJ
ajlm-1645	95	22	folate	folate	NOUN
ajlm-1645	95	23	deficiency	deficiency	NOUN
ajlm-1645	95	24	(	(	PUNCT
ajlm-1645	95	25	p	p	NOUN
ajlm-1645	95	26	=	=	NOUN
ajlm-1645	95	27	0.004	0.004	NUM
ajlm-1645	95	28	)	)	PUNCT
ajlm-1645	95	29	,	,	PUNCT
ajlm-1645	95	30	tuberculosis	tuberculosis	INTJ
ajlm-1645	95	31	(	(	PUNCT
ajlm-1645	95	32	p	p	X
ajlm-1645	95	33	<	<	X
ajlm-1645	95	34	0.0001	0.0001	NUM
ajlm-1645	95	35	)	)	PUNCT
ajlm-1645	95	36	and	and	CCONJ
ajlm-1645	95	37	thrombotic	thrombotic	ADJ
ajlm-1645	95	38	microangiopathy	microangiopathy	ADJ
ajlm-1645	95	39	(	(	PUNCT
ajlm-1645	95	40	p	p	NOUN
ajlm-1645	95	41	=	=	NOUN
ajlm-1645	95	42	0.011	0.011	NUM
ajlm-1645	95	43	)	)	PUNCT
ajlm-1645	95	44	were	be	AUX
ajlm-1645	95	45	more	more	ADV
ajlm-1645	95	46	common	common	ADJ
ajlm-1645	95	47	among	among	ADP
ajlm-1645	95	48	hiv	hiv	PROPN
ajlm-1645	95	49	-	-	PUNCT
ajlm-1645	95	50	positive	positive	ADJ
ajlm-1645	95	51	patients	patient	NOUN
ajlm-1645	95	52	.	.	PUNCT
ajlm-1645	96	1	there	there	PRON
ajlm-1645	96	2	was	be	VERB
ajlm-1645	96	3	no	no	DET
ajlm-1645	96	4	significant	significant	ADJ
ajlm-1645	96	5	difference	difference	NOUN
ajlm-1645	96	6	in	in	ADP
ajlm-1645	96	7	the	the	DET
ajlm-1645	96	8	proportion	proportion	NOUN
ajlm-1645	96	9	of	of	ADP
ajlm-1645	96	10	sepsis	sepsis	NOUN
ajlm-1645	96	11	cases	case	NOUN
ajlm-1645	96	12	between	between	ADP
ajlm-1645	96	13	the	the	DET
ajlm-1645	96	14	hiv	hiv	PROPN
ajlm-1645	96	15	-	-	PUNCT
ajlm-1645	96	16	positive	positive	ADJ
ajlm-1645	96	17	and	and	CCONJ
ajlm-1645	96	18	hiv	hiv	NOUN
ajlm-1645	96	19	-	-	PUNCT
ajlm-1645	96	20	negative	negative	ADJ
ajlm-1645	96	21	groups	group	NOUN
ajlm-1645	96	22	(	(	PUNCT
ajlm-1645	96	23	p	p	X
ajlm-1645	96	24	=	=	NOUN
ajlm-1645	96	25	0.66	0.66	NUM
ajlm-1645	96	26	)	)	PUNCT
ajlm-1645	96	27	.	.	PUNCT
ajlm-1645	97	1	figure	figure	VERB
ajlm-1645	97	2	4	4	NUM
ajlm-1645	97	3	:	:	PUNCT
ajlm-1645	97	4	proportions	proportion	NOUN
ajlm-1645	97	5	of	of	ADP
ajlm-1645	97	6	various	various	ADJ
ajlm-1645	97	7	causes	cause	NOUN
ajlm-1645	97	8	of	of	ADP
ajlm-1645	97	9	pancytopenia	pancytopenia	NOUN
ajlm-1645	97	10	among	among	ADP
ajlm-1645	97	11	hiv	hiv	PROPN
ajlm-1645	97	12	-	-	PUNCT
ajlm-1645	97	13	positive	positive	ADJ
ajlm-1645	97	14	and	and	CCONJ
ajlm-1645	97	15	hiv	hiv	NOUN
ajlm-1645	97	16	-	-	PUNCT
ajlm-1645	97	17	negative	negative	ADJ
ajlm-1645	97	18	patients	patient	NOUN
ajlm-1645	97	19	at	at	ADP
ajlm-1645	97	20	tygerberg	tygerberg	PROPN
ajlm-1645	97	21	academic	academic	ADJ
ajlm-1645	97	22	hospital	hospital	NOUN
ajlm-1645	97	23	,	,	PUNCT
ajlm-1645	97	24	cape	cape	NOUN
ajlm-1645	97	25	town	town	NOUN
ajlm-1645	97	26	,	,	PUNCT
ajlm-1645	97	27	south	south	PROPN
ajlm-1645	97	28	africa	africa	PROPN
ajlm-1645	97	29	,	,	PUNCT
ajlm-1645	97	30	from	from	ADP
ajlm-1645	97	31	january	january	PROPN
ajlm-1645	97	32	2016	2016	NUM
ajlm-1645	97	33	to	to	ADP
ajlm-1645	97	34	december	december	PROPN
ajlm-1645	97	35	2017	2017	NUM
ajlm-1645	97	36	.	.	PUNCT
ajlm-1645	98	1	bone	bone	NOUN
ajlm-1645	98	2	marrow	marrow	PROPN
ajlm-1645	98	3	examination	examination	NOUN
ajlm-1645	98	4	to	to	PART
ajlm-1645	98	5	determine	determine	VERB
ajlm-1645	98	6	pancytopenia	pancytopenia	NOUN
ajlm-1645	98	7	aetiology	aetiology	NOUN
ajlm-1645	98	8	bone	bone	NOUN
ajlm-1645	98	9	marrow	marrow	PROPN
ajlm-1645	98	10	examination	examination	NOUN
ajlm-1645	98	11	was	be	AUX
ajlm-1645	98	12	performed	perform	VERB
ajlm-1645	98	13	to	to	PART
ajlm-1645	98	14	determine	determine	VERB
ajlm-1645	98	15	the	the	DET
ajlm-1645	98	16	cause	cause	NOUN
ajlm-1645	98	17	of	of	ADP
ajlm-1645	98	18	pancytopenia	pancytopenia	NOUN
ajlm-1645	98	19	in	in	ADP
ajlm-1645	98	20	91	91	NUM
ajlm-1645	98	21	of	of	ADP
ajlm-1645	98	22	the	the	DET
ajlm-1645	98	23	non	non	ADJ
ajlm-1645	98	24	-	-	ADJ
ajlm-1645	98	25	iatrogenic	iatrogenic	ADJ
ajlm-1645	98	26	cases	case	NOUN
ajlm-1645	98	27	and	and	CCONJ
ajlm-1645	98	28	this	this	PRON
ajlm-1645	98	29	revealed	reveal	VERB
ajlm-1645	98	30	the	the	DET
ajlm-1645	98	31	cause	cause	NOUN
ajlm-1645	98	32	of	of	ADP
ajlm-1645	98	33	pancytopenia	pancytopenia	NOUN
ajlm-1645	98	34	in	in	ADP
ajlm-1645	98	35	52	52	NUM
ajlm-1645	98	36	cases	case	NOUN
ajlm-1645	98	37	(	(	PUNCT
ajlm-1645	98	38	57	57	NUM
ajlm-1645	98	39	%	%	NOUN
ajlm-1645	98	40	;	;	PUNCT
ajlm-1645	98	41	52/91	52/91	NUM
ajlm-1645	98	42	)	)	PUNCT
ajlm-1645	98	43	.	.	PUNCT
ajlm-1645	99	1	thirty	thirty	NUM
ajlm-1645	99	2	-	-	PUNCT
ajlm-1645	99	3	six	six	NUM
ajlm-1645	99	4	of	of	ADP
ajlm-1645	99	5	these	these	PRON
ajlm-1645	99	6	had	have	VERB
ajlm-1645	99	7	hm	hm	INTJ
ajlm-1645	99	8	(	(	PUNCT
ajlm-1645	99	9	40	40	NUM
ajlm-1645	99	10	%	%	NOUN
ajlm-1645	99	11	;	;	PUNCT
ajlm-1645	99	12	36/91	36/91	NUM
ajlm-1645	99	13	)	)	PUNCT
ajlm-1645	99	14	,	,	PUNCT
ajlm-1645	99	15	nine	nine	NUM
ajlm-1645	99	16	had	have	VERB
ajlm-1645	99	17	aplastic	aplastic	ADJ
ajlm-1645	99	18	anaemia	anaemia	NOUN
ajlm-1645	99	19	(	(	PUNCT
ajlm-1645	99	20	10	10	NUM
ajlm-1645	99	21	%	%	NOUN
ajlm-1645	99	22	;	;	PUNCT
ajlm-1645	99	23	9/91	9/91	NUM
ajlm-1645	99	24	)	)	PUNCT
ajlm-1645	99	25	,	,	PUNCT
ajlm-1645	99	26	and	and	CCONJ
ajlm-1645	99	27	three	three	NUM
ajlm-1645	99	28	had	have	VERB
ajlm-1645	99	29	non	non	ADJ
ajlm-1645	99	30	-	-	ADJ
ajlm-1645	99	31	haematological	haematological	ADJ
ajlm-1645	99	32	malignancies	malignancy	NOUN
ajlm-1645	99	33	(	(	PUNCT
ajlm-1645	99	34	3	3	NUM
ajlm-1645	99	35	%	%	NOUN
ajlm-1645	99	36	;	;	PUNCT
ajlm-1645	99	37	3/91	3/91	NUM
ajlm-1645	99	38	)	)	PUNCT
ajlm-1645	99	39	.	.	PUNCT
ajlm-1645	100	1	the	the	DET
ajlm-1645	100	2	most	most	ADV
ajlm-1645	100	3	common	common	ADJ
ajlm-1645	100	4	hms	hms	PROPN
ajlm-1645	100	5	were	be	AUX
ajlm-1645	100	6	myelodysplastic	myelodysplastic	ADJ
ajlm-1645	100	7	syndrome	syndrome	NOUN
ajlm-1645	100	8	(	(	PUNCT
ajlm-1645	100	9	11	11	NUM
ajlm-1645	100	10	%	%	NOUN
ajlm-1645	100	11	)	)	PUNCT
ajlm-1645	100	12	and	and	CCONJ
ajlm-1645	100	13	acute	acute	ADJ
ajlm-1645	100	14	leukaemia	leukaemia	NOUN
ajlm-1645	100	15	(	(	PUNCT
ajlm-1645	100	16	10	10	NUM
ajlm-1645	100	17	%	%	NOUN
ajlm-1645	100	18	)	)	PUNCT
ajlm-1645	100	19	.	.	PUNCT
ajlm-1645	101	1	notably	notably	ADV
ajlm-1645	101	2	,	,	PUNCT
ajlm-1645	101	3	in	in	ADP
ajlm-1645	101	4	four	four	NUM
ajlm-1645	101	5	of	of	ADP
ajlm-1645	101	6	the	the	DET
ajlm-1645	101	7	nine	nine	NUM
ajlm-1645	101	8	acute	acute	ADJ
ajlm-1645	101	9	leukaemia	leukaemia	NOUN
ajlm-1645	101	10	cases	case	NOUN
ajlm-1645	101	11	,	,	PUNCT
ajlm-1645	101	12	there	there	PRON
ajlm-1645	101	13	were	be	VERB
ajlm-1645	101	14	scanty	scanty	ADJ
ajlm-1645	101	15	or	or	CCONJ
ajlm-1645	101	16	no	no	DET
ajlm-1645	101	17	blasts	blast	NOUN
ajlm-1645	101	18	(	(	PUNCT
ajlm-1645	101	19	<	<	X
ajlm-1645	101	20	1	1	NUM
ajlm-1645	101	21	%	%	NOUN
ajlm-1645	101	22	)	)	PUNCT
ajlm-1645	101	23	on	on	ADP
ajlm-1645	101	24	the	the	DET
ajlm-1645	101	25	peripheral	peripheral	ADJ
ajlm-1645	101	26	blood	blood	NOUN
ajlm-1645	101	27	smear	smear	NOUN
ajlm-1645	101	28	.	.	PUNCT
ajlm-1645	102	1	in	in	ADP
ajlm-1645	102	2	the	the	DET
ajlm-1645	102	3	remaining	remain	VERB
ajlm-1645	102	4	39	39	NUM
ajlm-1645	102	5	bmes	bme	NOUN
ajlm-1645	102	6	,	,	PUNCT
ajlm-1645	102	7	no	no	DET
ajlm-1645	102	8	specific	specific	ADJ
ajlm-1645	102	9	bone	bone	NOUN
ajlm-1645	102	10	marrow	marrow	NOUN
ajlm-1645	102	11	pathology	pathology	NOUN
ajlm-1645	102	12	could	could	AUX
ajlm-1645	102	13	be	be	AUX
ajlm-1645	102	14	identified	identify	VERB
ajlm-1645	102	15	.	.	PUNCT
ajlm-1645	103	1	causes	cause	NOUN
ajlm-1645	103	2	of	of	ADP
ajlm-1645	103	3	pancytopenia	pancytopenia	NOUN
ajlm-1645	103	4	in	in	ADP
ajlm-1645	103	5	different	different	ADJ
ajlm-1645	103	6	age	age	NOUN
ajlm-1645	103	7	groups	group	NOUN
ajlm-1645	103	8	the	the	DET
ajlm-1645	103	9	aetiology	aetiology	NOUN
ajlm-1645	103	10	of	of	ADP
ajlm-1645	103	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	103	12	also	also	ADV
ajlm-1645	103	13	varied	varied	ADJ
ajlm-1645	103	14	according	accord	VERB
ajlm-1645	103	15	to	to	ADP
ajlm-1645	103	16	age	age	NOUN
ajlm-1645	103	17	(	(	PUNCT
ajlm-1645	103	18	figure	figure	NOUN
ajlm-1645	103	19	5	5	NUM
ajlm-1645	103	20	)	)	PUNCT
ajlm-1645	103	21	.	.	PUNCT
ajlm-1645	104	1	while	while	SCONJ
ajlm-1645	104	2	sepsis	sepsis	NOUN
ajlm-1645	104	3	was	be	AUX
ajlm-1645	104	4	the	the	DET
ajlm-1645	104	5	most	most	ADV
ajlm-1645	104	6	common	common	ADJ
ajlm-1645	104	7	cause	cause	NOUN
ajlm-1645	104	8	of	of	ADP
ajlm-1645	104	9	pancytopenia	pancytopenia	NOUN
ajlm-1645	104	10	among	among	ADP
ajlm-1645	104	11	young	young	ADJ
ajlm-1645	104	12	(	(	PUNCT
ajlm-1645	104	13	18–39	18–39	NUM
ajlm-1645	104	14	years	year	NOUN
ajlm-1645	104	15	old	old	ADJ
ajlm-1645	104	16	)	)	PUNCT
ajlm-1645	104	17	and	and	CCONJ
ajlm-1645	104	18	middle	middle	NOUN
ajlm-1645	104	19	-	-	PUNCT
ajlm-1645	104	20	aged	aged	ADJ
ajlm-1645	104	21	(	(	PUNCT
ajlm-1645	104	22	40–59	40–59	NUM
ajlm-1645	104	23	years	year	NOUN
ajlm-1645	104	24	old	old	ADJ
ajlm-1645	104	25	)	)	PUNCT
ajlm-1645	104	26	patients	patient	NOUN
ajlm-1645	104	27	,	,	PUNCT
ajlm-1645	104	28	hm	hm	INTJ
ajlm-1645	104	29	was	be	AUX
ajlm-1645	104	30	the	the	DET
ajlm-1645	104	31	most	most	ADV
ajlm-1645	104	32	common	common	ADJ
ajlm-1645	104	33	cause	cause	NOUN
ajlm-1645	104	34	of	of	ADP
ajlm-1645	104	35	pancytopenia	pancytopenia	NOUN
ajlm-1645	104	36	in	in	ADP
ajlm-1645	104	37	the	the	DET
ajlm-1645	104	38	oldest	old	ADJ
ajlm-1645	104	39	age	age	NOUN
ajlm-1645	104	40	group	group	NOUN
ajlm-1645	104	41	(	(	PUNCT
ajlm-1645	104	42	60–89	60–89	NUM
ajlm-1645	104	43	years	year	NOUN
ajlm-1645	104	44	old	old	ADJ
ajlm-1645	104	45	)	)	PUNCT
ajlm-1645	104	46	.	.	PUNCT
ajlm-1645	105	1	there	there	PRON
ajlm-1645	105	2	was	be	VERB
ajlm-1645	105	3	a	a	DET
ajlm-1645	105	4	significantly	significantly	ADV
ajlm-1645	105	5	higher	high	ADJ
ajlm-1645	105	6	proportion	proportion	NOUN
ajlm-1645	105	7	of	of	ADP
ajlm-1645	105	8	patients	patient	NOUN
ajlm-1645	105	9	diagnosed	diagnose	VERB
ajlm-1645	105	10	with	with	ADP
ajlm-1645	105	11	hm	hm	INTJ
ajlm-1645	105	12	(	(	PUNCT
ajlm-1645	105	13	p	p	X
ajlm-1645	105	14	<	<	X
ajlm-1645	105	15	0.0001	0.0001	NUM
ajlm-1645	105	16	)	)	PUNCT
ajlm-1645	105	17	and	and	CCONJ
ajlm-1645	105	18	non	non	ADJ
ajlm-1645	105	19	-	-	ADJ
ajlm-1645	105	20	haematological	haematological	ADJ
ajlm-1645	105	21	malignancies	malignancy	NOUN
ajlm-1645	105	22	(	(	PUNCT
ajlm-1645	105	23	p	p	X
ajlm-1645	105	24	=	=	NOUN
ajlm-1645	105	25	0.012	0.012	NUM
ajlm-1645	105	26	)	)	PUNCT
ajlm-1645	105	27	among	among	ADP
ajlm-1645	105	28	patients	patient	NOUN
ajlm-1645	105	29	aged	age	VERB
ajlm-1645	105	30	60–89	60–89	NUM
ajlm-1645	105	31	years	year	NOUN
ajlm-1645	105	32	old	old	ADJ
ajlm-1645	105	33	.	.	PUNCT
ajlm-1645	106	1	the	the	DET
ajlm-1645	106	2	increase	increase	NOUN
ajlm-1645	106	3	in	in	ADP
ajlm-1645	106	4	hm	hm	INTJ
ajlm-1645	106	5	seen	see	VERB
ajlm-1645	106	6	in	in	ADP
ajlm-1645	106	7	the	the	DET
ajlm-1645	106	8	60–89	60–89	NUM
ajlm-1645	106	9	-	-	PUNCT
ajlm-1645	106	10	year	year	NOUN
ajlm-1645	106	11	-	-	PUNCT
ajlm-1645	106	12	old	old	ADJ
ajlm-1645	106	13	category	category	NOUN
ajlm-1645	106	14	was	be	AUX
ajlm-1645	106	15	mainly	mainly	ADV
ajlm-1645	106	16	due	due	ADJ
ajlm-1645	106	17	to	to	ADP
ajlm-1645	106	18	an	an	DET
ajlm-1645	106	19	increase	increase	NOUN
ajlm-1645	106	20	in	in	ADP
ajlm-1645	106	21	the	the	DET
ajlm-1645	106	22	number	number	NOUN
ajlm-1645	106	23	of	of	ADP
ajlm-1645	106	24	myelodysplastic	myelodysplastic	ADJ
ajlm-1645	106	25	syndrome	syndrome	NOUN
ajlm-1645	106	26	cases	case	NOUN
ajlm-1645	106	27	.	.	PUNCT
ajlm-1645	107	1	the	the	DET
ajlm-1645	107	2	number	number	NOUN
ajlm-1645	107	3	of	of	ADP
ajlm-1645	107	4	cases	case	NOUN
ajlm-1645	107	5	of	of	ADP
ajlm-1645	107	6	sepsis	sepsis	NOUN
ajlm-1645	107	7	,	,	PUNCT
ajlm-1645	107	8	megaloblastic	megaloblastic	ADJ
ajlm-1645	107	9	anaemia	anaemia	NOUN
ajlm-1645	107	10	and	and	CCONJ
ajlm-1645	107	11	aplastic	aplastic	ADJ
ajlm-1645	107	12	anaemia	anaemia	NOUN
ajlm-1645	107	13	did	do	AUX
ajlm-1645	107	14	not	not	PART
ajlm-1645	107	15	significantly	significantly	ADV
ajlm-1645	107	16	differ	differ	VERB
ajlm-1645	107	17	between	between	ADP
ajlm-1645	107	18	the	the	DET
ajlm-1645	107	19	age	age	NOUN
ajlm-1645	107	20	categories	category	NOUN
ajlm-1645	107	21	.	.	PUNCT
ajlm-1645	108	1	figure	figure	VERB
ajlm-1645	108	2	5	5	NUM
ajlm-1645	108	3	:	:	PUNCT
ajlm-1645	108	4	most	most	ADV
ajlm-1645	108	5	common	common	ADJ
ajlm-1645	108	6	causes	cause	NOUN
ajlm-1645	108	7	of	of	ADP
ajlm-1645	108	8	non	non	ADJ
ajlm-1645	108	9	-	-	ADJ
ajlm-1645	108	10	treatment	treatment	NOUN
ajlm-1645	108	11	-	-	PUNCT
ajlm-1645	108	12	related	relate	VERB
ajlm-1645	108	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	108	14	among	among	ADP
ajlm-1645	108	15	adult	adult	NOUN
ajlm-1645	108	16	patients	patient	NOUN
ajlm-1645	108	17	at	at	ADP
ajlm-1645	108	18	tygerberg	tygerberg	PROPN
ajlm-1645	108	19	academic	academic	ADJ
ajlm-1645	108	20	hospital	hospital	NOUN
ajlm-1645	108	21	,	,	PUNCT
ajlm-1645	108	22	cape	cape	NOUN
ajlm-1645	108	23	town	town	NOUN
ajlm-1645	108	24	,	,	PUNCT
ajlm-1645	108	25	south	south	PROPN
ajlm-1645	108	26	africa	africa	PROPN
ajlm-1645	108	27	,	,	PUNCT
ajlm-1645	108	28	from	from	ADP
ajlm-1645	108	29	january	january	PROPN
ajlm-1645	108	30	2016	2016	NUM
ajlm-1645	108	31	to	to	ADP
ajlm-1645	108	32	december	december	PROPN
ajlm-1645	108	33	2017	2017	NUM
ajlm-1645	108	34	.	.	PUNCT
ajlm-1645	109	1	(	(	PUNCT
ajlm-1645	109	2	a	a	X
ajlm-1645	109	3	)	)	PUNCT
ajlm-1645	109	4	all	all	DET
ajlm-1645	109	5	patients	patient	NOUN
ajlm-1645	109	6	(	(	PUNCT
ajlm-1645	109	7	n	n	NOUN
ajlm-1645	109	8	=	=	SYM
ajlm-1645	109	9	507	507	NUM
ajlm-1645	109	10	)	)	PUNCT
ajlm-1645	109	11	,	,	PUNCT
ajlm-1645	109	12	(	(	PUNCT
ajlm-1645	109	13	b	b	X
ajlm-1645	109	14	)	)	PUNCT
ajlm-1645	109	15	18–39	18–39	NUM
ajlm-1645	109	16	years	year	NOUN
ajlm-1645	109	17	old	old	ADJ
ajlm-1645	109	18	(	(	PUNCT
ajlm-1645	109	19	n	n	NOUN
ajlm-1645	109	20	=	=	SYM
ajlm-1645	109	21	250	250	NUM
ajlm-1645	109	22	)	)	PUNCT
ajlm-1645	109	23	,	,	PUNCT
ajlm-1645	109	24	(	(	PUNCT
ajlm-1645	109	25	c	c	X
ajlm-1645	109	26	)	)	PUNCT
ajlm-1645	109	27	40–59	40–59	NUM
ajlm-1645	109	28	years	year	NOUN
ajlm-1645	109	29	old	old	ADJ
ajlm-1645	109	30	(	(	PUNCT
ajlm-1645	109	31	n	n	NOUN
ajlm-1645	109	32	=	=	SYM
ajlm-1645	109	33	172	172	NUM
ajlm-1645	109	34	)	)	PUNCT
ajlm-1645	109	35	,	,	PUNCT
ajlm-1645	109	36	(	(	PUNCT
ajlm-1645	109	37	d	d	X
ajlm-1645	109	38	)	)	PUNCT
ajlm-1645	109	39	60–89	60–89	NUM
ajlm-1645	109	40	years	year	NOUN
ajlm-1645	109	41	old	old	ADJ
ajlm-1645	109	42	(	(	PUNCT
ajlm-1645	109	43	n	n	NOUN
ajlm-1645	109	44	=	=	NUM
ajlm-1645	109	45	85	85	NUM
ajlm-1645	109	46	)	)	PUNCT
ajlm-1645	109	47	.	.	PUNCT
ajlm-1645	110	1	discussion	discussion	NOUN
ajlm-1645	110	2	this	this	DET
ajlm-1645	110	3	study	study	NOUN
ajlm-1645	110	4	showed	show	VERB
ajlm-1645	110	5	that	that	SCONJ
ajlm-1645	110	6	chemoradiation	chemoradiation	NOUN
ajlm-1645	110	7	therapy	therapy	NOUN
ajlm-1645	110	8	was	be	AUX
ajlm-1645	110	9	the	the	DET
ajlm-1645	110	10	most	most	ADV
ajlm-1645	110	11	common	common	ADJ
ajlm-1645	110	12	cause	cause	NOUN
ajlm-1645	110	13	of	of	ADP
ajlm-1645	110	14	pancytopenia	pancytopenia	NOUN
ajlm-1645	110	15	in	in	ADP
ajlm-1645	110	16	adult	adult	NOUN
ajlm-1645	110	17	patients	patient	NOUN
ajlm-1645	110	18	at	at	ADP
ajlm-1645	110	19	a	a	DET
ajlm-1645	110	20	south	south	ADJ
ajlm-1645	110	21	african	african	ADJ
ajlm-1645	110	22	tertiary	tertiary	ADJ
ajlm-1645	110	23	academic	academic	ADJ
ajlm-1645	110	24	centre	centre	NOUN
ajlm-1645	110	25	.	.	PUNCT
ajlm-1645	111	1	the	the	DET
ajlm-1645	111	2	most	most	ADV
ajlm-1645	111	3	common	common	ADJ
ajlm-1645	111	4	non	non	ADJ
ajlm-1645	111	5	-	-	ADJ
ajlm-1645	111	6	treatment	treatment	NOUN
ajlm-1645	111	7	-	-	PUNCT
ajlm-1645	111	8	related	relate	VERB
ajlm-1645	111	9	causes	cause	NOUN
ajlm-1645	111	10	of	of	ADP
ajlm-1645	111	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	111	12	were	be	AUX
ajlm-1645	111	13	sepsis	sepsis	NOUN
ajlm-1645	111	14	,	,	PUNCT
ajlm-1645	111	15	hm	hm	INTJ
ajlm-1645	111	16	,	,	PUNCT
ajlm-1645	111	17	advanced	advanced	ADJ
ajlm-1645	111	18	hiv	hiv	PROPN
ajlm-1645	111	19	,	,	PUNCT
ajlm-1645	111	20	and	and	CCONJ
ajlm-1645	111	21	megaloblastic	megaloblastic	ADJ
ajlm-1645	111	22	anaemia	anaemia	NOUN
ajlm-1645	111	23	.	.	PUNCT
ajlm-1645	112	1	the	the	DET
ajlm-1645	112	2	aetiology	aetiology	NOUN
ajlm-1645	112	3	of	of	ADP
ajlm-1645	112	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	112	5	as	as	SCONJ
ajlm-1645	112	6	found	find	VERB
ajlm-1645	112	7	in	in	ADP
ajlm-1645	112	8	our	our	PRON
ajlm-1645	112	9	study	study	NOUN
ajlm-1645	112	10	is	be	AUX
ajlm-1645	112	11	comparable	comparable	ADJ
ajlm-1645	112	12	to	to	ADP
ajlm-1645	112	13	the	the	DET
ajlm-1645	112	14	findings	finding	NOUN
ajlm-1645	112	15	of	of	ADP
ajlm-1645	112	16	a	a	DET
ajlm-1645	112	17	previous	previous	ADJ
ajlm-1645	112	18	south	south	ADJ
ajlm-1645	112	19	african	african	ADJ
ajlm-1645	112	20	tertiary	tertiary	ADJ
ajlm-1645	112	21	institution	institution	NOUN
ajlm-1645	112	22	study.38	study.38	NOUN
ajlm-1645	112	23	their	their	PRON
ajlm-1645	112	24	study	study	NOUN
ajlm-1645	112	25	showed	show	VERB
ajlm-1645	112	26	chemoradiation	chemoradiation	NOUN
ajlm-1645	112	27	therapy	therapy	NOUN
ajlm-1645	112	28	to	to	PART
ajlm-1645	112	29	be	be	AUX
ajlm-1645	112	30	the	the	DET
ajlm-1645	112	31	most	most	ADV
ajlm-1645	112	32	common	common	ADJ
ajlm-1645	112	33	cause	cause	NOUN
ajlm-1645	112	34	of	of	ADP
ajlm-1645	112	35	pancytopenia	pancytopenia	NOUN
ajlm-1645	112	36	and	and	CCONJ
ajlm-1645	112	37	revealed	reveal	VERB
ajlm-1645	112	38	infection	infection	NOUN
ajlm-1645	112	39	as	as	ADP
ajlm-1645	112	40	another	another	DET
ajlm-1645	112	41	prominent	prominent	ADJ
ajlm-1645	112	42	cause.38	cause.38	NOUN
ajlm-1645	112	43	haematological	haematological	ADJ
ajlm-1645	112	44	malignancy	malignancy	NOUN
ajlm-1645	112	45	,	,	PUNCT
ajlm-1645	112	46	which	which	PRON
ajlm-1645	112	47	was	be	AUX
ajlm-1645	112	48	not	not	PART
ajlm-1645	112	49	a	a	DET
ajlm-1645	112	50	prominent	prominent	ADJ
ajlm-1645	112	51	cause	cause	NOUN
ajlm-1645	112	52	of	of	ADP
ajlm-1645	112	53	pancytopenia	pancytopenia	NOUN
ajlm-1645	112	54	in	in	ADP
ajlm-1645	112	55	their	their	PRON
ajlm-1645	112	56	study	study	NOUN
ajlm-1645	112	57	,	,	PUNCT
ajlm-1645	112	58	was	be	AUX
ajlm-1645	112	59	the	the	DET
ajlm-1645	112	60	third	third	ADJ
ajlm-1645	112	61	most	most	ADV
ajlm-1645	112	62	common	common	ADJ
ajlm-1645	112	63	cause	cause	NOUN
ajlm-1645	112	64	of	of	ADP
ajlm-1645	112	65	pancytopenia	pancytopenia	NOUN
ajlm-1645	112	66	in	in	ADP
ajlm-1645	112	67	this	this	DET
ajlm-1645	112	68	study	study	NOUN
ajlm-1645	112	69	.	.	PUNCT
ajlm-1645	113	1	infection	infection	NOUN
ajlm-1645	113	2	,	,	PUNCT
ajlm-1645	113	3	megaloblastic	megaloblastic	ADJ
ajlm-1645	113	4	anaemia	anaemia	NOUN
ajlm-1645	113	5	and	and	CCONJ
ajlm-1645	113	6	aplastic	aplastic	ADJ
ajlm-1645	113	7	anaemia	anaemia	NOUN
ajlm-1645	113	8	are	be	AUX
ajlm-1645	113	9	common	common	ADJ
ajlm-1645	113	10	causes	cause	NOUN
ajlm-1645	113	11	of	of	ADP
ajlm-1645	113	12	pancytopenia	pancytopenia	NOUN
ajlm-1645	113	13	in	in	ADP
ajlm-1645	113	14	developing	develop	VERB
ajlm-1645	113	15	countries	country	NOUN
ajlm-1645	113	16	while	while	SCONJ
ajlm-1645	113	17	hm	hm	INTJ
ajlm-1645	113	18	is	be	VERB
ajlm-1645	113	19	the	the	DET
ajlm-1645	113	20	most	most	ADV
ajlm-1645	113	21	common	common	ADJ
ajlm-1645	113	22	cause	cause	NOUN
ajlm-1645	113	23	in	in	ADP
ajlm-1645	113	24	developed	develop	VERB
ajlm-1645	113	25	countries	country	NOUN
ajlm-1645	113	26	(	(	PUNCT
ajlm-1645	113	27	table	table	NOUN
ajlm-1645	113	28	1	1	NUM
ajlm-1645	113	29	)	)	PUNCT
ajlm-1645	113	30	.	.	PUNCT
ajlm-1645	114	1	in	in	ADP
ajlm-1645	114	2	comparison	comparison	NOUN
ajlm-1645	114	3	to	to	ADP
ajlm-1645	114	4	the	the	DET
ajlm-1645	114	5	aetiologies	aetiology	NOUN
ajlm-1645	114	6	of	of	ADP
ajlm-1645	114	7	pancytopenia	pancytopenia	PROPN
ajlm-1645	114	8	described	describe	VERB
ajlm-1645	114	9	by	by	ADP
ajlm-1645	114	10	studies	study	NOUN
ajlm-1645	114	11	across	across	ADP
ajlm-1645	114	12	the	the	DET
ajlm-1645	114	13	world	world	NOUN
ajlm-1645	114	14	,	,	PUNCT
ajlm-1645	114	15	our	our	PRON
ajlm-1645	114	16	study	study	NOUN
ajlm-1645	114	17	shows	show	VERB
ajlm-1645	114	18	features	feature	VERB
ajlm-1645	114	19	common	common	ADJ
ajlm-1645	114	20	to	to	ADP
ajlm-1645	114	21	both	both	CCONJ
ajlm-1645	114	22	developing	develop	VERB
ajlm-1645	114	23	and	and	CCONJ
ajlm-1645	114	24	developed	developed	ADJ
ajlm-1645	114	25	countries	country	NOUN
ajlm-1645	114	26	.	.	PUNCT
ajlm-1645	115	1	this	this	PRON
ajlm-1645	115	2	is	be	AUX
ajlm-1645	115	3	similar	similar	ADJ
ajlm-1645	115	4	to	to	ADP
ajlm-1645	115	5	the	the	DET
ajlm-1645	115	6	findings	finding	NOUN
ajlm-1645	115	7	of	of	ADP
ajlm-1645	115	8	a	a	DET
ajlm-1645	115	9	study	study	NOUN
ajlm-1645	115	10	performed	perform	VERB
ajlm-1645	115	11	in	in	ADP
ajlm-1645	115	12	mexico	mexico	PROPN
ajlm-1645	115	13	where	where	SCONJ
ajlm-1645	115	14	the	the	DET
ajlm-1645	115	15	most	most	ADV
ajlm-1645	115	16	common	common	ADJ
ajlm-1645	115	17	causes	cause	NOUN
ajlm-1645	115	18	of	of	ADP
ajlm-1645	115	19	pancytopenia	pancytopenia	NOUN
ajlm-1645	115	20	were	be	AUX
ajlm-1645	115	21	hm	hm	INTJ
ajlm-1645	115	22	and	and	CCONJ
ajlm-1645	115	23	megaloblastic	megaloblastic	ADJ
ajlm-1645	115	24	anaemia.32	anaemia.32	VERB
ajlm-1645	115	25	in	in	ADP
ajlm-1645	115	26	south	south	PROPN
ajlm-1645	115	27	africa	africa	PROPN
ajlm-1645	115	28	,	,	PUNCT
ajlm-1645	115	29	there	there	PRON
ajlm-1645	115	30	are	be	VERB
ajlm-1645	115	31	considerable	considerable	ADJ
ajlm-1645	115	32	differences	difference	NOUN
ajlm-1645	115	33	in	in	ADP
ajlm-1645	115	34	access	access	NOUN
ajlm-1645	115	35	to	to	ADP
ajlm-1645	115	36	health	health	NOUN
ajlm-1645	115	37	services	service	NOUN
ajlm-1645	115	38	between	between	ADP
ajlm-1645	115	39	socio	socio	NOUN
ajlm-1645	115	40	-	-	PUNCT
ajlm-1645	115	41	economic	economic	ADJ
ajlm-1645	115	42	groups	group	NOUN
ajlm-1645	115	43	,	,	PUNCT
ajlm-1645	115	44	and	and	CCONJ
ajlm-1645	115	45	the	the	DET
ajlm-1645	115	46	poor	poor	ADJ
ajlm-1645	115	47	face	face	VERB
ajlm-1645	115	48	many	many	ADJ
ajlm-1645	115	49	predisposing	predispose	VERB
ajlm-1645	115	50	factors	factor	NOUN
ajlm-1645	115	51	that	that	PRON
ajlm-1645	115	52	are	be	AUX
ajlm-1645	115	53	recognised	recognise	VERB
ajlm-1645	115	54	as	as	ADP
ajlm-1645	115	55	social	social	ADJ
ajlm-1645	115	56	determinants	determinant	NOUN
ajlm-1645	115	57	of	of	ADP
ajlm-1645	115	58	ill	ill	ADJ
ajlm-1645	115	59	health.49	health.49	ADP
ajlm-1645	115	60	hiv	hiv	PROPN
ajlm-1645	115	61	and	and	CCONJ
ajlm-1645	115	62	other	other	ADJ
ajlm-1645	115	63	communicable	communicable	NOUN
ajlm-1645	115	64	diseases	disease	NOUN
ajlm-1645	115	65	are	be	AUX
ajlm-1645	115	66	concentrated	concentrate	VERB
ajlm-1645	115	67	among	among	ADP
ajlm-1645	115	68	the	the	DET
ajlm-1645	115	69	lower	low	ADJ
ajlm-1645	115	70	socio	socio	NOUN
ajlm-1645	115	71	-	-	PUNCT
ajlm-1645	115	72	economic	economic	ADJ
ajlm-1645	115	73	groups	group	NOUN
ajlm-1645	115	74	of	of	ADP
ajlm-1645	115	75	south	south	PROPN
ajlm-1645	115	76	africa.50	africa.50	PROPN
ajlm-1645	115	77	this	this	PRON
ajlm-1645	115	78	may	may	AUX
ajlm-1645	115	79	explain	explain	VERB
ajlm-1645	115	80	why	why	SCONJ
ajlm-1645	115	81	infections	infection	NOUN
ajlm-1645	115	82	contributed	contribute	VERB
ajlm-1645	115	83	considerably	considerably	ADV
ajlm-1645	115	84	to	to	ADP
ajlm-1645	115	85	the	the	DET
ajlm-1645	115	86	aetiology	aetiology	NOUN
ajlm-1645	115	87	of	of	ADP
ajlm-1645	115	88	pancytopenia	pancytopenia	NOUN
ajlm-1645	115	89	in	in	ADP
ajlm-1645	115	90	our	our	PRON
ajlm-1645	115	91	study	study	NOUN
ajlm-1645	115	92	.	.	PUNCT
ajlm-1645	116	1	table	table	NOUN
ajlm-1645	116	2	1	1	NUM
ajlm-1645	116	3	:	:	PUNCT
ajlm-1645	116	4	 	 	SPACE
ajlm-1645	116	5	most	most	ADV
ajlm-1645	116	6	common	common	ADJ
ajlm-1645	116	7	causes	cause	NOUN
ajlm-1645	116	8	of	of	ADP
ajlm-1645	116	9	pancytopenia	pancytopenia	NOUN
ajlm-1645	116	10	across	across	ADP
ajlm-1645	116	11	different	different	ADJ
ajlm-1645	116	12	studies	study	NOUN
ajlm-1645	116	13	globally	globally	ADV
ajlm-1645	116	14	,	,	PUNCT
ajlm-1645	116	15	1976–2019	1976–2019	NUM
ajlm-1645	116	16	.	.	PUNCT
ajlm-1645	117	1	advanced	advanced	PROPN
ajlm-1645	117	2	hiv	hiv	PROPN
ajlm-1645	117	3	was	be	AUX
ajlm-1645	117	4	found	find	VERB
ajlm-1645	117	5	to	to	PART
ajlm-1645	117	6	be	be	AUX
ajlm-1645	117	7	one	one	NUM
ajlm-1645	117	8	of	of	ADP
ajlm-1645	117	9	the	the	DET
ajlm-1645	117	10	common	common	ADJ
ajlm-1645	117	11	causes	cause	NOUN
ajlm-1645	117	12	of	of	ADP
ajlm-1645	117	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	117	14	in	in	ADP
ajlm-1645	117	15	our	our	PRON
ajlm-1645	117	16	study	study	NOUN
ajlm-1645	117	17	,	,	PUNCT
ajlm-1645	117	18	similar	similar	ADJ
ajlm-1645	117	19	to	to	ADP
ajlm-1645	117	20	studies	study	NOUN
ajlm-1645	117	21	performed	perform	VERB
ajlm-1645	117	22	in	in	ADP
ajlm-1645	117	23	zimbabwe	zimbabwe	PROPN
ajlm-1645	117	24	,	,	PUNCT
ajlm-1645	117	25	djibouti	djibouti	PROPN
ajlm-1645	117	26	,	,	PUNCT
ajlm-1645	117	27	india	india	PROPN
ajlm-1645	117	28	and	and	CCONJ
ajlm-1645	117	29	the	the	DET
ajlm-1645	117	30	united	united	ADJ
ajlm-1645	117	31	states.12,32,34,35	states.12,32,34,35	PROPN
ajlm-1645	117	32	in	in	ADP
ajlm-1645	117	33	our	our	PRON
ajlm-1645	117	34	study	study	NOUN
ajlm-1645	117	35	,	,	PUNCT
ajlm-1645	117	36	41	41	NUM
ajlm-1645	117	37	%	%	NOUN
ajlm-1645	117	38	of	of	ADP
ajlm-1645	117	39	patients	patient	NOUN
ajlm-1645	117	40	were	be	AUX
ajlm-1645	117	41	hiv	hiv	NOUN
ajlm-1645	117	42	-	-	PUNCT
ajlm-1645	117	43	positive	positive	ADJ
ajlm-1645	117	44	.	.	PUNCT
ajlm-1645	118	1	the	the	DET
ajlm-1645	118	2	majority	majority	NOUN
ajlm-1645	118	3	of	of	ADP
ajlm-1645	118	4	these	these	DET
ajlm-1645	118	5	patients	patient	NOUN
ajlm-1645	118	6	had	have	AUX
ajlm-1645	118	7	advanced	advance	VERB
ajlm-1645	118	8	hiv	hiv	PROPN
ajlm-1645	118	9	,	,	PUNCT
ajlm-1645	118	10	and	and	CCONJ
ajlm-1645	118	11	in	in	ADP
ajlm-1645	118	12	a	a	DET
ajlm-1645	118	13	quarter	quarter	NOUN
ajlm-1645	118	14	of	of	ADP
ajlm-1645	118	15	these	these	PRON
ajlm-1645	118	16	,	,	PUNCT
ajlm-1645	118	17	advanced	advanced	ADJ
ajlm-1645	118	18	hiv	hiv	PROPN
ajlm-1645	118	19	was	be	AUX
ajlm-1645	118	20	found	find	VERB
ajlm-1645	118	21	to	to	PART
ajlm-1645	118	22	be	be	AUX
ajlm-1645	118	23	the	the	DET
ajlm-1645	118	24	only	only	ADJ
ajlm-1645	118	25	identifiable	identifiable	ADJ
ajlm-1645	118	26	cause	cause	NOUN
ajlm-1645	118	27	of	of	ADP
ajlm-1645	118	28	pancytopenia	pancytopenia	NOUN
ajlm-1645	118	29	.	.	PUNCT
ajlm-1645	119	1	additionally	additionally	ADV
ajlm-1645	119	2	,	,	PUNCT
ajlm-1645	119	3	our	our	PRON
ajlm-1645	119	4	study	study	NOUN
ajlm-1645	119	5	showed	show	VERB
ajlm-1645	119	6	that	that	SCONJ
ajlm-1645	119	7	hiv	hiv	PROPN
ajlm-1645	119	8	status	status	NOUN
ajlm-1645	119	9	alters	alter	VERB
ajlm-1645	119	10	the	the	DET
ajlm-1645	119	11	aetiology	aetiology	NOUN
ajlm-1645	119	12	of	of	ADP
ajlm-1645	119	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	119	14	;	;	PUNCT
ajlm-1645	119	15	folate	folate	NOUN
ajlm-1645	119	16	deficiency	deficiency	NOUN
ajlm-1645	119	17	,	,	PUNCT
ajlm-1645	119	18	tuberculosis	tuberculosis	NOUN
ajlm-1645	119	19	and	and	CCONJ
ajlm-1645	119	20	thrombotic	thrombotic	ADJ
ajlm-1645	119	21	microangiopathy	microangiopathy	PROPN
ajlm-1645	119	22	were	be	AUX
ajlm-1645	119	23	significantly	significantly	ADV
ajlm-1645	119	24	more	more	ADV
ajlm-1645	119	25	common	common	ADJ
ajlm-1645	119	26	among	among	ADP
ajlm-1645	119	27	hiv	hiv	PROPN
ajlm-1645	119	28	-	-	PUNCT
ajlm-1645	119	29	positive	positive	ADJ
ajlm-1645	119	30	patients	patient	NOUN
ajlm-1645	119	31	,	,	PUNCT
ajlm-1645	119	32	while	while	SCONJ
ajlm-1645	119	33	aplastic	aplastic	ADJ
ajlm-1645	119	34	anaemia	anaemia	NOUN
ajlm-1645	119	35	and	and	CCONJ
ajlm-1645	119	36	hm	hm	INTJ
ajlm-1645	119	37	were	be	AUX
ajlm-1645	119	38	significantly	significantly	ADV
ajlm-1645	119	39	more	more	ADV
ajlm-1645	119	40	common	common	ADJ
ajlm-1645	119	41	among	among	ADP
ajlm-1645	119	42	hiv	hiv	PROPN
ajlm-1645	119	43	-	-	PUNCT
ajlm-1645	119	44	negative	negative	ADJ
ajlm-1645	119	45	patients	patient	NOUN
ajlm-1645	119	46	.	.	PUNCT
ajlm-1645	120	1	interestingly	interestingly	ADV
ajlm-1645	120	2	,	,	PUNCT
ajlm-1645	120	3	despite	despite	SCONJ
ajlm-1645	120	4	the	the	DET
ajlm-1645	120	5	known	know	VERB
ajlm-1645	120	6	risk	risk	NOUN
ajlm-1645	120	7	of	of	ADP
ajlm-1645	120	8	hiv	hiv	PROPN
ajlm-1645	120	9	-	-	PUNCT
ajlm-1645	120	10	associated	associate	VERB
ajlm-1645	120	11	lymphomas	lymphoma	NOUN
ajlm-1645	120	12	in	in	ADP
ajlm-1645	120	13	advanced	advanced	ADJ
ajlm-1645	120	14	hiv,51	hiv,51	PROPN
ajlm-1645	120	15	we	we	PRON
ajlm-1645	120	16	did	do	AUX
ajlm-1645	120	17	not	not	PART
ajlm-1645	120	18	find	find	VERB
ajlm-1645	120	19	an	an	DET
ajlm-1645	120	20	increase	increase	NOUN
ajlm-1645	120	21	in	in	ADP
ajlm-1645	120	22	hm	hm	ADV
ajlm-1645	120	23	-	-	PUNCT
ajlm-1645	120	24	associated	associate	VERB
ajlm-1645	120	25	pancytopenia	pancytopenia	NOUN
ajlm-1645	120	26	in	in	ADP
ajlm-1645	120	27	hiv	hiv	PROPN
ajlm-1645	120	28	-	-	PUNCT
ajlm-1645	120	29	positive	positive	ADJ
ajlm-1645	120	30	patients	patient	NOUN
ajlm-1645	120	31	.	.	PUNCT
ajlm-1645	121	1	this	this	PRON
ajlm-1645	121	2	may	may	AUX
ajlm-1645	121	3	be	be	AUX
ajlm-1645	121	4	because	because	SCONJ
ajlm-1645	121	5	lymphomas	lymphoma	NOUN
ajlm-1645	121	6	do	do	AUX
ajlm-1645	121	7	not	not	PART
ajlm-1645	121	8	typically	typically	ADV
ajlm-1645	121	9	cause	cause	VERB
ajlm-1645	121	10	pancytopenia	pancytopenia	NOUN
ajlm-1645	121	11	even	even	ADV
ajlm-1645	121	12	when	when	SCONJ
ajlm-1645	121	13	there	there	PRON
ajlm-1645	121	14	is	be	VERB
ajlm-1645	121	15	bone	bone	NOUN
ajlm-1645	121	16	marrow	marrow	NOUN
ajlm-1645	121	17	infiltration.52	infiltration.52	PROPN
ajlm-1645	121	18	haematological	haematological	ADJ
ajlm-1645	121	19	malignancies	malignancy	NOUN
ajlm-1645	121	20	were	be	AUX
ajlm-1645	121	21	a	a	DET
ajlm-1645	121	22	more	more	ADV
ajlm-1645	121	23	common	common	ADJ
ajlm-1645	121	24	cause	cause	NOUN
ajlm-1645	121	25	of	of	ADP
ajlm-1645	121	26	pancytopenia	pancytopenia	NOUN
ajlm-1645	121	27	in	in	ADP
ajlm-1645	121	28	our	our	PRON
ajlm-1645	121	29	study	study	NOUN
ajlm-1645	121	30	than	than	ADP
ajlm-1645	121	31	in	in	ADP
ajlm-1645	121	32	other	other	ADJ
ajlm-1645	121	33	studies	study	NOUN
ajlm-1645	121	34	performed	perform	VERB
ajlm-1645	121	35	in	in	ADP
ajlm-1645	121	36	developing	develop	VERB
ajlm-1645	121	37	nations	nation	NOUN
ajlm-1645	121	38	(	(	PUNCT
ajlm-1645	121	39	table	table	NOUN
ajlm-1645	121	40	1	1	NUM
ajlm-1645	121	41	)	)	PUNCT
ajlm-1645	121	42	.	.	PUNCT
ajlm-1645	122	1	the	the	DET
ajlm-1645	122	2	burden	burden	NOUN
ajlm-1645	122	3	of	of	ADP
ajlm-1645	122	4	cancer	cancer	NOUN
ajlm-1645	122	5	is	be	AUX
ajlm-1645	122	6	highest	high	ADJ
ajlm-1645	122	7	in	in	ADP
ajlm-1645	122	8	affluent	affluent	ADJ
ajlm-1645	122	9	regions	region	NOUN
ajlm-1645	122	10	and	and	CCONJ
ajlm-1645	122	11	is	be	AUX
ajlm-1645	122	12	thought	think	VERB
ajlm-1645	122	13	to	to	PART
ajlm-1645	122	14	be	be	AUX
ajlm-1645	122	15	associated	associate	VERB
ajlm-1645	122	16	with	with	ADP
ajlm-1645	122	17	diet	diet	NOUN
ajlm-1645	122	18	,	,	PUNCT
ajlm-1645	122	19	lifestyle	lifestyle	NOUN
ajlm-1645	122	20	and	and	CCONJ
ajlm-1645	122	21	environmental	environmental	ADJ
ajlm-1645	122	22	exposures	exposure	NOUN
ajlm-1645	122	23	.	.	PUNCT
ajlm-1645	123	1	with	with	ADP
ajlm-1645	123	2	increasing	increase	VERB
ajlm-1645	123	3	urbanisation	urbanisation	NOUN
ajlm-1645	123	4	and	and	CCONJ
ajlm-1645	123	5	globalisation	globalisation	NOUN
ajlm-1645	123	6	,	,	PUNCT
ajlm-1645	123	7	developing	develop	VERB
ajlm-1645	123	8	nations	nation	NOUN
ajlm-1645	123	9	are	be	AUX
ajlm-1645	123	10	increasingly	increasingly	ADV
ajlm-1645	123	11	exposed	expose	VERB
ajlm-1645	123	12	to	to	ADP
ajlm-1645	123	13	diet	diet	NOUN
ajlm-1645	123	14	and	and	CCONJ
ajlm-1645	123	15	lifestyle	lifestyle	NOUN
ajlm-1645	123	16	changes	change	NOUN
ajlm-1645	123	17	,	,	PUNCT
ajlm-1645	123	18	including	include	VERB
ajlm-1645	123	19	smoking	smoking	NOUN
ajlm-1645	123	20	,	,	PUNCT
ajlm-1645	123	21	a	a	DET
ajlm-1645	123	22	sedentary	sedentary	ADJ
ajlm-1645	123	23	lifestyle	lifestyle	NOUN
ajlm-1645	123	24	and	and	CCONJ
ajlm-1645	123	25	obesity	obesity	NOUN
ajlm-1645	123	26	,	,	PUNCT
ajlm-1645	123	27	which	which	PRON
ajlm-1645	123	28	were	be	AUX
ajlm-1645	123	29	previously	previously	ADV
ajlm-1645	123	30	mainly	mainly	ADV
ajlm-1645	123	31	seen	see	VERB
ajlm-1645	123	32	in	in	ADP
ajlm-1645	123	33	developed	develop	VERB
ajlm-1645	123	34	societies.53	societies.53	NOUN
ajlm-1645	123	35	in	in	ADP
ajlm-1645	123	36	addition	addition	NOUN
ajlm-1645	123	37	,	,	PUNCT
ajlm-1645	123	38	developing	develop	VERB
ajlm-1645	123	39	nations	nation	NOUN
ajlm-1645	123	40	have	have	VERB
ajlm-1645	123	41	an	an	DET
ajlm-1645	123	42	increased	increase	VERB
ajlm-1645	123	43	risk	risk	NOUN
ajlm-1645	123	44	of	of	ADP
ajlm-1645	123	45	viral	viral	ADJ
ajlm-1645	123	46	infection	infection	NOUN
ajlm-1645	123	47	,	,	PUNCT
ajlm-1645	123	48	including	include	VERB
ajlm-1645	123	49	infection	infection	NOUN
ajlm-1645	123	50	with	with	ADP
ajlm-1645	123	51	oncoviruses	oncoviruse	NOUN
ajlm-1645	123	52	,	,	PUNCT
ajlm-1645	123	53	which	which	PRON
ajlm-1645	123	54	can	can	AUX
ajlm-1645	123	55	lead	lead	VERB
ajlm-1645	123	56	to	to	ADP
ajlm-1645	123	57	malignancy.53	malignancy.53	NOUN
ajlm-1645	123	58	expensive	expensive	ADJ
ajlm-1645	123	59	diagnostic	diagnostic	ADJ
ajlm-1645	123	60	approaches	approach	NOUN
ajlm-1645	123	61	are	be	AUX
ajlm-1645	123	62	also	also	ADV
ajlm-1645	123	63	increasingly	increasingly	ADV
ajlm-1645	123	64	available	available	ADJ
ajlm-1645	123	65	in	in	ADP
ajlm-1645	123	66	tertiary	tertiary	ADJ
ajlm-1645	123	67	centres	centre	NOUN
ajlm-1645	123	68	,	,	PUNCT
ajlm-1645	123	69	allowing	allow	VERB
ajlm-1645	123	70	for	for	ADP
ajlm-1645	123	71	easier	easy	ADJ
ajlm-1645	123	72	diagnosis	diagnosis	NOUN
ajlm-1645	123	73	of	of	ADP
ajlm-1645	123	74	malignancy	malignancy	NOUN
ajlm-1645	123	75	,	,	PUNCT
ajlm-1645	123	76	which	which	PRON
ajlm-1645	123	77	may	may	AUX
ajlm-1645	123	78	be	be	AUX
ajlm-1645	123	79	missed	miss	VERB
ajlm-1645	123	80	in	in	ADP
ajlm-1645	123	81	rural	rural	ADJ
ajlm-1645	123	82	regions	region	NOUN
ajlm-1645	123	83	or	or	CCONJ
ajlm-1645	123	84	countries	country	NOUN
ajlm-1645	123	85	with	with	ADP
ajlm-1645	123	86	fewer	few	ADJ
ajlm-1645	123	87	resources	resource	NOUN
ajlm-1645	123	88	.	.	PUNCT
ajlm-1645	124	1	these	these	DET
ajlm-1645	124	2	factors	factor	NOUN
ajlm-1645	124	3	are	be	AUX
ajlm-1645	124	4	likely	likely	ADV
ajlm-1645	124	5	contributing	contribute	VERB
ajlm-1645	124	6	to	to	ADP
ajlm-1645	124	7	the	the	DET
ajlm-1645	124	8	changing	change	VERB
ajlm-1645	124	9	landscape	landscape	NOUN
ajlm-1645	124	10	of	of	ADP
ajlm-1645	124	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	124	12	aetiology	aetiology	NOUN
ajlm-1645	124	13	in	in	ADP
ajlm-1645	124	14	south	south	PROPN
ajlm-1645	124	15	africa	africa	PROPN
ajlm-1645	124	16	.	.	PUNCT
ajlm-1645	125	1	megaloblastic	megaloblastic	ADJ
ajlm-1645	125	2	anaemia	anaemia	NOUN
ajlm-1645	125	3	as	as	ADP
ajlm-1645	125	4	a	a	DET
ajlm-1645	125	5	cause	cause	NOUN
ajlm-1645	125	6	of	of	ADP
ajlm-1645	125	7	pancytopenia	pancytopenia	NOUN
ajlm-1645	125	8	was	be	AUX
ajlm-1645	125	9	not	not	PART
ajlm-1645	125	10	as	as	ADV
ajlm-1645	125	11	prevalent	prevalent	ADJ
ajlm-1645	125	12	in	in	ADP
ajlm-1645	125	13	our	our	PRON
ajlm-1645	125	14	study	study	NOUN
ajlm-1645	125	15	as	as	ADP
ajlm-1645	125	16	in	in	ADP
ajlm-1645	125	17	studies	study	NOUN
ajlm-1645	125	18	performed	perform	VERB
ajlm-1645	125	19	in	in	ADP
ajlm-1645	125	20	india3,4,5,7,8,9,10,11,13,15	india3,4,5,7,8,9,10,11,13,15	ADJ
ajlm-1645	125	21	and	and	CCONJ
ajlm-1645	125	22	the	the	DET
ajlm-1645	125	23	rest	rest	NOUN
ajlm-1645	125	24	of	of	ADP
ajlm-1645	125	25	africa.34,35,36,37	africa.34,35,36,37	PROPN
ajlm-1645	125	26	this	this	PRON
ajlm-1645	125	27	is	be	AUX
ajlm-1645	125	28	likely	likely	ADJ
ajlm-1645	125	29	because	because	SCONJ
ajlm-1645	125	30	the	the	DET
ajlm-1645	125	31	south	south	ADJ
ajlm-1645	125	32	african	african	ADJ
ajlm-1645	125	33	government	government	NOUN
ajlm-1645	125	34	introduced	introduce	VERB
ajlm-1645	125	35	legislation	legislation	NOUN
ajlm-1645	125	36	in	in	ADP
ajlm-1645	125	37	2003	2003	NUM
ajlm-1645	125	38	for	for	ADP
ajlm-1645	125	39	the	the	DET
ajlm-1645	125	40	mandatory	mandatory	ADJ
ajlm-1645	125	41	folate	folate	NOUN
ajlm-1645	125	42	fortification	fortification	NOUN
ajlm-1645	125	43	of	of	ADP
ajlm-1645	125	44	the	the	DET
ajlm-1645	125	45	staple	staple	NOUN
ajlm-1645	125	46	maize	maize	NOUN
ajlm-1645	125	47	meal	meal	NOUN
ajlm-1645	125	48	and	and	CCONJ
ajlm-1645	125	49	wheat	wheat	NOUN
ajlm-1645	125	50	flour.57,58	flour.57,58	NOUN
ajlm-1645	125	51	nevertheless	nevertheless	ADV
ajlm-1645	125	52	,	,	PUNCT
ajlm-1645	125	53	folate	folate	NOUN
ajlm-1645	125	54	deficiency	deficiency	NOUN
ajlm-1645	125	55	was	be	AUX
ajlm-1645	125	56	more	more	ADV
ajlm-1645	125	57	common	common	ADJ
ajlm-1645	125	58	in	in	ADP
ajlm-1645	125	59	hiv	hiv	PROPN
ajlm-1645	125	60	-	-	PUNCT
ajlm-1645	125	61	positive	positive	ADJ
ajlm-1645	125	62	patients	patient	NOUN
ajlm-1645	125	63	than	than	ADP
ajlm-1645	125	64	in	in	ADP
ajlm-1645	125	65	hiv	hiv	PROPN
ajlm-1645	125	66	-	-	PUNCT
ajlm-1645	125	67	negative	negative	ADJ
ajlm-1645	125	68	patients	patient	NOUN
ajlm-1645	125	69	in	in	ADP
ajlm-1645	125	70	this	this	DET
ajlm-1645	125	71	study	study	NOUN
ajlm-1645	125	72	,	,	PUNCT
ajlm-1645	125	73	likely	likely	ADV
ajlm-1645	125	74	reflecting	reflect	VERB
ajlm-1645	125	75	poor	poor	ADJ
ajlm-1645	125	76	folate	folate	NOUN
ajlm-1645	125	77	absorption	absorption	NOUN
ajlm-1645	125	78	due	due	ADP
ajlm-1645	125	79	to	to	ADP
ajlm-1645	125	80	hiv	hiv	PROPN
ajlm-1645	125	81	-	-	PUNCT
ajlm-1645	125	82	associated	associate	VERB
ajlm-1645	125	83	gastrointestinal	gastrointestinal	ADJ
ajlm-1645	125	84	disease	disease	NOUN
ajlm-1645	125	85	.	.	PUNCT
ajlm-1645	126	1	importantly	importantly	ADV
ajlm-1645	126	2	,	,	PUNCT
ajlm-1645	126	3	six	six	NUM
ajlm-1645	126	4	of	of	ADP
ajlm-1645	126	5	the	the	DET
ajlm-1645	126	6	48	48	NUM
ajlm-1645	126	7	patients	patient	NOUN
ajlm-1645	126	8	with	with	ADP
ajlm-1645	126	9	megaloblastic	megaloblastic	ADJ
ajlm-1645	126	10	anaemia	anaemia	NOUN
ajlm-1645	126	11	in	in	ADP
ajlm-1645	126	12	our	our	PRON
ajlm-1645	126	13	study	study	NOUN
ajlm-1645	126	14	had	have	VERB
ajlm-1645	126	15	an	an	DET
ajlm-1645	126	16	underlying	underlying	ADJ
ajlm-1645	126	17	pathology	pathology	NOUN
ajlm-1645	126	18	leading	lead	VERB
ajlm-1645	126	19	to	to	ADP
ajlm-1645	126	20	depletion	depletion	NOUN
ajlm-1645	126	21	of	of	ADP
ajlm-1645	126	22	folate	folate	NOUN
ajlm-1645	126	23	reserve	reserve	NOUN
ajlm-1645	126	24	.	.	PUNCT
ajlm-1645	127	1	this	this	PRON
ajlm-1645	127	2	highlights	highlight	VERB
ajlm-1645	127	3	the	the	DET
ajlm-1645	127	4	importance	importance	NOUN
ajlm-1645	127	5	of	of	ADP
ajlm-1645	127	6	follow	follow	NOUN
ajlm-1645	127	7	-	-	PUNCT
ajlm-1645	127	8	up	up	NOUN
ajlm-1645	127	9	in	in	ADP
ajlm-1645	127	10	patients	patient	NOUN
ajlm-1645	127	11	with	with	ADP
ajlm-1645	127	12	haematinic	haematinic	ADJ
ajlm-1645	127	13	deficiencies	deficiency	NOUN
ajlm-1645	127	14	and	and	CCONJ
ajlm-1645	127	15	the	the	DET
ajlm-1645	127	16	importance	importance	NOUN
ajlm-1645	127	17	of	of	ADP
ajlm-1645	127	18	further	further	ADJ
ajlm-1645	127	19	investigation	investigation	NOUN
ajlm-1645	127	20	if	if	SCONJ
ajlm-1645	127	21	there	there	PRON
ajlm-1645	127	22	is	be	VERB
ajlm-1645	127	23	a	a	DET
ajlm-1645	127	24	poor	poor	ADJ
ajlm-1645	127	25	response	response	NOUN
ajlm-1645	127	26	to	to	ADP
ajlm-1645	127	27	the	the	DET
ajlm-1645	127	28	haematinic	haematinic	ADJ
ajlm-1645	127	29	replacement	replacement	NOUN
ajlm-1645	127	30	or	or	CCONJ
ajlm-1645	127	31	clinical	clinical	ADJ
ajlm-1645	127	32	suspicion	suspicion	NOUN
ajlm-1645	127	33	of	of	ADP
ajlm-1645	127	34	an	an	DET
ajlm-1645	127	35	underlying	underlie	VERB
ajlm-1645	127	36	condition	condition	NOUN
ajlm-1645	127	37	.	.	PUNCT
ajlm-1645	128	1	the	the	DET
ajlm-1645	128	2	aetiology	aetiology	NOUN
ajlm-1645	128	3	of	of	ADP
ajlm-1645	128	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	128	5	also	also	ADV
ajlm-1645	128	6	varied	varied	ADJ
ajlm-1645	128	7	with	with	ADP
ajlm-1645	128	8	age	age	NOUN
ajlm-1645	128	9	.	.	PUNCT
ajlm-1645	129	1	there	there	PRON
ajlm-1645	129	2	were	be	VERB
ajlm-1645	129	3	significantly	significantly	ADV
ajlm-1645	129	4	more	more	ADJ
ajlm-1645	129	5	malignancies	malignancy	NOUN
ajlm-1645	129	6	,	,	PUNCT
ajlm-1645	129	7	both	both	CCONJ
ajlm-1645	129	8	haematological	haematological	ADJ
ajlm-1645	129	9	and	and	CCONJ
ajlm-1645	129	10	non	non	ADJ
ajlm-1645	129	11	-	-	ADJ
ajlm-1645	129	12	haematological	haematological	ADJ
ajlm-1645	129	13	,	,	PUNCT
ajlm-1645	129	14	in	in	ADP
ajlm-1645	129	15	the	the	DET
ajlm-1645	129	16	age	age	NOUN
ajlm-1645	129	17	group	group	NOUN
ajlm-1645	129	18	60–89	60–89	NUM
ajlm-1645	129	19	years	year	NOUN
ajlm-1645	129	20	.	.	PUNCT
ajlm-1645	130	1	this	this	PRON
ajlm-1645	130	2	is	be	AUX
ajlm-1645	130	3	comparable	comparable	ADJ
ajlm-1645	130	4	to	to	ADP
ajlm-1645	130	5	the	the	DET
ajlm-1645	130	6	findings	finding	NOUN
ajlm-1645	130	7	of	of	ADP
ajlm-1645	130	8	studies	study	NOUN
ajlm-1645	130	9	in	in	ADP
ajlm-1645	130	10	turkey	turkey	PROPN
ajlm-1645	130	11	and	and	CCONJ
ajlm-1645	130	12	iran.45,46	iran.45,46	NOUN
ajlm-1645	130	13	globally	globally	ADV
ajlm-1645	130	14	,	,	PUNCT
ajlm-1645	130	15	malignancies	malignancy	NOUN
ajlm-1645	130	16	are	be	AUX
ajlm-1645	130	17	not	not	PART
ajlm-1645	130	18	a	a	DET
ajlm-1645	130	19	more	more	ADV
ajlm-1645	130	20	common	common	ADJ
ajlm-1645	130	21	cause	cause	NOUN
ajlm-1645	130	22	of	of	ADP
ajlm-1645	130	23	pancytopenia	pancytopenia	NOUN
ajlm-1645	130	24	in	in	ADP
ajlm-1645	130	25	older	old	ADJ
ajlm-1645	130	26	patients	patient	NOUN
ajlm-1645	130	27	.	.	PUNCT
ajlm-1645	131	1	in	in	ADP
ajlm-1645	131	2	studies	study	NOUN
ajlm-1645	131	3	conducted	conduct	VERB
ajlm-1645	131	4	in	in	ADP
ajlm-1645	131	5	india	india	PROPN
ajlm-1645	131	6	,	,	PUNCT
ajlm-1645	131	7	megaloblastic	megaloblastic	ADJ
ajlm-1645	131	8	anaemia	anaemia	NOUN
ajlm-1645	131	9	was	be	AUX
ajlm-1645	131	10	found	find	VERB
ajlm-1645	131	11	to	to	PART
ajlm-1645	131	12	be	be	AUX
ajlm-1645	131	13	the	the	DET
ajlm-1645	131	14	most	most	ADV
ajlm-1645	131	15	common	common	ADJ
ajlm-1645	131	16	cause	cause	NOUN
ajlm-1645	131	17	of	of	ADP
ajlm-1645	131	18	pancytopenia	pancytopenia	NOUN
ajlm-1645	131	19	,	,	PUNCT
ajlm-1645	131	20	with	with	ADP
ajlm-1645	131	21	no	no	DET
ajlm-1645	131	22	noticeably	noticeably	ADV
ajlm-1645	131	23	higher	high	ADJ
ajlm-1645	131	24	frequency	frequency	NOUN
ajlm-1645	131	25	of	of	ADP
ajlm-1645	131	26	malignancy	malignancy	NOUN
ajlm-1645	131	27	among	among	ADP
ajlm-1645	131	28	older	old	ADJ
ajlm-1645	131	29	people.6,12,15	people.6,12,15	VERB
ajlm-1645	131	30	the	the	DET
ajlm-1645	131	31	substantial	substantial	ADJ
ajlm-1645	131	32	variation	variation	NOUN
ajlm-1645	131	33	in	in	ADP
ajlm-1645	131	34	the	the	DET
ajlm-1645	131	35	frequency	frequency	NOUN
ajlm-1645	131	36	of	of	ADP
ajlm-1645	131	37	malignancy	malignancy	NOUN
ajlm-1645	131	38	as	as	ADP
ajlm-1645	131	39	a	a	DET
ajlm-1645	131	40	cause	cause	NOUN
ajlm-1645	131	41	of	of	ADP
ajlm-1645	131	42	pancytopenia	pancytopenia	NOUN
ajlm-1645	131	43	in	in	ADP
ajlm-1645	131	44	the	the	DET
ajlm-1645	131	45	elderly	elderly	ADJ
ajlm-1645	131	46	is	be	AUX
ajlm-1645	131	47	most	most	ADV
ajlm-1645	131	48	likely	likely	ADJ
ajlm-1645	131	49	due	due	ADJ
ajlm-1645	131	50	to	to	ADP
ajlm-1645	131	51	regional	regional	ADJ
ajlm-1645	131	52	risk	risk	NOUN
ajlm-1645	131	53	factors	factor	NOUN
ajlm-1645	131	54	for	for	ADP
ajlm-1645	131	55	megaloblastic	megaloblastic	ADJ
ajlm-1645	131	56	anaemia	anaemia	NOUN
ajlm-1645	131	57	,	,	PUNCT
ajlm-1645	131	58	as	as	ADV
ajlm-1645	131	59	well	well	ADV
ajlm-1645	131	60	as	as	ADP
ajlm-1645	131	61	variable	variable	ADJ
ajlm-1645	131	62	availability	availability	NOUN
ajlm-1645	131	63	of	of	ADP
ajlm-1645	131	64	expensive	expensive	ADJ
ajlm-1645	131	65	diagnostic	diagnostic	ADJ
ajlm-1645	131	66	approaches	approach	NOUN
ajlm-1645	131	67	such	such	ADJ
ajlm-1645	131	68	as	as	ADP
ajlm-1645	131	69	flow	flow	NOUN
ajlm-1645	131	70	cytometry	cytometry	NOUN
ajlm-1645	131	71	,	,	PUNCT
ajlm-1645	131	72	cytogenetics	cytogenetic	NOUN
ajlm-1645	131	73	and	and	CCONJ
ajlm-1645	131	74	next	next	ADJ
ajlm-1645	131	75	-	-	PUNCT
ajlm-1645	131	76	generation	generation	NOUN
ajlm-1645	131	77	sequencing	sequencing	NOUN
ajlm-1645	131	78	for	for	ADP
ajlm-1645	131	79	the	the	DET
ajlm-1645	131	80	diagnosis	diagnosis	NOUN
ajlm-1645	131	81	of	of	ADP
ajlm-1645	131	82	malignancy	malignancy	NOUN
ajlm-1645	131	83	.	.	PUNCT
ajlm-1645	132	1	the	the	DET
ajlm-1645	132	2	findings	finding	NOUN
ajlm-1645	132	3	of	of	ADP
ajlm-1645	132	4	this	this	DET
ajlm-1645	132	5	study	study	NOUN
ajlm-1645	132	6	highlight	highlight	VERB
ajlm-1645	132	7	that	that	PRON
ajlm-1645	132	8	good	good	ADJ
ajlm-1645	132	9	clinical	clinical	ADJ
ajlm-1645	132	10	and	and	CCONJ
ajlm-1645	132	11	laboratory	laboratory	NOUN
ajlm-1645	132	12	correlation	correlation	NOUN
ajlm-1645	132	13	is	be	AUX
ajlm-1645	132	14	required	require	VERB
ajlm-1645	132	15	for	for	ADP
ajlm-1645	132	16	prompt	prompt	ADJ
ajlm-1645	132	17	and	and	CCONJ
ajlm-1645	132	18	cost	cost	NOUN
ajlm-1645	132	19	-	-	PUNCT
ajlm-1645	132	20	effective	effective	ADJ
ajlm-1645	132	21	identification	identification	NOUN
ajlm-1645	132	22	of	of	ADP
ajlm-1645	132	23	the	the	DET
ajlm-1645	132	24	underlying	underlying	ADJ
ajlm-1645	132	25	cause	cause	NOUN
ajlm-1645	132	26	of	of	ADP
ajlm-1645	132	27	pancytopenia	pancytopenia	NOUN
ajlm-1645	132	28	to	to	PART
ajlm-1645	132	29	guide	guide	VERB
ajlm-1645	132	30	management	management	NOUN
ajlm-1645	132	31	.	.	PUNCT
ajlm-1645	133	1	chemoradiation	chemoradiation	NOUN
ajlm-1645	133	2	is	be	AUX
ajlm-1645	133	3	a	a	DET
ajlm-1645	133	4	predictable	predictable	ADJ
ajlm-1645	133	5	cause	cause	NOUN
ajlm-1645	133	6	of	of	ADP
ajlm-1645	133	7	pancytopenia	pancytopenia	NOUN
ajlm-1645	133	8	;	;	PUNCT
ajlm-1645	133	9	however	however	ADV
ajlm-1645	133	10	,	,	PUNCT
ajlm-1645	133	11	cell	cell	NOUN
ajlm-1645	133	12	counts	count	NOUN
ajlm-1645	133	13	should	should	AUX
ajlm-1645	133	14	also	also	ADV
ajlm-1645	133	15	be	be	AUX
ajlm-1645	133	16	monitored	monitor	VERB
ajlm-1645	133	17	,	,	PUNCT
ajlm-1645	133	18	and	and	CCONJ
ajlm-1645	133	19	if	if	SCONJ
ajlm-1645	133	20	the	the	DET
ajlm-1645	133	21	cell	cell	NOUN
ajlm-1645	133	22	counts	count	VERB
ajlm-1645	133	23	do	do	AUX
ajlm-1645	133	24	not	not	PART
ajlm-1645	133	25	improve	improve	VERB
ajlm-1645	133	26	,	,	PUNCT
ajlm-1645	133	27	investigation	investigation	NOUN
ajlm-1645	133	28	for	for	ADP
ajlm-1645	133	29	vitamin	vitamin	NOUN
ajlm-1645	133	30	b12	b12	NOUN
ajlm-1645	133	31	/	/	SYM
ajlm-1645	133	32	folate	folate	NOUN
ajlm-1645	133	33	deficiency	deficiency	NOUN
ajlm-1645	133	34	or	or	CCONJ
ajlm-1645	133	35	marrow	marrow	NOUN
ajlm-1645	133	36	infiltration	infiltration	NOUN
ajlm-1645	133	37	should	should	AUX
ajlm-1645	133	38	be	be	AUX
ajlm-1645	133	39	performed	perform	VERB
ajlm-1645	133	40	.	.	PUNCT
ajlm-1645	134	1	sepsis	sepsis	NOUN
ajlm-1645	134	2	was	be	AUX
ajlm-1645	134	3	another	another	DET
ajlm-1645	134	4	easily	easily	ADV
ajlm-1645	134	5	identifiable	identifiable	ADJ
ajlm-1645	134	6	cause	cause	NOUN
ajlm-1645	134	7	of	of	ADP
ajlm-1645	134	8	pancytopenia	pancytopenia	NOUN
ajlm-1645	134	9	in	in	ADP
ajlm-1645	134	10	our	our	PRON
ajlm-1645	134	11	study	study	NOUN
ajlm-1645	134	12	.	.	PUNCT
ajlm-1645	135	1	the	the	DET
ajlm-1645	135	2	median	median	ADJ
ajlm-1645	135	3	time	time	NOUN
ajlm-1645	135	4	to	to	ADP
ajlm-1645	135	5	resolution	resolution	NOUN
ajlm-1645	135	6	of	of	ADP
ajlm-1645	135	7	sepsis	sepsis	NOUN
ajlm-1645	135	8	-	-	PUNCT
ajlm-1645	135	9	induced	induce	VERB
ajlm-1645	135	10	pancytopenia	pancytopenia	NOUN
ajlm-1645	135	11	was	be	AUX
ajlm-1645	135	12	two	two	NUM
ajlm-1645	135	13	days	day	NOUN
ajlm-1645	135	14	.	.	PUNCT
ajlm-1645	136	1	therefore	therefore	ADV
ajlm-1645	136	2	,	,	PUNCT
ajlm-1645	136	3	when	when	SCONJ
ajlm-1645	136	4	sepsis	sepsis	NOUN
ajlm-1645	136	5	is	be	AUX
ajlm-1645	136	6	treated	treat	VERB
ajlm-1645	136	7	empirically	empirically	ADV
ajlm-1645	136	8	,	,	PUNCT
ajlm-1645	136	9	cell	cell	NOUN
ajlm-1645	136	10	counts	count	NOUN
ajlm-1645	136	11	should	should	AUX
ajlm-1645	136	12	be	be	AUX
ajlm-1645	136	13	monitored	monitor	VERB
ajlm-1645	136	14	for	for	ADP
ajlm-1645	136	15	recovery	recovery	NOUN
ajlm-1645	136	16	.	.	PUNCT
ajlm-1645	137	1	should	should	AUX
ajlm-1645	137	2	cell	cell	NOUN
ajlm-1645	137	3	counts	count	NOUN
ajlm-1645	137	4	fail	fail	VERB
ajlm-1645	137	5	to	to	PART
ajlm-1645	137	6	recover	recover	VERB
ajlm-1645	137	7	,	,	PUNCT
ajlm-1645	137	8	further	further	ADJ
ajlm-1645	137	9	investigation	investigation	NOUN
ajlm-1645	137	10	is	be	AUX
ajlm-1645	137	11	required	require	VERB
ajlm-1645	137	12	.	.	PUNCT
ajlm-1645	138	1	vitamin	vitamin	NOUN
ajlm-1645	138	2	b12	b12	NOUN
ajlm-1645	138	3	and	and	CCONJ
ajlm-1645	138	4	folate	folate	NOUN
ajlm-1645	138	5	deficiency	deficiency	NOUN
ajlm-1645	138	6	are	be	AUX
ajlm-1645	138	7	important	important	ADJ
ajlm-1645	138	8	to	to	PART
ajlm-1645	138	9	exclude	exclude	VERB
ajlm-1645	138	10	in	in	ADP
ajlm-1645	138	11	cases	case	NOUN
ajlm-1645	138	12	of	of	ADP
ajlm-1645	138	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	138	14	.	.	PUNCT
ajlm-1645	139	1	in	in	ADP
ajlm-1645	139	2	cases	case	NOUN
ajlm-1645	139	3	where	where	SCONJ
ajlm-1645	139	4	haematinic	haematinic	ADJ
ajlm-1645	139	5	deficiency	deficiency	NOUN
ajlm-1645	139	6	is	be	AUX
ajlm-1645	139	7	confirmed	confirm	VERB
ajlm-1645	139	8	based	base	VERB
ajlm-1645	139	9	on	on	ADP
ajlm-1645	139	10	serum	serum	NOUN
ajlm-1645	139	11	levels	level	NOUN
ajlm-1645	139	12	,	,	PUNCT
ajlm-1645	139	13	poor	poor	ADJ
ajlm-1645	139	14	response	response	NOUN
ajlm-1645	139	15	to	to	ADP
ajlm-1645	139	16	replacement	replacement	NOUN
ajlm-1645	139	17	therapy	therapy	NOUN
ajlm-1645	139	18	may	may	AUX
ajlm-1645	139	19	indicate	indicate	VERB
ajlm-1645	139	20	underlying	underlie	VERB
ajlm-1645	139	21	marrow	marrow	NOUN
ajlm-1645	139	22	pathology	pathology	NOUN
ajlm-1645	139	23	requiring	require	VERB
ajlm-1645	139	24	bme	bme	NOUN
ajlm-1645	139	25	.	.	PUNCT
ajlm-1645	140	1	knowledge	knowledge	NOUN
ajlm-1645	140	2	of	of	ADP
ajlm-1645	140	3	the	the	DET
ajlm-1645	140	4	vitamin	vitamin	NOUN
ajlm-1645	140	5	b12	b12	NOUN
ajlm-1645	140	6	and	and	CCONJ
ajlm-1645	140	7	folate	folate	NOUN
ajlm-1645	140	8	serum	serum	NOUN
ajlm-1645	140	9	levels	level	NOUN
ajlm-1645	140	10	are	be	AUX
ajlm-1645	140	11	also	also	ADV
ajlm-1645	140	12	important	important	ADJ
ajlm-1645	140	13	for	for	ADP
ajlm-1645	140	14	the	the	DET
ajlm-1645	140	15	interpretation	interpretation	NOUN
ajlm-1645	140	16	of	of	ADP
ajlm-1645	140	17	bmes	bme	NOUN
ajlm-1645	140	18	,	,	PUNCT
ajlm-1645	140	19	especially	especially	ADV
ajlm-1645	140	20	if	if	SCONJ
ajlm-1645	140	21	myelodysplastic	myelodysplastic	ADJ
ajlm-1645	140	22	syndrome	syndrome	NOUN
ajlm-1645	140	23	is	be	AUX
ajlm-1645	140	24	suspected	suspect	VERB
ajlm-1645	140	25	.	.	PUNCT
ajlm-1645	141	1	additionally	additionally	ADV
ajlm-1645	141	2	,	,	PUNCT
ajlm-1645	141	3	if	if	SCONJ
ajlm-1645	141	4	there	there	PRON
ajlm-1645	141	5	are	be	VERB
ajlm-1645	141	6	features	feature	NOUN
ajlm-1645	141	7	of	of	ADP
ajlm-1645	141	8	myelodysplastic	myelodysplastic	ADJ
ajlm-1645	141	9	syndrome	syndrome	NOUN
ajlm-1645	141	10	,	,	PUNCT
ajlm-1645	141	11	acute	acute	ADJ
ajlm-1645	141	12	leukaemia	leukaemia	NOUN
ajlm-1645	141	13	or	or	CCONJ
ajlm-1645	141	14	bone	bone	NOUN
ajlm-1645	141	15	marrow	marrow	NOUN
ajlm-1645	141	16	infiltration	infiltration	NOUN
ajlm-1645	141	17	(	(	PUNCT
ajlm-1645	141	18	such	such	ADJ
ajlm-1645	141	19	as	as	ADP
ajlm-1645	141	20	unexplained	unexplained	ADJ
ajlm-1645	141	21	leucoerythroblastic	leucoerythroblastic	ADJ
ajlm-1645	141	22	reaction	reaction	NOUN
ajlm-1645	141	23	)	)	PUNCT
ajlm-1645	141	24	in	in	ADP
ajlm-1645	141	25	peripheral	peripheral	ADJ
ajlm-1645	141	26	blood	blood	NOUN
ajlm-1645	141	27	or	or	CCONJ
ajlm-1645	141	28	,	,	PUNCT
ajlm-1645	141	29	importantly	importantly	ADV
ajlm-1645	141	30	,	,	PUNCT
ajlm-1645	141	31	if	if	SCONJ
ajlm-1645	141	32	the	the	DET
ajlm-1645	141	33	pancytopenia	pancytopenia	NOUN
ajlm-1645	141	34	is	be	AUX
ajlm-1645	141	35	unexplained	unexplained	ADJ
ajlm-1645	141	36	,	,	PUNCT
ajlm-1645	141	37	a	a	DET
ajlm-1645	141	38	bme	bme	NOUN
ajlm-1645	141	39	should	should	AUX
ajlm-1645	141	40	be	be	AUX
ajlm-1645	141	41	fast	fast	ADV
ajlm-1645	141	42	-	-	PUNCT
ajlm-1645	141	43	tracked	track	VERB
ajlm-1645	141	44	in	in	ADP
ajlm-1645	141	45	the	the	DET
ajlm-1645	141	46	investigation	investigation	NOUN
ajlm-1645	141	47	of	of	ADP
ajlm-1645	141	48	the	the	DET
ajlm-1645	141	49	pancytopenia	pancytopenia	NOUN
ajlm-1645	141	50	.	.	PUNCT
ajlm-1645	142	1	furthermore	furthermore	ADV
ajlm-1645	142	2	,	,	PUNCT
ajlm-1645	142	3	in	in	ADP
ajlm-1645	142	4	patients	patient	NOUN
ajlm-1645	142	5	with	with	ADP
ajlm-1645	142	6	hiv	hiv	PROPN
ajlm-1645	142	7	,	,	PUNCT
ajlm-1645	142	8	vitamin	vitamin	NOUN
ajlm-1645	142	9	b12	b12	NOUN
ajlm-1645	142	10	and	and	CCONJ
ajlm-1645	142	11	folate	folate	NOUN
ajlm-1645	142	12	deficiency	deficiency	NOUN
ajlm-1645	142	13	should	should	AUX
ajlm-1645	142	14	be	be	AUX
ajlm-1645	142	15	excluded	exclude	VERB
ajlm-1645	142	16	early	early	ADV
ajlm-1645	142	17	,	,	PUNCT
ajlm-1645	142	18	as	as	SCONJ
ajlm-1645	142	19	folate	folate	NOUN
ajlm-1645	142	20	deficiency	deficiency	NOUN
ajlm-1645	142	21	was	be	AUX
ajlm-1645	142	22	found	find	VERB
ajlm-1645	142	23	to	to	PART
ajlm-1645	142	24	be	be	AUX
ajlm-1645	142	25	common	common	ADJ
ajlm-1645	142	26	in	in	ADP
ajlm-1645	142	27	the	the	DET
ajlm-1645	142	28	hiv	hiv	PROPN
ajlm-1645	142	29	patients	patient	NOUN
ajlm-1645	142	30	in	in	ADP
ajlm-1645	142	31	our	our	PRON
ajlm-1645	142	32	study	study	NOUN
ajlm-1645	142	33	.	.	PUNCT
ajlm-1645	143	1	moreover	moreover	ADV
ajlm-1645	143	2	,	,	PUNCT
ajlm-1645	143	3	in	in	ADP
ajlm-1645	143	4	hiv	hiv	PROPN
ajlm-1645	143	5	-	-	PUNCT
ajlm-1645	143	6	positive	positive	ADJ
ajlm-1645	143	7	patients	patient	NOUN
ajlm-1645	143	8	,	,	PUNCT
ajlm-1645	143	9	there	there	PRON
ajlm-1645	143	10	should	should	AUX
ajlm-1645	143	11	be	be	AUX
ajlm-1645	143	12	a	a	DET
ajlm-1645	143	13	thorough	thorough	ADJ
ajlm-1645	143	14	investigation	investigation	NOUN
ajlm-1645	143	15	for	for	ADP
ajlm-1645	143	16	tuberculosis	tuberculosis	NOUN
ajlm-1645	143	17	,	,	PUNCT
ajlm-1645	143	18	and	and	CCONJ
ajlm-1645	143	19	a	a	DET
ajlm-1645	143	20	bme	bme	NOUN
ajlm-1645	143	21	is	be	AUX
ajlm-1645	143	22	recommended	recommend	VERB
ajlm-1645	143	23	to	to	PART
ajlm-1645	143	24	investigate	investigate	VERB
ajlm-1645	143	25	marrow	marrow	NOUN
ajlm-1645	143	26	infiltration	infiltration	NOUN
ajlm-1645	143	27	by	by	ADP
ajlm-1645	143	28	opportunistic	opportunistic	ADJ
ajlm-1645	143	29	infections	infection	NOUN
ajlm-1645	143	30	and	and	CCONJ
ajlm-1645	143	31	malignancy	malignancy	NOUN
ajlm-1645	143	32	.	.	PUNCT
ajlm-1645	144	1	in	in	ADP
ajlm-1645	144	2	older	old	ADJ
ajlm-1645	144	3	patients	patient	NOUN
ajlm-1645	144	4	,	,	PUNCT
ajlm-1645	144	5	there	there	PRON
ajlm-1645	144	6	should	should	AUX
ajlm-1645	144	7	be	be	AUX
ajlm-1645	144	8	a	a	DET
ajlm-1645	144	9	high	high	ADJ
ajlm-1645	144	10	clinical	clinical	ADJ
ajlm-1645	144	11	suspicion	suspicion	NOUN
ajlm-1645	144	12	of	of	ADP
ajlm-1645	144	13	malignancy	malignancy	NOUN
ajlm-1645	144	14	.	.	PUNCT
ajlm-1645	145	1	ultimately	ultimately	ADV
ajlm-1645	145	2	,	,	PUNCT
ajlm-1645	145	3	bme	bme	NOUN
ajlm-1645	145	4	remains	remain	VERB
ajlm-1645	145	5	a	a	DET
ajlm-1645	145	6	valuable	valuable	ADJ
ajlm-1645	145	7	procedure	procedure	NOUN
ajlm-1645	145	8	for	for	ADP
ajlm-1645	145	9	the	the	DET
ajlm-1645	145	10	investigation	investigation	NOUN
ajlm-1645	145	11	of	of	ADP
ajlm-1645	145	12	unexplained	unexplained	ADJ
ajlm-1645	145	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	145	14	.	.	PUNCT
ajlm-1645	146	1	limitations	limitation	NOUN
ajlm-1645	146	2	one	one	NUM
ajlm-1645	146	3	of	of	ADP
ajlm-1645	146	4	the	the	DET
ajlm-1645	146	5	limitations	limitation	NOUN
ajlm-1645	146	6	of	of	ADP
ajlm-1645	146	7	our	our	PRON
ajlm-1645	146	8	study	study	NOUN
ajlm-1645	146	9	was	be	AUX
ajlm-1645	146	10	that	that	SCONJ
ajlm-1645	146	11	only	only	ADV
ajlm-1645	146	12	retrospective	retrospective	ADJ
ajlm-1645	146	13	information	information	NOUN
ajlm-1645	146	14	available	available	ADJ
ajlm-1645	146	15	on	on	ADP
ajlm-1645	146	16	the	the	DET
ajlm-1645	146	17	lis	li	NOUN
ajlm-1645	146	18	was	be	AUX
ajlm-1645	146	19	used	use	VERB
ajlm-1645	146	20	to	to	PART
ajlm-1645	146	21	identify	identify	VERB
ajlm-1645	146	22	the	the	DET
ajlm-1645	146	23	cause	cause	NOUN
ajlm-1645	146	24	of	of	ADP
ajlm-1645	146	25	pancytopenia	pancytopenia	NOUN
ajlm-1645	146	26	.	.	PUNCT
ajlm-1645	147	1	as	as	ADP
ajlm-1645	147	2	a	a	DET
ajlm-1645	147	3	result	result	NOUN
ajlm-1645	147	4	,	,	PUNCT
ajlm-1645	147	5	the	the	DET
ajlm-1645	147	6	contribution	contribution	NOUN
ajlm-1645	147	7	of	of	ADP
ajlm-1645	147	8	drugs	drug	NOUN
ajlm-1645	147	9	and	and	CCONJ
ajlm-1645	147	10	co	co	NOUN
ajlm-1645	147	11	-	-	NOUN
ajlm-1645	147	12	morbidities	morbidity	NOUN
ajlm-1645	147	13	was	be	AUX
ajlm-1645	147	14	unknown	unknown	ADJ
ajlm-1645	147	15	and	and	CCONJ
ajlm-1645	147	16	a	a	DET
ajlm-1645	147	17	cause	cause	NOUN
ajlm-1645	147	18	for	for	ADP
ajlm-1645	147	19	pancytopenia	pancytopenia	NOUN
ajlm-1645	147	20	could	could	AUX
ajlm-1645	147	21	not	not	PART
ajlm-1645	147	22	be	be	AUX
ajlm-1645	147	23	identified	identify	VERB
ajlm-1645	147	24	in	in	ADP
ajlm-1645	147	25	14	14	NUM
ajlm-1645	147	26	%	%	NOUN
ajlm-1645	147	27	of	of	ADP
ajlm-1645	147	28	patients	patient	NOUN
ajlm-1645	147	29	.	.	PUNCT
ajlm-1645	148	1	the	the	DET
ajlm-1645	148	2	world	world	PROPN
ajlm-1645	148	3	health	health	PROPN
ajlm-1645	148	4	organization	organization	PROPN
ajlm-1645	148	5	defines	define	VERB
ajlm-1645	148	6	advanced	advance	VERB
ajlm-1645	148	7	hiv	hiv	PROPN
ajlm-1645	148	8	as	as	ADP
ajlm-1645	148	9	either	either	CCONJ
ajlm-1645	148	10	cd4	cd4	PROPN
ajlm-1645	148	11	count	count	VERB
ajlm-1645	148	12	<	<	X
ajlm-1645	148	13	200/µl	200/µl	NUM
ajlm-1645	148	14	or	or	CCONJ
ajlm-1645	148	15	clinical	clinical	ADJ
ajlm-1645	148	16	stage	stage	NOUN
ajlm-1645	148	17	iii	iii	NOUN
ajlm-1645	148	18	or	or	CCONJ
ajlm-1645	148	19	stage	stage	NOUN
ajlm-1645	148	20	iv	iv	NUM
ajlm-1645	148	21	disease	disease	NOUN
ajlm-1645	148	22	.	.	PUNCT
ajlm-1645	149	1	however	however	ADV
ajlm-1645	149	2	,	,	PUNCT
ajlm-1645	149	3	the	the	DET
ajlm-1645	149	4	clinical	clinical	ADJ
ajlm-1645	149	5	stage	stage	NOUN
ajlm-1645	149	6	of	of	ADP
ajlm-1645	149	7	hiv	hiv	PROPN
ajlm-1645	149	8	disease	disease	NOUN
ajlm-1645	149	9	was	be	AUX
ajlm-1645	149	10	not	not	PART
ajlm-1645	149	11	known	know	VERB
ajlm-1645	149	12	in	in	ADP
ajlm-1645	149	13	this	this	DET
ajlm-1645	149	14	study	study	NOUN
ajlm-1645	149	15	.	.	PUNCT
ajlm-1645	150	1	thus	thus	ADV
ajlm-1645	150	2	the	the	DET
ajlm-1645	150	3	definition	definition	NOUN
ajlm-1645	150	4	of	of	ADP
ajlm-1645	150	5	advanced	advanced	PROPN
ajlm-1645	150	6	hiv	hiv	PROPN
ajlm-1645	150	7	was	be	AUX
ajlm-1645	150	8	based	base	VERB
ajlm-1645	150	9	only	only	ADV
ajlm-1645	150	10	on	on	ADP
ajlm-1645	150	11	cd4	cd4	PROPN
ajlm-1645	150	12	count	count	NOUN
ajlm-1645	150	13	,	,	PUNCT
ajlm-1645	150	14	and	and	CCONJ
ajlm-1645	150	15	the	the	DET
ajlm-1645	150	16	patients	patient	NOUN
ajlm-1645	150	17	with	with	ADP
ajlm-1645	150	18	advanced	advanced	ADJ
ajlm-1645	150	19	hiv	hiv	PROPN
ajlm-1645	150	20	may	may	AUX
ajlm-1645	150	21	be	be	AUX
ajlm-1645	150	22	underestimated.48	underestimated.48	ADJ
ajlm-1645	150	23	clinicopathological	clinicopathological	ADJ
ajlm-1645	150	24	correlation	correlation	NOUN
ajlm-1645	150	25	would	would	AUX
ajlm-1645	150	26	also	also	ADV
ajlm-1645	150	27	have	have	AUX
ajlm-1645	150	28	improved	improve	VERB
ajlm-1645	150	29	the	the	DET
ajlm-1645	150	30	study	study	NOUN
ajlm-1645	150	31	.	.	PUNCT
ajlm-1645	151	1	furthermore	furthermore	ADV
ajlm-1645	151	2	,	,	PUNCT
ajlm-1645	151	3	it	it	PRON
ajlm-1645	151	4	is	be	AUX
ajlm-1645	151	5	noteworthy	noteworthy	ADJ
ajlm-1645	151	6	that	that	SCONJ
ajlm-1645	151	7	our	our	PRON
ajlm-1645	151	8	study	study	NOUN
ajlm-1645	151	9	was	be	AUX
ajlm-1645	151	10	performed	perform	VERB
ajlm-1645	151	11	in	in	ADP
ajlm-1645	151	12	a	a	DET
ajlm-1645	151	13	tertiary	tertiary	ADJ
ajlm-1645	151	14	hospital	hospital	NOUN
ajlm-1645	151	15	,	,	PUNCT
ajlm-1645	151	16	thus	thus	ADV
ajlm-1645	151	17	selection	selection	NOUN
ajlm-1645	151	18	bias	bias	NOUN
ajlm-1645	151	19	may	may	AUX
ajlm-1645	151	20	have	have	AUX
ajlm-1645	151	21	resulted	result	VERB
ajlm-1645	151	22	in	in	ADP
ajlm-1645	151	23	chemoradiation	chemoradiation	NOUN
ajlm-1645	151	24	therapy	therapy	NOUN
ajlm-1645	151	25	being	be	AUX
ajlm-1645	151	26	the	the	DET
ajlm-1645	151	27	most	most	ADV
ajlm-1645	151	28	common	common	ADJ
ajlm-1645	151	29	cause	cause	NOUN
ajlm-1645	151	30	of	of	ADP
ajlm-1645	151	31	pancytopenia	pancytopenia	NOUN
ajlm-1645	151	32	.	.	PUNCT
ajlm-1645	152	1	socio	socio	NOUN
ajlm-1645	152	2	-	-	PUNCT
ajlm-1645	152	3	economic	economic	ADJ
ajlm-1645	152	4	,	,	PUNCT
ajlm-1645	152	5	geographical	geographical	ADJ
ajlm-1645	152	6	and	and	CCONJ
ajlm-1645	152	7	ethnic	ethnic	ADJ
ajlm-1645	152	8	factors	factor	NOUN
ajlm-1645	152	9	are	be	AUX
ajlm-1645	152	10	known	know	VERB
ajlm-1645	152	11	to	to	PART
ajlm-1645	152	12	influence	influence	VERB
ajlm-1645	152	13	the	the	DET
ajlm-1645	152	14	aetiology	aetiology	NOUN
ajlm-1645	152	15	of	of	ADP
ajlm-1645	152	16	pancytopenia	pancytopenia	NOUN
ajlm-1645	152	17	.	.	PUNCT
ajlm-1645	153	1	it	it	PRON
ajlm-1645	153	2	is	be	AUX
ajlm-1645	153	3	noteworthy	noteworthy	ADJ
ajlm-1645	153	4	,	,	PUNCT
ajlm-1645	153	5	however	however	ADV
ajlm-1645	153	6	,	,	PUNCT
ajlm-1645	153	7	that	that	SCONJ
ajlm-1645	153	8	differences	difference	NOUN
ajlm-1645	153	9	in	in	ADP
ajlm-1645	153	10	study	study	NOUN
ajlm-1645	153	11	design	design	NOUN
ajlm-1645	153	12	also	also	ADV
ajlm-1645	153	13	influence	influence	VERB
ajlm-1645	153	14	the	the	DET
ajlm-1645	153	15	described	describe	VERB
ajlm-1645	153	16	aetiology	aetiology	NOUN
ajlm-1645	153	17	of	of	ADP
ajlm-1645	153	18	pancytopenia	pancytopenia	NOUN
ajlm-1645	153	19	reported	report	VERB
ajlm-1645	153	20	by	by	ADP
ajlm-1645	153	21	different	different	ADJ
ajlm-1645	153	22	studies	study	NOUN
ajlm-1645	153	23	.	.	PUNCT
ajlm-1645	154	1	study	study	NOUN
ajlm-1645	154	2	designs	design	NOUN
ajlm-1645	154	3	differ	differ	VERB
ajlm-1645	154	4	in	in	ADP
ajlm-1645	154	5	their	their	PRON
ajlm-1645	154	6	definitions	definition	NOUN
ajlm-1645	154	7	of	of	ADP
ajlm-1645	154	8	pancytopenia	pancytopenia	NOUN
ajlm-1645	154	9	and	and	CCONJ
ajlm-1645	154	10	whether	whether	SCONJ
ajlm-1645	154	11	clinical	clinical	ADJ
ajlm-1645	154	12	or	or	CCONJ
ajlm-1645	154	13	laboratory	laboratory	NOUN
ajlm-1645	154	14	data	datum	NOUN
ajlm-1645	154	15	or	or	CCONJ
ajlm-1645	154	16	both	both	PRON
ajlm-1645	154	17	were	be	AUX
ajlm-1645	154	18	used	use	VERB
ajlm-1645	154	19	.	.	PUNCT
ajlm-1645	155	1	additionally	additionally	ADV
ajlm-1645	155	2	,	,	PUNCT
ajlm-1645	155	3	some	some	DET
ajlm-1645	155	4	studies	study	NOUN
ajlm-1645	155	5	only	only	ADV
ajlm-1645	155	6	evaluate	evaluate	VERB
ajlm-1645	155	7	bme	bme	NOUN
ajlm-1645	155	8	patients	patient	NOUN
ajlm-1645	155	9	,	,	PUNCT
ajlm-1645	155	10	while	while	SCONJ
ajlm-1645	155	11	some	some	PRON
ajlm-1645	155	12	include	include	VERB
ajlm-1645	155	13	all	all	DET
ajlm-1645	155	14	patients	patient	NOUN
ajlm-1645	155	15	with	with	ADP
ajlm-1645	155	16	pancytopenia	pancytopenia	NOUN
ajlm-1645	155	17	.	.	PUNCT
ajlm-1645	156	1	some	some	DET
ajlm-1645	156	2	studies	study	NOUN
ajlm-1645	156	3	may	may	AUX
ajlm-1645	156	4	also	also	ADV
ajlm-1645	156	5	include	include	VERB
ajlm-1645	156	6	children	child	NOUN
ajlm-1645	156	7	,	,	PUNCT
ajlm-1645	156	8	and	and	CCONJ
ajlm-1645	156	9	others	other	NOUN
ajlm-1645	156	10	may	may	AUX
ajlm-1645	156	11	include	include	VERB
ajlm-1645	156	12	patients	patient	NOUN
ajlm-1645	156	13	that	that	PRON
ajlm-1645	156	14	had	have	VERB
ajlm-1645	156	15	chemotherapy	chemotherapy	NOUN
ajlm-1645	156	16	or	or	CCONJ
ajlm-1645	156	17	radiation	radiation	NOUN
ajlm-1645	156	18	therapy	therapy	NOUN
ajlm-1645	156	19	.	.	PUNCT
ajlm-1645	157	1	these	these	DET
ajlm-1645	157	2	differences	difference	NOUN
ajlm-1645	157	3	influence	influence	VERB
ajlm-1645	157	4	the	the	DET
ajlm-1645	157	5	top	top	ADJ
ajlm-1645	157	6	causes	cause	NOUN
ajlm-1645	157	7	of	of	ADP
ajlm-1645	157	8	pancytopenia	pancytopenia	NOUN
ajlm-1645	157	9	between	between	ADP
ajlm-1645	157	10	different	different	ADJ
ajlm-1645	157	11	studies	study	NOUN
ajlm-1645	157	12	.	.	PUNCT
ajlm-1645	158	1	conclusion	conclusion	NOUN
ajlm-1645	158	2	this	this	DET
ajlm-1645	158	3	study	study	NOUN
ajlm-1645	158	4	shows	show	VERB
ajlm-1645	158	5	that	that	SCONJ
ajlm-1645	158	6	the	the	DET
ajlm-1645	158	7	most	most	ADV
ajlm-1645	158	8	common	common	ADJ
ajlm-1645	158	9	causes	cause	NOUN
ajlm-1645	158	10	of	of	ADP
ajlm-1645	158	11	new	new	ADJ
ajlm-1645	158	12	-	-	PUNCT
ajlm-1645	158	13	onset	onset	NOUN
ajlm-1645	158	14	pancytopenia	pancytopenia	NOUN
ajlm-1645	158	15	in	in	ADP
ajlm-1645	158	16	adults	adult	NOUN
ajlm-1645	158	17	at	at	ADP
ajlm-1645	158	18	a	a	DET
ajlm-1645	158	19	south	south	ADJ
ajlm-1645	158	20	african	african	ADJ
ajlm-1645	158	21	tertiary	tertiary	ADJ
ajlm-1645	158	22	academic	academic	ADJ
ajlm-1645	158	23	centre	centre	NOUN
ajlm-1645	158	24	are	be	AUX
ajlm-1645	158	25	chemoradiation	chemoradiation	NOUN
ajlm-1645	158	26	therapy	therapy	NOUN
ajlm-1645	158	27	,	,	PUNCT
ajlm-1645	158	28	sepsis	sepsis	NOUN
ajlm-1645	158	29	,	,	PUNCT
ajlm-1645	158	30	hm	hm	INTJ
ajlm-1645	158	31	,	,	PUNCT
ajlm-1645	158	32	advanced	advance	VERB
ajlm-1645	158	33	hiv	hiv	NOUN
ajlm-1645	158	34	and	and	CCONJ
ajlm-1645	158	35	megaloblastic	megaloblastic	ADJ
ajlm-1645	158	36	anaemia	anaemia	NOUN
ajlm-1645	158	37	.	.	PUNCT
ajlm-1645	159	1	these	these	DET
ajlm-1645	159	2	results	result	NOUN
ajlm-1645	159	3	demonstrate	demonstrate	VERB
ajlm-1645	159	4	the	the	DET
ajlm-1645	159	5	need	need	NOUN
ajlm-1645	159	6	for	for	ADP
ajlm-1645	159	7	the	the	DET
ajlm-1645	159	8	prompt	prompt	ADJ
ajlm-1645	159	9	recognition	recognition	NOUN
ajlm-1645	159	10	and	and	CCONJ
ajlm-1645	159	11	treatment	treatment	NOUN
ajlm-1645	159	12	of	of	ADP
ajlm-1645	159	13	sepsis	sepsis	NOUN
ajlm-1645	159	14	and	and	CCONJ
ajlm-1645	159	15	megaloblastic	megaloblastic	ADJ
ajlm-1645	159	16	anaemia	anaemia	NOUN
ajlm-1645	159	17	,	,	PUNCT
ajlm-1645	159	18	early	early	ADJ
ajlm-1645	159	19	recognition	recognition	NOUN
ajlm-1645	159	20	of	of	ADP
ajlm-1645	159	21	hiv	hiv	PROPN
ajlm-1645	159	22	and	and	CCONJ
ajlm-1645	159	23	initiation	initiation	NOUN
ajlm-1645	159	24	of	of	ADP
ajlm-1645	159	25	antiretroviral	antiretroviral	ADJ
ajlm-1645	159	26	therapy	therapy	NOUN
ajlm-1645	159	27	,	,	PUNCT
ajlm-1645	159	28	and	and	CCONJ
ajlm-1645	159	29	a	a	DET
ajlm-1645	159	30	thorough	thorough	ADJ
ajlm-1645	159	31	investigation	investigation	NOUN
ajlm-1645	159	32	for	for	ADP
ajlm-1645	159	33	malignancy	malignancy	NOUN
ajlm-1645	159	34	.	.	PUNCT
ajlm-1645	160	1	integration	integration	NOUN
ajlm-1645	160	2	of	of	ADP
ajlm-1645	160	3	clinical	clinical	ADJ
ajlm-1645	160	4	,	,	PUNCT
ajlm-1645	160	5	laboratory	laboratory	NOUN
ajlm-1645	160	6	and	and	CCONJ
ajlm-1645	160	7	radiological	radiological	ADJ
ajlm-1645	160	8	findings	finding	NOUN
ajlm-1645	160	9	to	to	PART
ajlm-1645	160	10	guide	guide	VERB
ajlm-1645	160	11	investigation	investigation	NOUN
ajlm-1645	160	12	of	of	ADP
ajlm-1645	160	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	160	14	allows	allow	VERB
ajlm-1645	160	15	for	for	ADP
ajlm-1645	160	16	prompt	prompt	ADJ
ajlm-1645	160	17	diagnosis	diagnosis	NOUN
ajlm-1645	160	18	,	,	PUNCT
ajlm-1645	160	19	while	while	SCONJ
ajlm-1645	160	20	also	also	ADV
ajlm-1645	160	21	elucidating	elucidate	VERB
ajlm-1645	160	22	where	where	SCONJ
ajlm-1645	160	23	bme	bme	NOUN
ajlm-1645	160	24	should	should	AUX
ajlm-1645	160	25	be	be	AUX
ajlm-1645	160	26	expedited	expedite	VERB
ajlm-1645	160	27	in	in	ADP
ajlm-1645	160	28	the	the	DET
ajlm-1645	160	29	investigation	investigation	NOUN
ajlm-1645	160	30	of	of	ADP
ajlm-1645	160	31	pancytopenia	pancytopenia	NOUN
ajlm-1645	160	32	.	.	PUNCT
ajlm-1645	161	1	acknowledgements	acknowledgement	NOUN
ajlm-1645	161	2	we	we	PRON
ajlm-1645	161	3	would	would	AUX
ajlm-1645	161	4	like	like	VERB
ajlm-1645	161	5	to	to	PART
ajlm-1645	161	6	acknowledge	acknowledge	VERB
ajlm-1645	161	7	mr	mr	PROPN
ajlm-1645	161	8	wessel	wessel	PROPN
ajlm-1645	161	9	kleinhans	kleinhan	NOUN
ajlm-1645	161	10	for	for	ADP
ajlm-1645	161	11	his	his	PRON
ajlm-1645	161	12	assistance	assistance	NOUN
ajlm-1645	161	13	with	with	ADP
ajlm-1645	161	14	data	datum	NOUN
ajlm-1645	161	15	extraction	extraction	NOUN
ajlm-1645	161	16	from	from	ADP
ajlm-1645	161	17	the	the	DET
ajlm-1645	161	18	laboratory	laboratory	NOUN
ajlm-1645	161	19	information	information	NOUN
ajlm-1645	161	20	system	system	NOUN
ajlm-1645	161	21	.	.	PUNCT
ajlm-1645	162	1	competing	compete	VERB
ajlm-1645	162	2	interests	interest	NOUN
ajlm-1645	162	3	the	the	DET
ajlm-1645	162	4	authors	author	NOUN
ajlm-1645	162	5	declare	declare	VERB
ajlm-1645	162	6	that	that	SCONJ
ajlm-1645	162	7	the	the	DET
ajlm-1645	162	8	research	research	NOUN
ajlm-1645	162	9	was	be	AUX
ajlm-1645	162	10	conducted	conduct	VERB
ajlm-1645	162	11	in	in	ADP
ajlm-1645	162	12	the	the	DET
ajlm-1645	162	13	absence	absence	NOUN
ajlm-1645	162	14	of	of	ADP
ajlm-1645	162	15	any	any	DET
ajlm-1645	162	16	commercial	commercial	ADJ
ajlm-1645	162	17	or	or	CCONJ
ajlm-1645	162	18	financial	financial	ADJ
ajlm-1645	162	19	relationships	relationship	NOUN
ajlm-1645	162	20	that	that	PRON
ajlm-1645	162	21	could	could	AUX
ajlm-1645	162	22	be	be	AUX
ajlm-1645	162	23	construed	construe	VERB
ajlm-1645	162	24	as	as	ADP
ajlm-1645	162	25	a	a	DET
ajlm-1645	162	26	potential	potential	ADJ
ajlm-1645	162	27	conflict	conflict	NOUN
ajlm-1645	162	28	of	of	ADP
ajlm-1645	162	29	interest	interest	NOUN
ajlm-1645	162	30	.	.	PUNCT
ajlm-1645	163	1	authors	author	NOUN
ajlm-1645	163	2	’	'	PUNCT
ajlm-1645	163	3	contributions	contribution	NOUN
ajlm-1645	163	4	e.n	e.n	PROPN
ajlm-1645	163	5	.	.	PROPN
ajlm-1645	163	6	was	be	AUX
ajlm-1645	163	7	the	the	DET
ajlm-1645	163	8	primary	primary	ADJ
ajlm-1645	163	9	investigator	investigator	NOUN
ajlm-1645	163	10	and	and	CCONJ
ajlm-1645	163	11	partook	partook	VERB
ajlm-1645	163	12	in	in	ADP
ajlm-1645	163	13	data	data	NOUN
ajlm-1645	163	14	collection	collection	NOUN
ajlm-1645	163	15	,	,	PUNCT
ajlm-1645	163	16	analysis	analysis	NOUN
ajlm-1645	163	17	and	and	CCONJ
ajlm-1645	163	18	writing	writing	NOUN
ajlm-1645	163	19	of	of	ADP
ajlm-1645	163	20	the	the	DET
ajlm-1645	163	21	manuscript	manuscript	NOUN
ajlm-1645	163	22	.	.	PUNCT
ajlm-1645	164	1	z.c.c	z.c.c	NOUN
ajlm-1645	164	2	.	.	PROPN
ajlm-1645	164	3	supervised	supervise	VERB
ajlm-1645	164	4	the	the	DET
ajlm-1645	164	5	research	research	NOUN
ajlm-1645	164	6	,	,	PUNCT
ajlm-1645	164	7	assisted	assist	VERB
ajlm-1645	164	8	in	in	ADP
ajlm-1645	164	9	critical	critical	ADJ
ajlm-1645	164	10	appraisal	appraisal	NOUN
ajlm-1645	164	11	of	of	ADP
ajlm-1645	164	12	the	the	DET
ajlm-1645	164	13	work	work	NOUN
ajlm-1645	164	14	and	and	CCONJ
ajlm-1645	164	15	contributed	contribute	VERB
ajlm-1645	164	16	to	to	ADP
ajlm-1645	164	17	the	the	DET
ajlm-1645	164	18	writing	writing	NOUN
ajlm-1645	164	19	of	of	ADP
ajlm-1645	164	20	the	the	DET
ajlm-1645	164	21	manuscript	manuscript	NOUN
ajlm-1645	164	22	.	.	PUNCT
ajlm-1645	165	1	sources	source	NOUN
ajlm-1645	165	2	of	of	ADP
ajlm-1645	165	3	support	support	NOUN
ajlm-1645	165	4	this	this	DET
ajlm-1645	165	5	research	research	NOUN
ajlm-1645	165	6	received	receive	VERB
ajlm-1645	165	7	no	no	DET
ajlm-1645	165	8	specific	specific	ADJ
ajlm-1645	165	9	grant	grant	NOUN
ajlm-1645	165	10	from	from	ADP
ajlm-1645	165	11	any	any	DET
ajlm-1645	165	12	funding	funding	NOUN
ajlm-1645	165	13	agency	agency	NOUN
ajlm-1645	165	14	in	in	ADP
ajlm-1645	165	15	the	the	DET
ajlm-1645	165	16	public	public	ADJ
ajlm-1645	165	17	,	,	PUNCT
ajlm-1645	165	18	commercial	commercial	ADJ
ajlm-1645	165	19	or	or	CCONJ
ajlm-1645	165	20	non	non	ADJ
ajlm-1645	165	21	-	-	ADJ
ajlm-1645	165	22	profit	profit	ADJ
ajlm-1645	165	23	sectors	sector	NOUN
ajlm-1645	165	24	.	.	PUNCT
ajlm-1645	166	1	data	datum	NOUN
ajlm-1645	166	2	availability	availability	NOUN
ajlm-1645	166	3	all	all	DET
ajlm-1645	166	4	data	datum	NOUN
ajlm-1645	166	5	generated	generate	VERB
ajlm-1645	166	6	or	or	CCONJ
ajlm-1645	166	7	analysed	analyse	VERB
ajlm-1645	166	8	during	during	ADP
ajlm-1645	166	9	this	this	DET
ajlm-1645	166	10	study	study	NOUN
ajlm-1645	166	11	are	be	AUX
ajlm-1645	166	12	included	include	VERB
ajlm-1645	166	13	in	in	ADP
ajlm-1645	166	14	this	this	DET
ajlm-1645	166	15	article	article	NOUN
ajlm-1645	166	16	.	.	PUNCT
ajlm-1645	167	1	disclaimer	disclaimer	VERB
ajlm-1645	167	2	the	the	DET
ajlm-1645	167	3	views	view	NOUN
ajlm-1645	167	4	expressed	express	VERB
ajlm-1645	167	5	in	in	ADP
ajlm-1645	167	6	the	the	DET
ajlm-1645	167	7	submitted	submit	VERB
ajlm-1645	167	8	article	article	NOUN
ajlm-1645	167	9	are	be	AUX
ajlm-1645	167	10	our	our	PRON
ajlm-1645	167	11	own	own	ADJ
ajlm-1645	167	12	and	and	CCONJ
ajlm-1645	167	13	not	not	PART
ajlm-1645	167	14	an	an	DET
ajlm-1645	167	15	official	official	ADJ
ajlm-1645	167	16	position	position	NOUN
ajlm-1645	167	17	of	of	ADP
ajlm-1645	167	18	the	the	DET
ajlm-1645	167	19	institution	institution	NOUN
ajlm-1645	167	20	.	.	PUNCT
ajlm-1645	168	1	references	reference	NOUN
ajlm-1645	168	2	weinzierl	weinzierl	VERB
ajlm-1645	168	3	ep	ep	PROPN
ajlm-1645	168	4	,	,	PUNCT
ajlm-1645	168	5	arber	arber	PROPN
ajlm-1645	168	6	da	da	PROPN
ajlm-1645	168	7	.	.	PUNCT
ajlm-1645	169	1	the	the	DET
ajlm-1645	169	2	differential	differential	ADJ
ajlm-1645	169	3	diagnosis	diagnosis	NOUN
ajlm-1645	169	4	and	and	CCONJ
ajlm-1645	169	5	bone	bone	NOUN
ajlm-1645	169	6	marrow	marrow	NOUN
ajlm-1645	169	7	evaluation	evaluation	NOUN
ajlm-1645	169	8	of	of	ADP
ajlm-1645	169	9	new	new	ADJ
ajlm-1645	169	10	-	-	PUNCT
ajlm-1645	169	11	onset	onset	NOUN
ajlm-1645	169	12	pancytopenia	pancytopenia	NOUN
ajlm-1645	169	13	.	.	PUNCT
ajlm-1645	170	1	am	be	AUX
ajlm-1645	170	2	j	j	PROPN
ajlm-1645	170	3	clin	clin	PROPN
ajlm-1645	170	4	pathol	pathol	NOUN
ajlm-1645	170	5	.	.	PUNCT
ajlm-1645	171	1	2013;139(1):9–29	2013;139(1):9–29	ADJ
ajlm-1645	171	2	.	.	PUNCT
ajlm-1645	172	1	https://doi.org/10.1309/ajcp50aeeygrewuz	https://doi.org/10.1309/ajcp50aeeygrewuz	PROPN
ajlm-1645	172	2	varma	varma	PROPN
ajlm-1645	172	3	n	n	CCONJ
ajlm-1645	172	4	,	,	PUNCT
ajlm-1645	172	5	dash	dash	NOUN
ajlm-1645	172	6	s.	s.	PROPN
ajlm-1645	172	7	a	a	DET
ajlm-1645	172	8	reappraisal	reappraisal	NOUN
ajlm-1645	172	9	of	of	ADP
ajlm-1645	172	10	underlying	underlie	VERB
ajlm-1645	172	11	pathology	pathology	NOUN
ajlm-1645	172	12	in	in	ADP
ajlm-1645	172	13	adult	adult	NOUN
ajlm-1645	172	14	patients	patient	NOUN
ajlm-1645	172	15	presenting	present	VERB
ajlm-1645	172	16	with	with	ADP
ajlm-1645	172	17	pancytopenia	pancytopenia	NOUN
ajlm-1645	172	18	.	.	PUNCT
ajlm-1645	173	1	trop	trop	PROPN
ajlm-1645	173	2	geogr	geogr	VERB
ajlm-1645	173	3	med	med	PROPN
ajlm-1645	173	4	.	.	PUNCT
ajlm-1645	174	1	1992;44(4):322–327	1992;44(4):322–327	X
ajlm-1645	174	2	.	.	PUNCT
ajlm-1645	175	1	tilak	tilak	PROPN
ajlm-1645	175	2	v	v	PROPN
ajlm-1645	175	3	,	,	PUNCT
ajlm-1645	175	4	jain	jain	PROPN
ajlm-1645	175	5	r.	r.	PROPN
ajlm-1645	175	6	pancytopenia	pancytopenia	PROPN
ajlm-1645	175	7	–	–	PUNCT
ajlm-1645	175	8	a	a	DET
ajlm-1645	175	9	clinico	clinico	NOUN
ajlm-1645	175	10	-	-	PUNCT
ajlm-1645	175	11	hematologic	hematologic	NOUN
ajlm-1645	175	12	analysis	analysis	NOUN
ajlm-1645	175	13	of	of	ADP
ajlm-1645	175	14	77	77	NUM
ajlm-1645	175	15	cases	case	NOUN
ajlm-1645	175	16	.	.	PUNCT
ajlm-1645	176	1	indian	indian	PROPN
ajlm-1645	176	2	j	j	PROPN
ajlm-1645	176	3	pathol	pathol	VERB
ajlm-1645	176	4	microbiol	microbiol	NOUN
ajlm-1645	176	5	.	.	PUNCT
ajlm-1645	177	1	1999;42(4):399–404	1999;42(4):399–404	NUM
ajlm-1645	177	2	.	.	PUNCT
ajlm-1645	178	1	kumar	kumar	PROPN
ajlm-1645	178	2	r	r	PROPN
ajlm-1645	178	3	,	,	PUNCT
ajlm-1645	178	4	kalra	kalra	NOUN
ajlm-1645	178	5	sp	sp	PROPN
ajlm-1645	178	6	,	,	PUNCT
ajlm-1645	178	7	kumar	kumar	PROPN
ajlm-1645	178	8	h	h	PROPN
ajlm-1645	178	9	,	,	PUNCT
ajlm-1645	178	10	anand	anand	PROPN
ajlm-1645	178	11	ac	ac	PROPN
ajlm-1645	178	12	,	,	PUNCT
ajlm-1645	178	13	madan	madan	PROPN
ajlm-1645	178	14	h.	h.	PROPN
ajlm-1645	178	15	pancytopenia	pancytopenia	PROPN
ajlm-1645	178	16	–	–	PUNCT
ajlm-1645	178	17	a	a	DET
ajlm-1645	178	18	six	six	NUM
ajlm-1645	178	19	year	year	NOUN
ajlm-1645	178	20	study	study	NOUN
ajlm-1645	178	21	.	.	PUNCT
ajlm-1645	179	1	j	j	PROPN
ajlm-1645	179	2	assoc	assoc	PROPN
ajlm-1645	179	3	physicians	physicians	PROPN
ajlm-1645	179	4	india	india	PROPN
ajlm-1645	179	5	.	.	PUNCT
ajlm-1645	180	1	2001;49:1078–1081	2001;49:1078–1081	PROPN
ajlm-1645	180	2	.	.	PUNCT
ajlm-1645	180	3	khunger	khunger	PROPN
ajlm-1645	180	4	jm	jm	PROPN
ajlm-1645	180	5	,	,	PUNCT
ajlm-1645	180	6	arulselvi	arulselvi	PROPN
ajlm-1645	180	7	s	s	PART
ajlm-1645	180	8	,	,	PUNCT
ajlm-1645	180	9	sharma	sharma	PROPN
ajlm-1645	180	10	u	u	PROPN
ajlm-1645	180	11	,	,	PUNCT
ajlm-1645	180	12	ranga	ranga	PROPN
ajlm-1645	180	13	s	s	PROPN
ajlm-1645	180	14	,	,	PUNCT
ajlm-1645	180	15	talib	talib	PROPN
ajlm-1645	180	16	vh	vh	PROPN
ajlm-1645	180	17	.	.	PUNCT
ajlm-1645	181	1	pancytopenia	pancytopenia	PROPN
ajlm-1645	181	2	–	–	PUNCT
ajlm-1645	181	3	a	a	DET
ajlm-1645	181	4	clinico	clinico	NOUN
ajlm-1645	181	5	haematological	haematological	ADJ
ajlm-1645	181	6	study	study	NOUN
ajlm-1645	181	7	of	of	ADP
ajlm-1645	181	8	200	200	NUM
ajlm-1645	181	9	cases	case	NOUN
ajlm-1645	181	10	.	.	PUNCT
ajlm-1645	182	1	indian	indian	PROPN
ajlm-1645	182	2	j	j	PROPN
ajlm-1645	182	3	pathol	pathol	VERB
ajlm-1645	182	4	microbiol	microbiol	NOUN
ajlm-1645	182	5	.	.	PUNCT
ajlm-1645	183	1	2002;45(3):375–379	2002;45(3):375–379	NUM
ajlm-1645	183	2	.	.	PUNCT
ajlm-1645	183	3	devi	devi	PROPN
ajlm-1645	183	4	pm	pm	PROPN
ajlm-1645	183	5	,	,	PUNCT
ajlm-1645	183	6	laishram	laishram	NOUN
ajlm-1645	183	7	rs	rs	NOUN
ajlm-1645	183	8	,	,	PUNCT
ajlm-1645	183	9	sharma	sharma	PROPN
ajlm-1645	183	10	ps	ps	PROPN
ajlm-1645	183	11	,	,	PUNCT
ajlm-1645	183	12	singh	singh	PROPN
ajlm-1645	183	13	am	be	AUX
ajlm-1645	183	14	,	,	PUNCT
ajlm-1645	183	15	singh	singh	PROPN
ajlm-1645	183	16	mk	mk	PROPN
ajlm-1645	183	17	,	,	PUNCT
ajlm-1645	183	18	singh	singh	PROPN
ajlm-1645	183	19	ym	ym	PROPN
ajlm-1645	183	20	.	.	PUNCT
ajlm-1645	184	1	clinico	clinico	ADJ
ajlm-1645	184	2	-	-	PUNCT
ajlm-1645	184	3	hematological	hematological	ADJ
ajlm-1645	184	4	profile	profile	NOUN
ajlm-1645	184	5	of	of	ADP
ajlm-1645	184	6	pancytopenia	pancytopenia	NOUN
ajlm-1645	184	7	in	in	ADP
ajlm-1645	184	8	manipur	manipur	PROPN
ajlm-1645	184	9	,	,	PUNCT
ajlm-1645	184	10	india	india	PROPN
ajlm-1645	184	11	.	.	PUNCT
ajlm-1645	185	1	kuwait	kuwait	PROPN
ajlm-1645	185	2	med	med	PROPN
ajlm-1645	185	3	j.	j.	PROPN
ajlm-1645	185	4	2008;40(3):221–224	2008;40(3):221–224	PROPN
ajlm-1645	185	5	.	.	PUNCT
ajlm-1645	186	1	gayathri	gayathri	PROPN
ajlm-1645	186	2	bn	bn	PROPN
ajlm-1645	186	3	,	,	PUNCT
ajlm-1645	186	4	rao	rao	PROPN
ajlm-1645	186	5	ks	ks	PROPN
ajlm-1645	186	6	.	.	PROPN
ajlm-1645	186	7	pancytopenia	pancytopenia	PROPN
ajlm-1645	186	8	:	:	PUNCT
ajlm-1645	186	9	a	a	DET
ajlm-1645	186	10	clinico	clinico	NOUN
ajlm-1645	186	11	hematological	hematological	ADJ
ajlm-1645	186	12	study	study	NOUN
ajlm-1645	186	13	.	.	PUNCT
ajlm-1645	187	1	j	j	PROPN
ajlm-1645	187	2	lab	lab	PROPN
ajlm-1645	187	3	physicians	physician	NOUN
ajlm-1645	187	4	.	.	PUNCT
ajlm-1645	188	1	2011;3(1):15–20	2011;3(1):15–20	NUM
ajlm-1645	188	2	.	.	PUNCT
ajlm-1645	189	1	https://doi.org/10.4103/0974-2727.78555	https://doi.org/10.4103/0974-2727.78555	PROPN
ajlm-1645	189	2	rangaswamy	rangaswamy	PROPN
ajlm-1645	189	3	m	m	PROPN
ajlm-1645	189	4	,	,	PUNCT
ajlm-1645	189	5	prabhu	prabhu	PROPN
ajlm-1645	189	6	,	,	PUNCT
ajlm-1645	189	7	nandini	nandini	PROPN
ajlm-1645	189	8	nm	nm	PROPN
ajlm-1645	189	9	,	,	PUNCT
ajlm-1645	189	10	manjunath	manjunath	PROPN
ajlm-1645	189	11	gv	gv	PROPN
ajlm-1645	189	12	.	.	PUNCT
ajlm-1645	189	13	bone	bone	PROPN
ajlm-1645	189	14	marrow	marrow	PROPN
ajlm-1645	189	15	examination	examination	NOUN
ajlm-1645	189	16	in	in	ADP
ajlm-1645	189	17	pancytopenia	pancytopenia	NOUN
ajlm-1645	189	18	.	.	PUNCT
ajlm-1645	190	1	j	j	PROPN
ajlm-1645	190	2	indian	indian	PROPN
ajlm-1645	190	3	med	med	PROPN
ajlm-1645	190	4	assoc	assoc	PROPN
ajlm-1645	190	5	.	.	PUNCT
ajlm-1645	191	1	2012;110(8):560–562	2012;110(8):560–562	NUM
ajlm-1645	191	2	,	,	PUNCT
ajlm-1645	191	3	566	566	NUM
ajlm-1645	191	4	.	.	PUNCT
ajlm-1645	192	1	raphael	raphael	PROPN
ajlm-1645	192	2	v	v	PROPN
ajlm-1645	192	3	,	,	PUNCT
ajlm-1645	192	4	khonglah	khonglah	PROPN
ajlm-1645	192	5	y	y	PROPN
ajlm-1645	192	6	,	,	PUNCT
ajlm-1645	192	7	dey	dey	PROPN
ajlm-1645	192	8	b	b	PROPN
ajlm-1645	192	9	,	,	PUNCT
ajlm-1645	192	10	gogoi	gogoi	VERB
ajlm-1645	192	11	p	p	NOUN
ajlm-1645	192	12	,	,	PUNCT
ajlm-1645	192	13	bhuyan	bhuyan	ADJ
ajlm-1645	192	14	a.	a.	NOUN
ajlm-1645	192	15	pancytopenia	pancytopenia	PROPN
ajlm-1645	192	16	–	–	PUNCT
ajlm-1645	192	17	an	an	DET
ajlm-1645	192	18	etiological	etiological	ADJ
ajlm-1645	192	19	profile	profile	NOUN
ajlm-1645	192	20	.	.	PUNCT
ajlm-1645	193	1	turk	turk	PROPN
ajlm-1645	193	2	j	j	PROPN
ajlm-1645	193	3	hematol	hematol	PROPN
ajlm-1645	193	4	.	.	PUNCT
ajlm-1645	194	1	2012;29(1):85–86	2012;29(1):85–86	NUM
ajlm-1645	194	2	.	.	PUNCT
ajlm-1645	195	1	https://doi.org/10.5505/tjh.2012.98360	https://doi.org/10.5505/tjh.2012.98360	PROPN
ajlm-1645	195	2	premkumar	premkumar	PROPN
ajlm-1645	195	3	m	m	PROPN
ajlm-1645	195	4	,	,	PUNCT
ajlm-1645	195	5	gupta	gupta	PROPN
ajlm-1645	195	6	n	n	CCONJ
ajlm-1645	195	7	,	,	PUNCT
ajlm-1645	195	8	singh	singh	PROPN
ajlm-1645	195	9	t	t	PROPN
ajlm-1645	195	10	,	,	PUNCT
ajlm-1645	195	11	velpandian	velpandian	ADJ
ajlm-1645	195	12	t.	t.	NOUN
ajlm-1645	195	13	cobalamin	cobalamin	NOUN
ajlm-1645	195	14	and	and	CCONJ
ajlm-1645	195	15	folic	folic	ADJ
ajlm-1645	195	16	acid	acid	NOUN
ajlm-1645	195	17	status	status	NOUN
ajlm-1645	195	18	in	in	ADP
ajlm-1645	195	19	relation	relation	NOUN
ajlm-1645	195	20	to	to	ADP
ajlm-1645	195	21	the	the	DET
ajlm-1645	195	22	etiopathogenesis	etiopathogenesis	NOUN
ajlm-1645	195	23	of	of	ADP
ajlm-1645	195	24	pancytopenia	pancytopenia	NOUN
ajlm-1645	195	25	in	in	ADP
ajlm-1645	195	26	adults	adult	NOUN
ajlm-1645	195	27	at	at	ADP
ajlm-1645	195	28	a	a	DET
ajlm-1645	195	29	tertiary	tertiary	ADJ
ajlm-1645	195	30	care	care	NOUN
ajlm-1645	195	31	centre	centre	NOUN
ajlm-1645	195	32	in	in	ADP
ajlm-1645	195	33	north	north	PROPN
ajlm-1645	195	34	india	india	PROPN
ajlm-1645	195	35	.	.	PUNCT
ajlm-1645	196	1	anemia	anemia	NOUN
ajlm-1645	196	2	.	.	PUNCT
ajlm-1645	197	1	2012;2012	2012;2012	NUM
ajlm-1645	197	2	:	:	PUNCT
ajlm-1645	197	3	article	article	NOUN
ajlm-1645	197	4	i	i	PROPN
ajlm-1645	197	5	d	d	PROPN
ajlm-1645	197	6	707402	707402	NUM
ajlm-1645	197	7	.	.	PUNCT
ajlm-1645	198	1	https://doi.org/10.1155/2012/707402	https://doi.org/10.1155/2012/707402	PROPN
ajlm-1645	198	2	mir	mir	PROPN
ajlm-1645	198	3	ta	ta	PROPN
ajlm-1645	198	4	,	,	PUNCT
ajlm-1645	198	5	bhat	bhat	PROPN
ajlm-1645	198	6	mh	mh	PROPN
ajlm-1645	198	7	,	,	PUNCT
ajlm-1645	198	8	raina	raina	PROPN
ajlm-1645	198	9	aa	aa	PROPN
ajlm-1645	198	10	.	.	PUNCT
ajlm-1645	199	1	etiological	etiological	ADJ
ajlm-1645	199	2	profile	profile	NOUN
ajlm-1645	199	3	of	of	ADP
ajlm-1645	199	4	pancytopenia	pancytopenia	NOUN
ajlm-1645	199	5	in	in	ADP
ajlm-1645	199	6	a	a	DET
ajlm-1645	199	7	tertiary	tertiary	ADJ
ajlm-1645	199	8	care	care	NOUN
ajlm-1645	199	9	hospital	hospital	NOUN
ajlm-1645	199	10	of	of	ADP
ajlm-1645	199	11	kashmir	kashmir	PROPN
ajlm-1645	199	12	valley	valley	PROPN
ajlm-1645	199	13	.	.	PUNCT
ajlm-1645	200	1	int	int	PROPN
ajlm-1645	201	1	j	j	PROPN
ajlm-1645	201	2	sci	sci	PROPN
ajlm-1645	201	3	res	re	NOUN
ajlm-1645	201	4	.	.	PUNCT
ajlm-1645	202	1	2015;4(10):1186–1189	2015;4(10):1186–1189	PROPN
ajlm-1645	202	2	.	.	PUNCT
ajlm-1645	203	1	jain	jain	PROPN
ajlm-1645	203	2	a	a	DET
ajlm-1645	203	3	,	,	PUNCT
ajlm-1645	203	4	naniwadekar	naniwadekar	ADJ
ajlm-1645	203	5	m.	m.	NOUN
ajlm-1645	203	6	an	an	DET
ajlm-1645	203	7	etiological	etiological	ADJ
ajlm-1645	203	8	reappraisal	reappraisal	NOUN
ajlm-1645	203	9	of	of	ADP
ajlm-1645	203	10	pancytopenia	pancytopenia	NOUN
ajlm-1645	203	11	–	–	PUNCT
ajlm-1645	203	12	largest	large	ADJ
ajlm-1645	203	13	series	series	NOUN
ajlm-1645	203	14	reported	report	VERB
ajlm-1645	203	15	to	to	ADP
ajlm-1645	203	16	date	date	NOUN
ajlm-1645	203	17	from	from	ADP
ajlm-1645	203	18	a	a	DET
ajlm-1645	203	19	single	single	ADJ
ajlm-1645	203	20	tertiary	tertiary	ADJ
ajlm-1645	203	21	care	care	NOUN
ajlm-1645	203	22	teaching	teaching	NOUN
ajlm-1645	203	23	hospital	hospital	NOUN
ajlm-1645	203	24	.	.	PUNCT
ajlm-1645	204	1	bmc	bmc	ADJ
ajlm-1645	204	2	hematol	hematol	NOUN
ajlm-1645	204	3	.	.	PUNCT
ajlm-1645	205	1	2013;13(10):1–10	2013;13(10):1–10	X
ajlm-1645	205	2	.	.	PUNCT
ajlm-1645	206	1	https://doi.org/10.1186/2052-1839-13-10	https://doi.org/10.1186/2052-1839-13-10	PROPN
ajlm-1645	206	2	dasgupta	dasgupta	PROPN
ajlm-1645	206	3	s	s	PROPN
ajlm-1645	206	4	,	,	PUNCT
ajlm-1645	206	5	mandal	mandal	PROPN
ajlm-1645	206	6	p	p	PROPN
ajlm-1645	206	7	,	,	PUNCT
ajlm-1645	206	8	chakrabarti	chakrabarti	PROPN
ajlm-1645	206	9	s.	s.	PROPN
ajlm-1645	206	10	etiology	etiology	PROPN
ajlm-1645	206	11	of	of	ADP
ajlm-1645	206	12	pancytopenia	pancytopenia	NOUN
ajlm-1645	206	13	:	:	PUNCT
ajlm-1645	206	14	an	an	DET
ajlm-1645	206	15	observation	observation	NOUN
ajlm-1645	206	16	from	from	ADP
ajlm-1645	206	17	a	a	DET
ajlm-1645	206	18	referral	referral	ADJ
ajlm-1645	206	19	medical	medical	ADJ
ajlm-1645	206	20	institution	institution	NOUN
ajlm-1645	206	21	of	of	ADP
ajlm-1645	206	22	eastern	eastern	ADJ
ajlm-1645	206	23	region	region	NOUN
ajlm-1645	206	24	of	of	ADP
ajlm-1645	206	25	india	india	PROPN
ajlm-1645	206	26	.	.	PUNCT
ajlm-1645	207	1	j	j	PROPN
ajlm-1645	207	2	lab	lab	PROPN
ajlm-1645	207	3	physicians	physician	NOUN
ajlm-1645	207	4	.	.	PUNCT
ajlm-1645	208	1	2015;7(2):90–95	2015;7(2):90–95	X
ajlm-1645	208	2	.	.	PUNCT
ajlm-1645	209	1	https://doi.org/10.4103/0974-2727.163136	https://doi.org/10.4103/0974-2727.163136	PROPN
ajlm-1645	209	2	santra	santra	PROPN
ajlm-1645	209	3	g	g	PROPN
ajlm-1645	209	4	,	,	PUNCT
ajlm-1645	209	5	das	das	PROPN
ajlm-1645	209	6	bk	bk	PROPN
ajlm-1645	209	7	.	.	PUNCT
ajlm-1645	210	1	a	a	DET
ajlm-1645	210	2	cross	cross	ADJ
ajlm-1645	210	3	-	-	ADJ
ajlm-1645	210	4	sectional	sectional	ADJ
ajlm-1645	210	5	study	study	NOUN
ajlm-1645	210	6	of	of	ADP
ajlm-1645	210	7	the	the	DET
ajlm-1645	210	8	clinical	clinical	ADJ
ajlm-1645	210	9	profile	profile	NOUN
ajlm-1645	210	10	and	and	CCONJ
ajlm-1645	210	11	aetiological	aetiological	ADJ
ajlm-1645	210	12	spectrum	spectrum	NOUN
ajlm-1645	210	13	of	of	ADP
ajlm-1645	210	14	pancytopenia	pancytopenia	NOUN
ajlm-1645	210	15	in	in	ADP
ajlm-1645	210	16	a	a	DET
ajlm-1645	210	17	tertiary	tertiary	ADJ
ajlm-1645	210	18	care	care	NOUN
ajlm-1645	210	19	centre	centre	NOUN
ajlm-1645	210	20	.	.	PUNCT
ajlm-1645	211	1	singapore	singapore	PROPN
ajlm-1645	211	2	med	med	PROPN
ajlm-1645	211	3	j.	j.	PROPN
ajlm-1645	211	4	2010;51(10):806–812	2010;51(10):806–812	PROPN
ajlm-1645	211	5	.	.	PUNCT
ajlm-1645	212	1	thakkar	thakkar	PROPN
ajlm-1645	212	2	b	b	PROPN
ajlm-1645	212	3	,	,	PUNCT
ajlm-1645	212	4	bhavsar	bhavsar	ADJ
ajlm-1645	212	5	u	u	PROPN
ajlm-1645	212	6	,	,	PUNCT
ajlm-1645	212	7	trivedi	trivedi	PROPN
ajlm-1645	212	8	n	n	CCONJ
ajlm-1645	212	9	,	,	PUNCT
ajlm-1645	212	10	agnihotri	agnihotri	PROPN
ajlm-1645	212	11	a.	a.	NOUN
ajlm-1645	212	12	a	a	DET
ajlm-1645	212	13	study	study	NOUN
ajlm-1645	212	14	of	of	ADP
ajlm-1645	212	15	pancytopenia	pancytopenia	NOUN
ajlm-1645	212	16	in	in	ADP
ajlm-1645	212	17	adult	adult	NOUN
ajlm-1645	212	18	patients	patient	NOUN
ajlm-1645	212	19	more	more	ADJ
ajlm-1645	212	20	than	than	ADP
ajlm-1645	212	21	12	12	NUM
ajlm-1645	212	22	years	year	NOUN
ajlm-1645	212	23	of	of	ADP
ajlm-1645	212	24	age	age	NOUN
ajlm-1645	212	25	in	in	ADP
ajlm-1645	212	26	north	north	PROPN
ajlm-1645	212	27	west	west	PROPN
ajlm-1645	212	28	region	region	PROPN
ajlm-1645	212	29	of	of	ADP
ajlm-1645	212	30	saurashtra	saurashtra	PROPN
ajlm-1645	212	31	.	.	PUNCT
ajlm-1645	212	32	natl	natl	PROPN
ajlm-1645	212	33	j	j	PROPN
ajlm-1645	212	34	med	med	PROPN
ajlm-1645	212	35	res	re	NOUN
ajlm-1645	212	36	.	.	PUNCT
ajlm-1645	213	1	2013;3(1):48–52	2013;3(1):48–52	NUM
ajlm-1645	213	2	.	.	PUNCT
ajlm-1645	214	1	niazi	niazi	PROPN
ajlm-1645	214	2	m	m	PROPN
ajlm-1645	214	3	,	,	PUNCT
ajlm-1645	214	4	raziq	raziq	PROPN
ajlm-1645	214	5	f.	f.	PROPN
ajlm-1645	214	6	the	the	DET
ajlm-1645	214	7	incidence	incidence	NOUN
ajlm-1645	214	8	of	of	ADP
ajlm-1645	214	9	underlying	underlie	VERB
ajlm-1645	214	10	pathology	pathology	NOUN
ajlm-1645	214	11	in	in	ADP
ajlm-1645	214	12	pancytopenia	pancytopenia	NOUN
ajlm-1645	214	13	–	–	PUNCT
ajlm-1645	214	14	an	an	DET
ajlm-1645	214	15	experience	experience	NOUN
ajlm-1645	214	16	of	of	ADP
ajlm-1645	214	17	89	89	NUM
ajlm-1645	214	18	cases	case	NOUN
ajlm-1645	214	19	.	.	PUNCT
ajlm-1645	215	1	j	j	PROPN
ajlm-1645	215	2	postgrad	postgrad	PROPN
ajlm-1645	215	3	med	med	PROPN
ajlm-1645	215	4	inst	inst	NOUN
ajlm-1645	215	5	(	(	PUNCT
ajlm-1645	215	6	peshawar	peshawar	NOUN
ajlm-1645	215	7	–	–	PUNCT
ajlm-1645	215	8	pakistan	pakistan	PROPN
ajlm-1645	215	9	)	)	PUNCT
ajlm-1645	215	10	.	.	PUNCT
ajlm-1645	216	1	2004;18(1):76–79	2004;18(1):76–79	X
ajlm-1645	216	2	.	.	PUNCT
ajlm-1645	217	1	tariq	tariq	PROPN
ajlm-1645	217	2	m	m	PROPN
ajlm-1645	217	3	,	,	PUNCT
ajlm-1645	217	4	basri	basri	ADJ
ajlm-1645	217	5	r	r	NOUN
ajlm-1645	217	6	,	,	PUNCT
ajlm-1645	217	7	khan	khan	PROPN
ajlm-1645	217	8	nu	nu	PROPN
ajlm-1645	217	9	,	,	PUNCT
ajlm-1645	217	10	amin	amin	PROPN
ajlm-1645	217	11	s.	s.	PROPN
ajlm-1645	217	12	aetiology	aetiology	PROPN
ajlm-1645	217	13	of	of	ADP
ajlm-1645	217	14	pancytopenia	pancytopenia	PROPN
ajlm-1645	217	15	.	.	PUNCT
ajlm-1645	218	1	prof	prof	PROPN
ajlm-1645	218	2	med	med	PROPN
ajlm-1645	218	3	j.	j.	PROPN
ajlm-1645	218	4	2010;17(2):252–256	2010;17(2):252–256	PROPN
ajlm-1645	218	5	.	.	PUNCT
ajlm-1645	219	1	https://doi.org/10.29309/tpmj/2010.17.02.2371	https://doi.org/10.29309/tpmj/2010.17.02.2371	PROPN
ajlm-1645	219	2	aziz	aziz	PROPN
ajlm-1645	219	3	t	t	PROPN
ajlm-1645	219	4	,	,	PUNCT
ajlm-1645	219	5	ali	ali	PROPN
ajlm-1645	219	6	l	l	PROPN
ajlm-1645	219	7	,	,	PUNCT
ajlm-1645	219	8	ansari	ansari	PROPN
ajlm-1645	219	9	t	t	PROPN
ajlm-1645	219	10	,	,	PUNCT
ajlm-1645	219	11	liaquat	liaquat	PROPN
ajlm-1645	219	12	h	h	NOUN
ajlm-1645	219	13	,	,	PUNCT
ajlm-1645	219	14	shah	shah	PROPN
ajlm-1645	219	15	s	s	PROPN
ajlm-1645	219	16	,	,	PUNCT
ajlm-1645	219	17	ara	ara	PROPN
ajlm-1645	219	18	j.	j.	PROPN
ajlm-1645	219	19	pancytopenia	pancytopenia	PROPN
ajlm-1645	219	20	:	:	PUNCT
ajlm-1645	219	21	megaloblastic	megaloblastic	ADJ
ajlm-1645	219	22	anemia	anemia	NOUN
ajlm-1645	219	23	is	be	AUX
ajlm-1645	219	24	still	still	ADV
ajlm-1645	219	25	the	the	DET
ajlm-1645	219	26	commonest	commonest	NOUN
ajlm-1645	219	27	cause	cause	NOUN
ajlm-1645	219	28	.	.	PUNCT
ajlm-1645	220	1	pak	pak	PROPN
ajlm-1645	220	2	j	j	PROPN
ajlm-1645	220	3	med	med	PROPN
ajlm-1645	220	4	sci	sci	PROPN
ajlm-1645	220	5	.	.	PUNCT
ajlm-1645	221	1	2010;26(1):132–136	2010;26(1):132–136	NUM
ajlm-1645	221	2	.	.	PUNCT
ajlm-1645	222	1	makheja	makheja	PROPN
ajlm-1645	222	2	kd	kd	PROPN
ajlm-1645	222	3	,	,	PUNCT
ajlm-1645	222	4	maheshwari	maheshwari	PROPN
ajlm-1645	222	5	bk	bk	PROPN
ajlm-1645	222	6	,	,	PUNCT
ajlm-1645	222	7	arain	arain	PROPN
ajlm-1645	222	8	s	s	PROPN
ajlm-1645	222	9	,	,	PUNCT
ajlm-1645	222	10	kumar	kumar	PROPN
ajlm-1645	222	11	s	s	PROPN
ajlm-1645	222	12	,	,	PUNCT
ajlm-1645	222	13	kumari	kumari	PROPN
ajlm-1645	222	14	s	s	PROPN
ajlm-1645	222	15	,	,	PUNCT
ajlm-1645	222	16	vikash	vikash	PROPN
ajlm-1645	222	17	.	.	PUNCT
ajlm-1645	223	1	the	the	DET
ajlm-1645	223	2	common	common	ADJ
ajlm-1645	223	3	causes	cause	NOUN
ajlm-1645	223	4	leading	lead	VERB
ajlm-1645	223	5	to	to	ADP
ajlm-1645	223	6	pancytopenia	pancytopenia	NOUN
ajlm-1645	223	7	in	in	ADP
ajlm-1645	223	8	patients	patient	NOUN
ajlm-1645	223	9	presenting	present	VERB
ajlm-1645	223	10	to	to	ADP
ajlm-1645	223	11	tertiary	tertiary	ADJ
ajlm-1645	223	12	care	care	NOUN
ajlm-1645	223	13	hospital	hospital	NOUN
ajlm-1645	223	14	.	.	PUNCT
ajlm-1645	224	1	pak	pak	PROPN
ajlm-1645	224	2	j	j	PROPN
ajlm-1645	224	3	med	med	PROPN
ajlm-1645	224	4	sci	sci	PROPN
ajlm-1645	224	5	.	.	PUNCT
ajlm-1645	225	1	2013;29(5):1108–1111	2013;29(5):1108–1111	PROPN
ajlm-1645	225	2	.	.	PUNCT
ajlm-1645	226	1	https://doi.org/10.12669/pjms.295.3458	https://doi.org/10.12669/pjms.295.3458	PROPN
ajlm-1645	226	2	rehmani	rehmani	PROPN
ajlm-1645	226	3	th	th	PROPN
ajlm-1645	226	4	,	,	PUNCT
ajlm-1645	226	5	arif	arif	PROPN
ajlm-1645	226	6	m	m	PROPN
ajlm-1645	226	7	,	,	PUNCT
ajlm-1645	226	8	heraid	heraid	PROPN
ajlm-1645	226	9	s	s	PROPN
ajlm-1645	226	10	,	,	PUNCT
ajlm-1645	226	11	arif	arif	PROPN
ajlm-1645	226	12	s	s	PROPN
ajlm-1645	226	13	,	,	PUNCT
ajlm-1645	226	14	ahmad	ahmad	PROPN
ajlm-1645	226	15	r	r	PROPN
ajlm-1645	226	16	,	,	PUNCT
ajlm-1645	226	17	saeed	saeed	PROPN
ajlm-1645	226	18	m.	m.	PROPN
ajlm-1645	226	19	spectrum	spectrum	PROPN
ajlm-1645	226	20	of	of	ADP
ajlm-1645	226	21	pancytopenia	pancytopenia	NOUN
ajlm-1645	226	22	:	:	PUNCT
ajlm-1645	226	23	a	a	DET
ajlm-1645	226	24	tertiary	tertiary	ADJ
ajlm-1645	226	25	care	care	NOUN
ajlm-1645	226	26	experience	experience	NOUN
ajlm-1645	226	27	.	.	PUNCT
ajlm-1645	227	1	prof	prof	PROPN
ajlm-1645	227	2	med	med	PROPN
ajlm-1645	227	3	j.	j.	PROPN
ajlm-1645	227	4	2016;23(5):620–626	2016;23(5):620–626	PROPN
ajlm-1645	227	5	.	.	PUNCT
ajlm-1645	228	1	https://doi.org/10.29309/tpmj/2016.23.05.1594	https://doi.org/10.29309/tpmj/2016.23.05.1594	PROPN
ajlm-1645	228	2	biswas	biswas	PROPN
ajlm-1645	228	3	pk	pk	PROPN
ajlm-1645	228	4	,	,	PUNCT
ajlm-1645	228	5	sardar	sardar	PROPN
ajlm-1645	228	6	mh	mh	PROPN
ajlm-1645	228	7	,	,	PUNCT
ajlm-1645	228	8	saha	saha	PROPN
ajlm-1645	228	9	gc	gc	PROPN
ajlm-1645	228	10	,	,	PUNCT
ajlm-1645	228	11	et	et	PROPN
ajlm-1645	228	12	al	al	PROPN
ajlm-1645	228	13	.	.	PROPN
ajlm-1645	229	1	etiological	etiological	ADJ
ajlm-1645	229	2	and	and	CCONJ
ajlm-1645	229	3	clinical	clinical	ADJ
ajlm-1645	229	4	spectrum	spectrum	NOUN
ajlm-1645	229	5	of	of	ADP
ajlm-1645	229	6	pancytopenia	pancytopenia	NOUN
ajlm-1645	229	7	based	base	VERB
ajlm-1645	229	8	on	on	ADP
ajlm-1645	229	9	bone	bone	NOUN
ajlm-1645	229	10	marrow	marrow	NOUN
ajlm-1645	229	11	examination	examination	NOUN
ajlm-1645	229	12	.	.	PUNCT
ajlm-1645	230	1	j	j	PROPN
ajlm-1645	230	2	med	med	PROPN
ajlm-1645	230	3	.	.	PUNCT
ajlm-1645	231	1	2019;20(2):68–71	2019;20(2):68–71	NUM
ajlm-1645	231	2	.	.	PUNCT
ajlm-1645	232	1	https://doi.org/10.3329/jom.v20i2.42005	https://doi.org/10.3329/jom.v20i2.42005	PROPN
ajlm-1645	232	2	basavaiah	basavaiah	PROPN
ajlm-1645	232	3	sh	sh	PROPN
ajlm-1645	232	4	,	,	PUNCT
ajlm-1645	232	5	rai	rai	PROPN
ajlm-1645	232	6	s	s	PROPN
ajlm-1645	232	7	,	,	PUNCT
ajlm-1645	232	8	suresh	suresh	PROPN
ajlm-1645	232	9	pk	pk	PROPN
ajlm-1645	232	10	,	,	PUNCT
ajlm-1645	232	11	shivaprasad	shivaprasad	PROPN
ajlm-1645	232	12	sm	sm	PROPN
ajlm-1645	232	13	,	,	PUNCT
ajlm-1645	232	14	khandelia	khandelia	PROPN
ajlm-1645	232	15	b.	b.	PROPN
ajlm-1645	232	16	clinicopathological	clinicopathological	ADJ
ajlm-1645	232	17	diversity	diversity	NOUN
ajlm-1645	232	18	of	of	ADP
ajlm-1645	232	19	pancytopenia	pancytopenia	NOUN
ajlm-1645	232	20	:	:	PUNCT
ajlm-1645	232	21	a	a	DET
ajlm-1645	232	22	series	series	NOUN
ajlm-1645	232	23	of	of	ADP
ajlm-1645	232	24	400	400	NUM
ajlm-1645	232	25	cases	case	NOUN
ajlm-1645	232	26	.	.	PUNCT
ajlm-1645	233	1	j	j	PROPN
ajlm-1645	233	2	clin	clin	PROPN
ajlm-1645	233	3	diagnostic	diagnostic	PROPN
ajlm-1645	233	4	res	re	NOUN
ajlm-1645	233	5	.	.	PUNCT
ajlm-1645	234	1	2018;12(3):ec01	2018;12(3):ec01	NUM
ajlm-1645	234	2	–	–	PUNCT
ajlm-1645	234	3	ec05	ec05	PROPN
ajlm-1645	234	4	.	.	PUNCT
ajlm-1645	235	1	https://doi.org/10.7860/jcdr/2018/32116.11227	https://doi.org/10.7860/jcdr/2018/32116.11227	PROPN
ajlm-1645	235	2	jha	jha	PROPN
ajlm-1645	235	3	a	a	PROPN
ajlm-1645	235	4	,	,	PUNCT
ajlm-1645	235	5	sayami	sayami	VERB
ajlm-1645	235	6	g	g	PROPN
ajlm-1645	235	7	,	,	PUNCT
ajlm-1645	235	8	adhikari	adhikari	PROPN
ajlm-1645	235	9	rc	rc	PROPN
ajlm-1645	235	10	,	,	PUNCT
ajlm-1645	235	11	panta	panta	PROPN
ajlm-1645	235	12	ad	ad	NOUN
ajlm-1645	235	13	,	,	PUNCT
ajlm-1645	235	14	jha	jha	PROPN
ajlm-1645	235	15	r.	r.	PROPN
ajlm-1645	235	16	bone	bone	PROPN
ajlm-1645	235	17	marrow	marrow	PROPN
ajlm-1645	235	18	examination	examination	NOUN
ajlm-1645	235	19	in	in	ADP
ajlm-1645	235	20	cases	case	NOUN
ajlm-1645	235	21	of	of	ADP
ajlm-1645	235	22	pancytopenia	pancytopenia	NOUN
ajlm-1645	235	23	.	.	PUNCT
ajlm-1645	236	1	j	j	PROPN
ajlm-1645	236	2	nepal	nepal	PROPN
ajlm-1645	236	3	med	med	PROPN
ajlm-1645	236	4	assoc	assoc	PROPN
ajlm-1645	236	5	.	.	PUNCT
ajlm-1645	237	1	2008;47(169):12–17	2008;47(169):12–17	X
ajlm-1645	237	2	.	.	PUNCT
ajlm-1645	238	1	https://doi.org/10.31729/jnma.209	https://doi.org/10.31729/jnma.209	VERB
ajlm-1645	238	2	lakhey	lakhey	PROPN
ajlm-1645	238	3	a	a	PRON
ajlm-1645	238	4	,	,	PUNCT
ajlm-1645	238	5	talwar	talwar	PROPN
ajlm-1645	238	6	o	o	PROPN
ajlm-1645	238	7	,	,	PUNCT
ajlm-1645	238	8	singh	singh	PROPN
ajlm-1645	238	9	v	v	NOUN
ajlm-1645	238	10	,	,	PUNCT
ajlm-1645	238	11	shiva	shiva	PROPN
ajlm-1645	238	12	raj	raj	PROPN
ajlm-1645	238	13	k.	k.	PROPN
ajlm-1645	238	14	clinico	clinico	PROPN
ajlm-1645	238	15	-	-	PUNCT
ajlm-1645	238	16	hematological	hematological	ADJ
ajlm-1645	238	17	study	study	NOUN
ajlm-1645	238	18	of	of	ADP
ajlm-1645	238	19	pancytopenia	pancytopenia	NOUN
ajlm-1645	238	20	.	.	PUNCT
ajlm-1645	239	1	j	j	PROPN
ajlm-1645	239	2	pathol	pathol	PROPN
ajlm-1645	239	3	nepal	nepal	NOUN
ajlm-1645	239	4	.	.	PUNCT
ajlm-1645	240	1	2012;2(3):207–210	2012;2(3):207–210	X
ajlm-1645	240	2	.	.	PUNCT
ajlm-1645	241	1	https://doi.org/10.3126/jpn.v2i3.6023	https://doi.org/10.3126/jpn.v2i3.6023	PROPN
ajlm-1645	241	2	pathak	pathak	PROPN
ajlm-1645	241	3	r	r	PROPN
ajlm-1645	241	4	,	,	PUNCT
ajlm-1645	241	5	jha	jha	PROPN
ajlm-1645	241	6	a	a	PROPN
ajlm-1645	241	7	,	,	PUNCT
ajlm-1645	241	8	sayami	sayami	NOUN
ajlm-1645	241	9	g.	g.	NOUN
ajlm-1645	241	10	evaluation	evaluation	NOUN
ajlm-1645	241	11	of	of	ADP
ajlm-1645	241	12	bone	bone	NOUN
ajlm-1645	241	13	marrow	marrow	NOUN
ajlm-1645	241	14	in	in	ADP
ajlm-1645	241	15	patients	patient	NOUN
ajlm-1645	241	16	with	with	ADP
ajlm-1645	241	17	pancytopenia	pancytopenia	NOUN
ajlm-1645	241	18	.	.	PUNCT
ajlm-1645	242	1	j	j	PROPN
ajlm-1645	242	2	pathol	pathol	PROPN
ajlm-1645	242	3	nepal	nepal	NOUN
ajlm-1645	242	4	.	.	PUNCT
ajlm-1645	243	1	2012;2(4):265–271	2012;2(4):265–271	X
ajlm-1645	243	2	.	.	X
ajlm-1645	243	3	https://doi.org/10.3126/jpn.v2i4.6875	https://doi.org/10.3126/jpn.v2i4.6875	NUM
ajlm-1645	243	4	national	national	PROPN
ajlm-1645	243	5	research	research	PROPN
ajlm-1645	243	6	council	council	PROPN
ajlm-1645	243	7	(	(	PUNCT
ajlm-1645	243	8	us	us	PROPN
ajlm-1645	243	9	)	)	PUNCT
ajlm-1645	243	10	committee	committee	NOUN
ajlm-1645	243	11	on	on	ADP
ajlm-1645	243	12	climate	climate	NOUN
ajlm-1645	243	13	,	,	PUNCT
ajlm-1645	243	14	ecosystems	ecosystem	NOUN
ajlm-1645	243	15	,	,	PUNCT
ajlm-1645	243	16	infectious	infectious	ADJ
ajlm-1645	243	17	diseases	disease	NOUN
ajlm-1645	243	18	,	,	PUNCT
ajlm-1645	243	19	and	and	CCONJ
ajlm-1645	243	20	human	human	ADJ
ajlm-1645	243	21	health	health	NOUN
ajlm-1645	243	22	.	.	PUNCT
ajlm-1645	244	1	analytical	analytical	ADJ
ajlm-1645	244	2	approaches	approach	NOUN
ajlm-1645	244	3	to	to	ADP
ajlm-1645	244	4	studying	study	VERB
ajlm-1645	244	5	climate	climate	NOUN
ajlm-1645	244	6	/	/	SYM
ajlm-1645	244	7	disease	disease	NOUN
ajlm-1645	244	8	linkages	linkage	NOUN
ajlm-1645	244	9	.	.	PUNCT
ajlm-1645	245	1	in	in	ADP
ajlm-1645	245	2	:	:	PUNCT
ajlm-1645	245	3	national	national	PROPN
ajlm-1645	245	4	research	research	PROPN
ajlm-1645	245	5	council	council	PROPN
ajlm-1645	245	6	,	,	PUNCT
ajlm-1645	245	7	editor	editor	NOUN
ajlm-1645	245	8	.	.	PUNCT
ajlm-1645	246	1	under	under	ADP
ajlm-1645	246	2	the	the	DET
ajlm-1645	246	3	weather	weather	NOUN
ajlm-1645	246	4	:	:	PUNCT
ajlm-1645	246	5	climate	climate	NOUN
ajlm-1645	246	6	,	,	PUNCT
ajlm-1645	246	7	ecosystems	ecosystem	NOUN
ajlm-1645	246	8	,	,	PUNCT
ajlm-1645	246	9	and	and	CCONJ
ajlm-1645	246	10	infectious	infectious	ADJ
ajlm-1645	246	11	disease	disease	NOUN
ajlm-1645	246	12	.	.	PUNCT
ajlm-1645	247	1	washington	washington	PROPN
ajlm-1645	247	2	,	,	PUNCT
ajlm-1645	247	3	d.c	d.c	PROPN
ajlm-1645	247	4	.	.	PROPN
ajlm-1645	247	5	:	:	PUNCT
ajlm-1645	247	6	national	national	PROPN
ajlm-1645	247	7	academy	academy	PROPN
ajlm-1645	247	8	press	press	PROPN
ajlm-1645	247	9	.	.	PUNCT
ajlm-1645	248	1	2001	2001	NUM
ajlm-1645	248	2	;	;	PUNCT
ajlm-1645	249	1	p.	p.	NOUN
ajlm-1645	249	2	59–79	59–79	ADV
ajlm-1645	249	3	.	.	PUNCT
ajlm-1645	250	1	https://doi.org/10.17226/10025	https://doi.org/10.17226/10025	VERB
ajlm-1645	251	1	imbert	imbert	PROPN
ajlm-1645	251	2	m	m	PROPN
ajlm-1645	251	3	,	,	PUNCT
ajlm-1645	251	4	scoazec	scoazec	PROPN
ajlm-1645	251	5	jy	jy	PROPN
ajlm-1645	251	6	,	,	PUNCT
ajlm-1645	251	7	mary	mary	PROPN
ajlm-1645	251	8	jy	jy	PROPN
ajlm-1645	251	9	,	,	PUNCT
ajlm-1645	251	10	jouzult	jouzult	PROPN
ajlm-1645	251	11	h	h	PROPN
ajlm-1645	251	12	,	,	PUNCT
ajlm-1645	251	13	rochant	rochant	ADJ
ajlm-1645	251	14	h	h	NOUN
ajlm-1645	251	15	,	,	PUNCT
ajlm-1645	251	16	sultan	sultan	PROPN
ajlm-1645	251	17	c.	c.	PROPN
ajlm-1645	251	18	adult	adult	PROPN
ajlm-1645	251	19	patients	patient	NOUN
ajlm-1645	251	20	presenting	present	VERB
ajlm-1645	251	21	with	with	ADP
ajlm-1645	251	22	pancytopenia	pancytopenia	NOUN
ajlm-1645	251	23	:	:	PUNCT
ajlm-1645	251	24	a	a	DET
ajlm-1645	251	25	reappraisal	reappraisal	NOUN
ajlm-1645	251	26	of	of	ADP
ajlm-1645	251	27	underlying	underlie	VERB
ajlm-1645	251	28	pathology	pathology	NOUN
ajlm-1645	251	29	and	and	CCONJ
ajlm-1645	251	30	diagnostic	diagnostic	ADJ
ajlm-1645	251	31	procedures	procedure	NOUN
ajlm-1645	251	32	in	in	ADP
ajlm-1645	251	33	213	213	NUM
ajlm-1645	251	34	cases	case	NOUN
ajlm-1645	251	35	.	.	PUNCT
ajlm-1645	252	1	hematol	hematol	NOUN
ajlm-1645	252	2	pathol	pathol	NOUN
ajlm-1645	252	3	.	.	PUNCT
ajlm-1645	253	1	1989;3(4):159–167	1989;3(4):159–167	X
ajlm-1645	253	2	.	.	PUNCT
ajlm-1645	254	1	keisu	keisu	PROPN
ajlm-1645	254	2	m	m	PROPN
ajlm-1645	254	3	,	,	PUNCT
ajlm-1645	254	4	ost	ost	ADJ
ajlm-1645	254	5	a.	a.	NOUN
ajlm-1645	254	6	diagnoses	diagnosis	NOUN
ajlm-1645	254	7	in	in	ADP
ajlm-1645	254	8	patients	patient	NOUN
ajlm-1645	254	9	with	with	ADP
ajlm-1645	254	10	severe	severe	ADJ
ajlm-1645	254	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	254	12	suspected	suspect	VERB
ajlm-1645	254	13	of	of	ADP
ajlm-1645	254	14	having	have	VERB
ajlm-1645	254	15	aplastic	aplastic	ADJ
ajlm-1645	254	16	anemia	anemia	NOUN
ajlm-1645	254	17	.	.	PUNCT
ajlm-1645	255	1	eur	eur	PROPN
ajlm-1645	255	2	j	j	PROPN
ajlm-1645	255	3	haematol	haematol	NOUN
ajlm-1645	255	4	.	.	PUNCT
ajlm-1645	256	1	1990;45(1):11–14	1990;45(1):11–14	X
ajlm-1645	256	2	.	.	PUNCT
ajlm-1645	257	1	https://doi.org/10.1111/j.1600-0609.1990.tb00407.x	https://doi.org/10.1111/j.1600-0609.1990.tb00407.x	PROPN
ajlm-1645	257	2	bae	bae	PROPN
ajlm-1645	257	3	m	m	PROPN
ajlm-1645	257	4	-	-	PROPN
ajlm-1645	257	5	h	h	PROPN
ajlm-1645	257	6	,	,	PUNCT
ajlm-1645	257	7	cho	cho	PROPN
ajlm-1645	257	8	y	y	PROPN
ajlm-1645	257	9	-	-	PUNCT
ajlm-1645	257	10	u	u	PROPN
ajlm-1645	257	11	,	,	PUNCT
ajlm-1645	257	12	kim	kim	PROPN
ajlm-1645	257	13	b	b	PROPN
ajlm-1645	257	14	,	,	PUNCT
ajlm-1645	257	15	et	et	PROPN
ajlm-1645	257	16	al	al	PROPN
ajlm-1645	257	17	.	.	PROPN
ajlm-1645	257	18	pancytopenia	pancytopenia	PROPN
ajlm-1645	257	19	or	or	CCONJ
ajlm-1645	257	20	bicytopenia	bicytopenia	NOUN
ajlm-1645	257	21	in	in	ADP
ajlm-1645	257	22	a	a	DET
ajlm-1645	257	23	korean	korean	ADJ
ajlm-1645	257	24	tertiary	tertiary	ADJ
ajlm-1645	257	25	care	care	NOUN
ajlm-1645	257	26	center	center	NOUN
ajlm-1645	257	27	;	;	PUNCT
ajlm-1645	257	28	etiological	etiological	ADJ
ajlm-1645	257	29	profile	profile	NOUN
ajlm-1645	257	30	based	base	VERB
ajlm-1645	257	31	on	on	ADP
ajlm-1645	257	32	bone	bone	NOUN
ajlm-1645	257	33	marrow	marrow	NOUN
ajlm-1645	257	34	examination	examination	NOUN
ajlm-1645	257	35	and	and	CCONJ
ajlm-1645	257	36	suggestion	suggestion	NOUN
ajlm-1645	257	37	for	for	ADP
ajlm-1645	257	38	diagnostic	diagnostic	ADJ
ajlm-1645	257	39	approach	approach	NOUN
ajlm-1645	257	40	.	.	PUNCT
ajlm-1645	258	1	blood	blood	NOUN
ajlm-1645	258	2	.	.	PUNCT
ajlm-1645	259	1	2015;126(23):5610	2015;126(23):5610	NUM
ajlm-1645	259	2	.	.	PUNCT
ajlm-1645	260	1	https://doi.org/10.1182/blood.v126.23.5610.5610	https://doi.org/10.1182/blood.v126.23.5610.5610	PROPN
ajlm-1645	260	2	al	al	PROPN
ajlm-1645	260	3	-	-	PUNCT
ajlm-1645	260	4	khalisi	khalisi	VERB
ajlm-1645	260	5	ka	ka	PROPN
ajlm-1645	260	6	,	,	PUNCT
ajlm-1645	260	7	al	al	PROPN
ajlm-1645	260	8	-	-	PUNCT
ajlm-1645	260	9	zubaidy	zubaidy	PROPN
ajlm-1645	260	10	as	as	ADP
ajlm-1645	260	11	,	,	PUNCT
ajlm-1645	260	12	rhaima	rhaima	PROPN
ajlm-1645	260	13	m.	m.	NOUN
ajlm-1645	260	14	pancytopenia	pancytopenia	PROPN
ajlm-1645	260	15	adult	adult	NOUN
ajlm-1645	260	16	patients	patient	NOUN
ajlm-1645	260	17	at	at	ADP
ajlm-1645	260	18	baghdad	baghdad	PROPN
ajlm-1645	260	19	teaching	teach	VERB
ajlm-1645	260	20	hospital	hospital	NOUN
ajlm-1645	260	21	.	.	PUNCT
ajlm-1645	261	1	iraqi	iraqi	ADJ
ajlm-1645	261	2	acad	acad	PROPN
ajlm-1645	261	3	sci	sci	PROPN
ajlm-1645	261	4	j.	j.	PROPN
ajlm-1645	261	5	2011;10(4):441–448	2011;10(4):441–448	PROPN
ajlm-1645	261	6	.	.	PROPN
ajlm-1645	261	7	weinzierl	weinzierl	PROPN
ajlm-1645	261	8	ep	ep	PROPN
ajlm-1645	261	9	,	,	PUNCT
ajlm-1645	261	10	arber	arber	PROPN
ajlm-1645	261	11	da	da	PROPN
ajlm-1645	261	12	.	.	PUNCT
ajlm-1645	261	13	bone	bone	PROPN
ajlm-1645	261	14	marrow	marrow	PROPN
ajlm-1645	261	15	evaluation	evaluation	NOUN
ajlm-1645	261	16	in	in	ADP
ajlm-1645	261	17	new	new	ADJ
ajlm-1645	261	18	-	-	PUNCT
ajlm-1645	261	19	onset	onset	NOUN
ajlm-1645	261	20	pancytopenia	pancytopenia	NOUN
ajlm-1645	261	21	.	.	PUNCT
ajlm-1645	262	1	hum	hum	PROPN
ajlm-1645	262	2	pathol	pathol	PROPN
ajlm-1645	262	3	.	.	PUNCT
ajlm-1645	263	1	2013;44(6):1154–1164	2013;44(6):1154–1164	NOUN
ajlm-1645	263	2	.	.	PUNCT
ajlm-1645	264	1	https://doi.org/10.1016/j.humpath.2012.10.006	https://doi.org/10.1016/j.humpath.2012.10.006	PROPN
ajlm-1645	264	2	devitt	devitt	PROPN
ajlm-1645	264	3	ka	ka	PROPN
ajlm-1645	264	4	,	,	PUNCT
ajlm-1645	264	5	lunde	lunde	PROPN
ajlm-1645	264	6	jh	jh	PROPN
ajlm-1645	264	7	,	,	PUNCT
ajlm-1645	264	8	lewis	lewis	PROPN
ajlm-1645	264	9	mr	mr	PROPN
ajlm-1645	264	10	.	.	PROPN
ajlm-1645	264	11	new	new	ADJ
ajlm-1645	264	12	onset	onset	NOUN
ajlm-1645	264	13	pancytopenia	pancytopenia	NOUN
ajlm-1645	264	14	in	in	ADP
ajlm-1645	264	15	adults	adult	NOUN
ajlm-1645	264	16	:	:	PUNCT
ajlm-1645	264	17	a	a	DET
ajlm-1645	264	18	review	review	NOUN
ajlm-1645	264	19	of	of	ADP
ajlm-1645	264	20	underlying	underlie	VERB
ajlm-1645	264	21	pathologies	pathology	NOUN
ajlm-1645	264	22	and	and	CCONJ
ajlm-1645	264	23	their	their	PRON
ajlm-1645	264	24	associated	associated	ADJ
ajlm-1645	264	25	clinical	clinical	ADJ
ajlm-1645	264	26	and	and	CCONJ
ajlm-1645	264	27	laboratory	laboratory	NOUN
ajlm-1645	264	28	findings	finding	NOUN
ajlm-1645	264	29	.	.	PUNCT
ajlm-1645	265	1	leuk	leuk	PROPN
ajlm-1645	265	2	lymphoma	lymphoma	NOUN
ajlm-1645	265	3	.	.	PUNCT
ajlm-1645	266	1	2014;55(5):1099–1105	2014;55(5):1099–1105	NUM
ajlm-1645	266	2	.	.	PUNCT
ajlm-1645	267	1	https://doi.org/10.3109/10428194.2013.821703	https://doi.org/10.3109/10428194.2013.821703	NOUN
ajlm-1645	267	2	vargas	vargas	NOUN
ajlm-1645	267	3	-	-	PUNCT
ajlm-1645	267	4	carretero	carretero	NOUN
ajlm-1645	267	5	cj	cj	PROPN
ajlm-1645	267	6	,	,	PUNCT
ajlm-1645	267	7	fernandez	fernandez	NOUN
ajlm-1645	267	8	-	-	PUNCT
ajlm-1645	267	9	vargas	vargas	PROPN
ajlm-1645	267	10	oe	oe	PROPN
ajlm-1645	267	11	,	,	PUNCT
ajlm-1645	267	12	ron	ron	PROPN
ajlm-1645	267	13	-	-	PUNCT
ajlm-1645	267	14	magaña	magaña	VERB
ajlm-1645	267	15	al	al	PROPN
ajlm-1645	267	16	,	,	PUNCT
ajlm-1645	267	17	padilla	padilla	PROPN
ajlm-1645	267	18	-	-	PUNCT
ajlm-1645	267	19	ortega	ortega	PROPN
ajlm-1645	267	20	ja	ja	PROPN
ajlm-1645	267	21	,	,	PUNCT
ajlm-1645	267	22	ron	ron	PROPN
ajlm-1645	267	23	-	-	PUNCT
ajlm-1645	267	24	guerrero	guerrero	PROPN
ajlm-1645	267	25	cs	cs	PROPN
ajlm-1645	267	26	,	,	PUNCT
ajlm-1645	267	27	barrera	barrera	NOUN
ajlm-1645	267	28	-	-	PUNCT
ajlm-1645	267	29	chairez	chairez	NOUN
ajlm-1645	267	30	e.	e.	PROPN
ajlm-1645	267	31	etiology	etiology	PROPN
ajlm-1645	267	32	and	and	CCONJ
ajlm-1645	267	33	clinico	clinico	NOUN
ajlm-1645	267	34	-	-	PUNCT
ajlm-1645	267	35	hematological	hematological	ADJ
ajlm-1645	267	36	profile	profile	NOUN
ajlm-1645	267	37	of	of	ADP
ajlm-1645	267	38	pancytopenia	pancytopenia	NOUN
ajlm-1645	267	39	:	:	PUNCT
ajlm-1645	267	40	experience	experience	NOUN
ajlm-1645	267	41	of	of	ADP
ajlm-1645	267	42	a	a	DET
ajlm-1645	267	43	mexican	mexican	ADJ
ajlm-1645	267	44	tertiary	tertiary	ADJ
ajlm-1645	267	45	care	care	NOUN
ajlm-1645	267	46	center	center	NOUN
ajlm-1645	267	47	and	and	CCONJ
ajlm-1645	267	48	review	review	NOUN
ajlm-1645	267	49	of	of	ADP
ajlm-1645	267	50	the	the	DET
ajlm-1645	267	51	literature	literature	NOUN
ajlm-1645	267	52	.	.	PUNCT
ajlm-1645	268	1	hematology	hematology	NOUN
ajlm-1645	268	2	.	.	PUNCT
ajlm-1645	269	1	2019;24(1):399–404	2019;24(1):399–404	X
ajlm-1645	269	2	.	.	PUNCT
ajlm-1645	269	3	savage	savage	PROPN
ajlm-1645	269	4	dg	dg	PROPN
ajlm-1645	269	5	,	,	PUNCT
ajlm-1645	269	6	allen	allen	PROPN
ajlm-1645	269	7	rh	rh	PROPN
ajlm-1645	269	8	,	,	PUNCT
ajlm-1645	269	9	gangaidzo	gangaidzo	VERB
ajlm-1645	269	10	it	it	PRON
ajlm-1645	269	11	,	,	PUNCT
ajlm-1645	269	12	et	et	PROPN
ajlm-1645	269	13	al	al	PROPN
ajlm-1645	269	14	.	.	PROPN
ajlm-1645	269	15	pancytopenia	pancytopenia	PROPN
ajlm-1645	269	16	in	in	ADP
ajlm-1645	269	17	zimbabwe	zimbabwe	PROPN
ajlm-1645	269	18	.	.	PUNCT
ajlm-1645	270	1	am	be	AUX
ajlm-1645	270	2	j	j	PROPN
ajlm-1645	270	3	med	med	PROPN
ajlm-1645	270	4	sci	sci	PROPN
ajlm-1645	270	5	.	.	PUNCT
ajlm-1645	271	1	1999;317(1):22–32	1999;317(1):22–32	NUM
ajlm-1645	271	2	.	.	PUNCT
ajlm-1645	272	1	https://doi.org/10.1097/00000441-199901000-00004	https://doi.org/10.1097/00000441-199901000-00004	PROPN
ajlm-1645	272	2	lavigne	lavigne	PROPN
ajlm-1645	272	3	c	c	NOUN
ajlm-1645	272	4	,	,	PUNCT
ajlm-1645	272	5	lavigne	lavigne	PROPN
ajlm-1645	272	6	e	e	NOUN
ajlm-1645	272	7	,	,	PUNCT
ajlm-1645	272	8	massenet	massenet	PROPN
ajlm-1645	272	9	d	d	PROPN
ajlm-1645	272	10	,	,	PUNCT
ajlm-1645	272	11	binet	binet	PROPN
ajlm-1645	272	12	c	c	NOUN
ajlm-1645	272	13	,	,	PUNCT
ajlm-1645	272	14	brémond	brémond	ADJ
ajlm-1645	272	15	jl	jl	NOUN
ajlm-1645	272	16	,	,	PUNCT
ajlm-1645	272	17	prigent	prigent	ADJ
ajlm-1645	272	18	d.	d.	PROPN
ajlm-1645	272	19	role	role	NOUN
ajlm-1645	272	20	of	of	ADP
ajlm-1645	272	21	vitamin	vitamin	NOUN
ajlm-1645	272	22	deficiency	deficiency	NOUN
ajlm-1645	272	23	in	in	ADP
ajlm-1645	272	24	pancytopenia	pancytopenia	NOUN
ajlm-1645	272	25	in	in	ADP
ajlm-1645	272	26	djibouti	djibouti	PROPN
ajlm-1645	272	27	.	.	PUNCT
ajlm-1645	273	1	findings	finding	NOUN
ajlm-1645	273	2	in	in	ADP
ajlm-1645	273	3	a	a	DET
ajlm-1645	273	4	series	series	NOUN
ajlm-1645	273	5	of	of	ADP
ajlm-1645	273	6	81	81	NUM
ajlm-1645	273	7	consecutive	consecutive	ADJ
ajlm-1645	273	8	patients	patient	NOUN
ajlm-1645	273	9	.	.	PUNCT
ajlm-1645	274	1	med	med	ADJ
ajlm-1645	274	2	trop	trop	X
ajlm-1645	274	3	(	(	PUNCT
ajlm-1645	274	4	mars	mars	PROPN
ajlm-1645	274	5	)	)	PUNCT
ajlm-1645	274	6	.	.	PUNCT
ajlm-1645	275	1	2005;65(1):59–63	2005;65(1):59–63	NUM
ajlm-1645	275	2	.	.	PUNCT
ajlm-1645	275	3	nafil	nafil	PROPN
ajlm-1645	275	4	h	h	PROPN
ajlm-1645	275	5	,	,	PUNCT
ajlm-1645	275	6	tazi	tazi	NOUN
ajlm-1645	275	7	i	i	PRON
ajlm-1645	275	8	,	,	PUNCT
ajlm-1645	275	9	sifsalam	sifsalam	PROPN
ajlm-1645	275	10	m	m	PROPN
ajlm-1645	275	11	,	,	PUNCT
ajlm-1645	275	12	bouchtia	bouchtia	PROPN
ajlm-1645	275	13	m	m	PROPN
ajlm-1645	275	14	,	,	PUNCT
ajlm-1645	275	15	mahmal	mahmal	PROPN
ajlm-1645	275	16	l.	l.	PROPN
ajlm-1645	275	17	profil	profil	PROPN
ajlm-1645	275	18	étiologique	étiologique	PROPN
ajlm-1645	275	19	des	des	PROPN
ajlm-1645	275	20	pancytopénies	pancytopénie	NOUN
ajlm-1645	275	21	chez	chez	PROPN
ajlm-1645	275	22	l’adulte	l’adulte	PROPN
ajlm-1645	275	23	à	à	X
ajlm-1645	275	24	marrakech	marrakech	X
ajlm-1645	275	25	(	(	PUNCT
ajlm-1645	275	26	maroc	maroc	PROPN
ajlm-1645	275	27	)	)	PUNCT
ajlm-1645	275	28	.	.	PUNCT
ajlm-1645	276	1	east	east	PROPN
ajlm-1645	276	2	mediterr	mediterr	PROPN
ajlm-1645	276	3	health	health	PROPN
ajlm-1645	276	4	j.	j.	PROPN
ajlm-1645	276	5	2012;18(5):532–536	2012;18(5):532–536	PROPN
ajlm-1645	276	6	.	.	PUNCT
ajlm-1645	277	1	klii	klii	NOUN
ajlm-1645	277	2	r	r	NOUN
ajlm-1645	277	3	,	,	PUNCT
ajlm-1645	277	4	chaaben	chaaben	NOUN
ajlm-1645	277	5	i	i	PRON
ajlm-1645	277	6	,	,	PUNCT
ajlm-1645	277	7	kechida	kechida	PROPN
ajlm-1645	277	8	m	m	PROPN
ajlm-1645	277	9	,	,	PUNCT
ajlm-1645	277	10	et	et	PROPN
ajlm-1645	277	11	al	al	PROPN
ajlm-1645	277	12	.	.	PUNCT
ajlm-1645	278	1	profil	profil	PROPN
ajlm-1645	278	2	étiologique	étiologique	PROPN
ajlm-1645	278	3	des	des	PROPN
ajlm-1645	278	4	cytopénies	cytopénie	NOUN
ajlm-1645	278	5	dans	dans	PROPN
ajlm-1645	278	6	un	un	PROPN
ajlm-1645	278	7	service	service	PROPN
ajlm-1645	278	8	de	de	X
ajlm-1645	278	9	médecine	médecine	NOUN
ajlm-1645	278	10	interne	interne	NOUN
ajlm-1645	278	11	:	:	PUNCT
ajlm-1645	278	12	à	à	X
ajlm-1645	278	13	propos	propos	PROPN
ajlm-1645	278	14	de	de	PROPN
ajlm-1645	278	15	103	103	NUM
ajlm-1645	278	16	cas	cas	X
ajlm-1645	278	17	.	.	PUNCT
ajlm-1645	279	1	la	la	PROPN
ajlm-1645	279	2	rev	rev	PROPN
ajlm-1645	279	3	médecine	médecine	NOUN
ajlm-1645	279	4	interne	interne	NOUN
ajlm-1645	279	5	.	.	PUNCT
ajlm-1645	280	1	2016;37	2016;37	NUM
ajlm-1645	280	2	:	:	PUNCT
ajlm-1645	281	1	a145	a145	NUM
ajlm-1645	281	2	.	.	PUNCT
ajlm-1645	282	1	https://doi.org/10.1016/j.revmed.2016.10.144	https://doi.org/10.1016/j.revmed.2016.10.144	PROPN
ajlm-1645	282	2	retief	retief	PROPN
ajlm-1645	282	3	fp	fp	X
ajlm-1645	282	4	,	,	PUNCT
ajlm-1645	282	5	heyns	heyns	ADJ
ajlm-1645	282	6	a.d.p	a.d.p	PROPN
ajlm-1645	282	7	.	.	PUNCT
ajlm-1645	282	8	pansitopenie	pansitopenie	PROPN
ajlm-1645	282	9	en	en	PROPN
ajlm-1645	282	10	aplastiese	aplastiese	PROPN
ajlm-1645	282	11	anemie	anemie	PROPN
ajlm-1645	282	12	:	:	PUNCT
ajlm-1645	282	13	’	'	PUNCT
ajlm-1645	282	14	n	n	CCONJ
ajlm-1645	282	15	retrospektiewe	retrospektiewe	VERB
ajlm-1645	282	16	beoordeling	beoordele	VERB
ajlm-1645	282	17	.	.	PUNCT
ajlm-1645	283	1	s	s	PROPN
ajlm-1645	283	2	afr	afr	PROPN
ajlm-1645	283	3	med	med	PROPN
ajlm-1645	283	4	j.	j.	PROPN
ajlm-1645	283	5	1976;50(34):1318–1322	1976;50(34):1318–1322	PROPN
ajlm-1645	283	6	.	.	PUNCT
ajlm-1645	284	1	a	a	DET
ajlm-1645	284	2	timeline	timeline	NOUN
ajlm-1645	284	3	of	of	ADP
ajlm-1645	284	4	hiv	hiv	PROPN
ajlm-1645	284	5	and	and	CCONJ
ajlm-1645	284	6	aids	aid	NOUN
ajlm-1645	285	1	[	[	X
ajlm-1645	285	2	homepage	homepage	NOUN
ajlm-1645	285	3	on	on	ADP
ajlm-1645	285	4	the	the	DET
ajlm-1645	285	5	internet	internet	NOUN
ajlm-1645	285	6	]	]	PUNCT
ajlm-1645	285	7	.	.	PUNCT
ajlm-1645	286	1	hiv.gov	hiv.gov	PROPN
ajlm-1645	286	2	.	.	PUNCT
ajlm-1645	287	1	n.d	n.d	PROPN
ajlm-1645	287	2	.	.	PUNCT
ajlm-1645	288	1	[	[	X
ajlm-1645	288	2	cited	cite	VERB
ajlm-1645	288	3	2019	2019	NUM
ajlm-1645	288	4	dec	dec	PROPN
ajlm-1645	288	5	19	19	NUM
ajlm-1645	288	6	]	]	PUNCT
ajlm-1645	288	7	.	.	PUNCT
ajlm-1645	289	1	available	available	ADJ
ajlm-1645	289	2	from	from	ADP
ajlm-1645	289	3	:	:	PUNCT
ajlm-1645	289	4	https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline	https://www.hiv.gov/hiv-basics/overview/history/hiv-and-aids-timeline	VERB
ajlm-1645	289	5	statistical	statistical	ADJ
ajlm-1645	289	6	release	release	NOUN
ajlm-1645	289	7	:	:	PUNCT
ajlm-1645	289	8	mid	mid	ADJ
ajlm-1645	289	9	-	-	ADJ
ajlm-1645	289	10	year	year	NOUN
ajlm-1645	289	11	population	population	NOUN
ajlm-1645	289	12	estimates	estimate	VERB
ajlm-1645	289	13	2019	2019	NUM
ajlm-1645	290	1	[	[	X
ajlm-1645	290	2	homepage	homepage	NOUN
ajlm-1645	290	3	on	on	ADP
ajlm-1645	290	4	the	the	DET
ajlm-1645	290	5	internet	internet	NOUN
ajlm-1645	290	6	]	]	PUNCT
ajlm-1645	290	7	.	.	PUNCT
ajlm-1645	291	1	2019	2019	NUM
ajlm-1645	291	2	.	.	PUNCT
ajlm-1645	292	1	available	available	ADJ
ajlm-1645	292	2	from	from	ADP
ajlm-1645	292	3	:	:	PUNCT
ajlm-1645	292	4	http://www.statssa.gov.za/publications/p0302/p03022019.pdf	http://www.statssa.gov.za/publications/p0302/p03022019.pdf	PROPN
ajlm-1645	292	5	opie	opie	PROPN
ajlm-1645	292	6	j.	j.	PROPN
ajlm-1645	292	7	haematological	haematological	PROPN
ajlm-1645	292	8	complications	complication	NOUN
ajlm-1645	292	9	of	of	ADP
ajlm-1645	292	10	hiv	hiv	PROPN
ajlm-1645	292	11	infection	infection	NOUN
ajlm-1645	292	12	.	.	PUNCT
ajlm-1645	293	1	s	s	PROPN
ajlm-1645	293	2	afr	afr	PROPN
ajlm-1645	293	3	med	med	PROPN
ajlm-1645	293	4	j.	j.	PROPN
ajlm-1645	293	5	2012;102(6):465–468	2012;102(6):465–468	PROPN
ajlm-1645	293	6	.	.	PUNCT
ajlm-1645	293	7	https://doi.org/10.7196/samj.5595	https://doi.org/10.7196/samj.5595	NOUN
ajlm-1645	293	8	enawgaw	enawgaw	VERB
ajlm-1645	293	9	b	b	PROPN
ajlm-1645	293	10	,	,	PUNCT
ajlm-1645	293	11	alem	alem	PROPN
ajlm-1645	293	12	m	m	PROPN
ajlm-1645	293	13	,	,	PUNCT
ajlm-1645	293	14	addis	addis	PROPN
ajlm-1645	293	15	z	z	PROPN
ajlm-1645	293	16	,	,	PUNCT
ajlm-1645	293	17	melku	melku	NOUN
ajlm-1645	293	18	m.	m.	NOUN
ajlm-1645	293	19	determination	determination	NOUN
ajlm-1645	293	20	of	of	ADP
ajlm-1645	293	21	hematological	hematological	ADJ
ajlm-1645	293	22	and	and	CCONJ
ajlm-1645	293	23	immunological	immunological	ADJ
ajlm-1645	293	24	parameters	parameter	NOUN
ajlm-1645	293	25	among	among	ADP
ajlm-1645	293	26	hiv	hiv	PROPN
ajlm-1645	293	27	positive	positive	ADJ
ajlm-1645	293	28	patients	patient	NOUN
ajlm-1645	293	29	taking	take	VERB
ajlm-1645	293	30	highly	highly	ADV
ajlm-1645	293	31	active	active	ADJ
ajlm-1645	293	32	antiretroviral	antiretroviral	ADJ
ajlm-1645	293	33	treatment	treatment	NOUN
ajlm-1645	293	34	and	and	CCONJ
ajlm-1645	293	35	treatment	treatment	NOUN
ajlm-1645	293	36	naïve	naïve	ADJ
ajlm-1645	293	37	in	in	ADP
ajlm-1645	293	38	the	the	DET
ajlm-1645	293	39	antiretroviral	antiretroviral	ADJ
ajlm-1645	293	40	therapy	therapy	NOUN
ajlm-1645	293	41	clinic	clinic	NOUN
ajlm-1645	293	42	of	of	ADP
ajlm-1645	293	43	gondar	gondar	PROPN
ajlm-1645	293	44	university	university	NOUN
ajlm-1645	293	45	hospital	hospital	NOUN
ajlm-1645	293	46	,	,	PUNCT
ajlm-1645	293	47	gondar	gondar	NOUN
ajlm-1645	293	48	,	,	PUNCT
ajlm-1645	293	49	northwest	northwest	PROPN
ajlm-1645	293	50	ethiopia	ethiopia	PROPN
ajlm-1645	293	51	.	.	PUNCT
ajlm-1645	294	1	bmc	bmc	PROPN
ajlm-1645	294	2	hematol	hematol	NOUN
ajlm-1645	294	3	.	.	PUNCT
ajlm-1645	295	1	2014;14	2014;14	NUM
ajlm-1645	295	2	:	:	PUNCT
ajlm-1645	295	3	article	article	NOUN
ajlm-1645	295	4	number	number	NOUN
ajlm-1645	295	5	8	8	NUM
ajlm-1645	295	6	.	.	PUNCT
ajlm-1645	296	1	https://doi.org/10.1186/2052-1839-14-8	https://doi.org/10.1186/2052-1839-14-8	PRON
ajlm-1645	296	2	kyeyune	kyeyune	ADJ
ajlm-1645	296	3	r	r	NOUN
ajlm-1645	296	4	,	,	PUNCT
ajlm-1645	296	5	saathoff	saathoff	NOUN
ajlm-1645	296	6	e	e	NOUN
ajlm-1645	296	7	,	,	PUNCT
ajlm-1645	296	8	ezeamama	ezeamama	PROPN
ajlm-1645	296	9	ae	ae	PROPN
ajlm-1645	296	10	,	,	PUNCT
ajlm-1645	296	11	loscher	loscher	PROPN
ajlm-1645	296	12	t	t	PROPN
ajlm-1645	296	13	,	,	PUNCT
ajlm-1645	296	14	fawzi	fawzi	PROPN
ajlm-1645	296	15	w	w	PROPN
ajlm-1645	296	16	,	,	PUNCT
ajlm-1645	296	17	guwatudde	guwatudde	PROPN
ajlm-1645	296	18	d.	d.	PROPN
ajlm-1645	296	19	prevalence	prevalence	NOUN
ajlm-1645	296	20	and	and	CCONJ
ajlm-1645	296	21	correlates	correlate	VERB
ajlm-1645	296	22	of	of	ADP
ajlm-1645	296	23	cytopenias	cytopenia	NOUN
ajlm-1645	296	24	in	in	ADP
ajlm-1645	296	25	hiv	hiv	PROPN
ajlm-1645	296	26	-	-	PUNCT
ajlm-1645	296	27	infected	infect	VERB
ajlm-1645	296	28	adults	adult	NOUN
ajlm-1645	296	29	initiating	initiate	VERB
ajlm-1645	296	30	highly	highly	ADV
ajlm-1645	296	31	active	active	ADJ
ajlm-1645	296	32	antiretroviral	antiretroviral	ADJ
ajlm-1645	296	33	therapy	therapy	NOUN
ajlm-1645	296	34	in	in	ADP
ajlm-1645	296	35	uganda	uganda	PROPN
ajlm-1645	296	36	.	.	PUNCT
ajlm-1645	297	1	bmc	bmc	PROPN
ajlm-1645	297	2	infect	infect	PROPN
ajlm-1645	297	3	dis	dis	PROPN
ajlm-1645	297	4	.	.	PUNCT
ajlm-1645	298	1	2014;14(1):1–10	2014;14(1):1–10	X
ajlm-1645	298	2	.	.	PUNCT
ajlm-1645	299	1	https://doi.org/10.1186/1471-2334-14-496	https://doi.org/10.1186/1471-2334-14-496	NOUN
ajlm-1645	299	2	santiago	santiago	PROPN
ajlm-1645	299	3	-	-	PUNCT
ajlm-1645	299	4	rodríguez	rodríguez	NOUN
ajlm-1645	299	5	ej	ej	PROPN
ajlm-1645	299	6	,	,	PUNCT
ajlm-1645	299	7	mayor	mayor	NOUN
ajlm-1645	299	8	am	am	NOUN
ajlm-1645	299	9	,	,	PUNCT
ajlm-1645	299	10	fernández	fernández	PROPN
ajlm-1645	299	11	-	-	PUNCT
ajlm-1645	299	12	santos	santos	PROPN
ajlm-1645	299	13	dm	dm	PROPN
ajlm-1645	299	14	,	,	PUNCT
ajlm-1645	299	15	hunter	hunter	NOUN
ajlm-1645	299	16	-	-	PUNCT
ajlm-1645	299	17	mellado	mellado	NOUN
ajlm-1645	299	18	rf	rf	PROPN
ajlm-1645	299	19	.	.	PROPN
ajlm-1645	299	20	profile	profile	NOUN
ajlm-1645	299	21	of	of	ADP
ajlm-1645	299	22	hiv	hiv	PROPN
ajlm-1645	299	23	-	-	PUNCT
ajlm-1645	299	24	infected	infect	VERB
ajlm-1645	299	25	hispanics	hispanic	NOUN
ajlm-1645	299	26	with	with	ADP
ajlm-1645	299	27	pancytopenia	pancytopenia	NOUN
ajlm-1645	299	28	.	.	PUNCT
ajlm-1645	300	1	int	int	PROPN
ajlm-1645	301	1	j	j	PROPN
ajlm-1645	301	2	environ	environ	PROPN
ajlm-1645	301	3	res	re	VERB
ajlm-1645	301	4	public	public	ADJ
ajlm-1645	301	5	health	health	NOUN
ajlm-1645	301	6	.	.	PUNCT
ajlm-1645	302	1	2015;13(38):1–7	2015;13(38):1–7	X
ajlm-1645	302	2	.	.	PUNCT
ajlm-1645	302	3	https://doi.org/10.3390/ijerph13010038	https://doi.org/10.3390/ijerph13010038	NOUN
ajlm-1645	302	4	yokuş	yokuş	PROPN
ajlm-1645	302	5	o	o	NOUN
ajlm-1645	302	6	,	,	PUNCT
ajlm-1645	302	7	gedik	gedik	NOUN
ajlm-1645	302	8	h.	h.	NOUN
ajlm-1645	302	9	etiological	etiological	ADJ
ajlm-1645	302	10	causes	cause	NOUN
ajlm-1645	302	11	of	of	ADP
ajlm-1645	302	12	pancytopenia	pancytopenia	NOUN
ajlm-1645	302	13	:	:	PUNCT
ajlm-1645	302	14	a	a	DET
ajlm-1645	302	15	report	report	NOUN
ajlm-1645	302	16	of	of	ADP
ajlm-1645	302	17	137	137	NUM
ajlm-1645	302	18	cases	case	NOUN
ajlm-1645	302	19	.	.	PUNCT
ajlm-1645	303	1	avicenna	avicenna	PROPN
ajlm-1645	303	2	j	j	PROPN
ajlm-1645	303	3	med	med	PROPN
ajlm-1645	303	4	.	.	PUNCT
ajlm-1645	304	1	2016;6(4):109–112	2016;6(4):109–112	X
ajlm-1645	304	2	.	.	PUNCT
ajlm-1645	305	1	https://doi.org/10.4103/2231-0770.191447	https://doi.org/10.4103/2231-0770.191447	PROPN
ajlm-1645	305	2	jalaeikhoo	jalaeikhoo	PROPN
ajlm-1645	305	3	h	h	PROPN
ajlm-1645	305	4	,	,	PUNCT
ajlm-1645	305	5	mohammad	mohammad	PROPN
ajlm-1645	305	6	s	s	PROPN
ajlm-1645	305	7	,	,	PUNCT
ajlm-1645	305	8	kashfi	kashfi	PROPN
ajlm-1645	305	9	h	h	NOUN
ajlm-1645	305	10	,	,	PUNCT
ajlm-1645	305	11	azimzadeh	azimzadeh	ADV
ajlm-1645	305	12	p	p	NOUN
ajlm-1645	305	13	,	,	PUNCT
ajlm-1645	305	14	narimani	narimani	ADJ
ajlm-1645	305	15	a.	a.	NOUN
ajlm-1645	305	16	acute	acute	PROPN
ajlm-1645	305	17	myeloid	myeloid	PROPN
ajlm-1645	305	18	leukemia	leukemia	NOUN
ajlm-1645	305	19	as	as	ADP
ajlm-1645	305	20	the	the	DET
ajlm-1645	305	21	main	main	ADJ
ajlm-1645	305	22	cause	cause	NOUN
ajlm-1645	305	23	of	of	ADP
ajlm-1645	305	24	pancytopenia	pancytopenia	NOUN
ajlm-1645	305	25	in	in	ADP
ajlm-1645	305	26	iranian	iranian	ADJ
ajlm-1645	305	27	population	population	NOUN
ajlm-1645	305	28	.	.	PUNCT
ajlm-1645	306	1	iran	iran	PROPN
ajlm-1645	306	2	j	j	PROPN
ajlm-1645	306	3	pathol	pathol	PROPN
ajlm-1645	306	4	.	.	PUNCT
ajlm-1645	307	1	2017;12(3):265–271	2017;12(3):265–271	X
ajlm-1645	307	2	.	.	PUNCT
ajlm-1645	308	1	https://doi.org/10.30699/ijp.2017.25647	https://doi.org/10.30699/ijp.2017.25647	ADJ
ajlm-1645	308	2	waldrop	waldrop	PROPN
ajlm-1645	308	3	g	g	PROPN
ajlm-1645	308	4	,	,	PUNCT
ajlm-1645	308	5	doherty	doherty	PROPN
ajlm-1645	308	6	m	m	PROPN
ajlm-1645	308	7	,	,	PUNCT
ajlm-1645	308	8	vitoria	vitoria	PROPN
ajlm-1645	308	9	m	m	PROPN
ajlm-1645	308	10	,	,	PUNCT
ajlm-1645	308	11	ford	ford	PROPN
ajlm-1645	308	12	n.	n.	PROPN
ajlm-1645	308	13	stable	stable	ADJ
ajlm-1645	308	14	patients	patient	NOUN
ajlm-1645	308	15	and	and	CCONJ
ajlm-1645	308	16	patients	patient	NOUN
ajlm-1645	308	17	with	with	ADP
ajlm-1645	308	18	advanced	advanced	ADJ
ajlm-1645	308	19	disease	disease	NOUN
ajlm-1645	308	20	:	:	PUNCT
ajlm-1645	308	21	consensus	consensus	NOUN
ajlm-1645	308	22	definitions	definition	NOUN
ajlm-1645	308	23	to	to	PART
ajlm-1645	308	24	support	support	VERB
ajlm-1645	308	25	sustained	sustained	ADJ
ajlm-1645	308	26	scale	scale	NOUN
ajlm-1645	308	27	up	up	ADP
ajlm-1645	308	28	of	of	ADP
ajlm-1645	308	29	antiretroviral	antiretroviral	ADJ
ajlm-1645	308	30	therapy	therapy	NOUN
ajlm-1645	308	31	.	.	PUNCT
ajlm-1645	309	1	trop	trop	PROPN
ajlm-1645	309	2	med	med	ADJ
ajlm-1645	309	3	int	int	PROPN
ajlm-1645	309	4	health	health	NOUN
ajlm-1645	309	5	.	.	PUNCT
ajlm-1645	310	1	2016;21(9):1124–1130	2016;21(9):1124–1130	NOUN
ajlm-1645	310	2	.	.	PUNCT
ajlm-1645	311	1	https://doi.org/10.1111/tmi.12746	https://doi.org/10.1111/tmi.12746	PROPN
ajlm-1645	311	2	who	who	PRON
ajlm-1645	311	3	.	.	PUNCT
ajlm-1645	312	1	advanced	advanced	ADJ
ajlm-1645	312	2	hiv	hiv	PROPN
ajlm-1645	312	3	disease	disease	NOUN
ajlm-1645	312	4	.	.	PUNCT
ajlm-1645	313	1	n.d	n.d	PROPN
ajlm-1645	313	2	.	.	PUNCT
ajlm-1645	314	1	[	[	X
ajlm-1645	314	2	cited	cite	VERB
ajlm-1645	314	3	2019	2019	NUM
ajlm-1645	314	4	dec	dec	PROPN
ajlm-1645	314	5	17	17	NUM
ajlm-1645	314	6	]	]	PUNCT
ajlm-1645	314	7	.	.	PUNCT
ajlm-1645	315	1	available	available	ADJ
ajlm-1645	315	2	from	from	ADP
ajlm-1645	315	3	:	:	PUNCT
ajlm-1645	315	4	https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/treatment/advanced-hiv-disease	https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/treatment/advanced-hiv-disease	NOUN
ajlm-1645	315	5	marmot	marmot	PROPN
ajlm-1645	315	6	m	m	PROPN
ajlm-1645	315	7	,	,	PUNCT
ajlm-1645	315	8	friel	friel	PROPN
ajlm-1645	315	9	s	s	PROPN
ajlm-1645	315	10	,	,	PUNCT
ajlm-1645	315	11	bell	bell	NOUN
ajlm-1645	315	12	r	r	NOUN
ajlm-1645	315	13	,	,	PUNCT
ajlm-1645	315	14	houweling	houwele	VERB
ajlm-1645	315	15	ta	ta	PROPN
ajlm-1645	315	16	,	,	PUNCT
ajlm-1645	315	17	taylor	taylor	PROPN
ajlm-1645	315	18	s.	s.	PROPN
ajlm-1645	315	19	closing	close	VERB
ajlm-1645	315	20	the	the	DET
ajlm-1645	315	21	gap	gap	NOUN
ajlm-1645	315	22	in	in	ADP
ajlm-1645	315	23	a	a	DET
ajlm-1645	315	24	generation	generation	NOUN
ajlm-1645	315	25	:	:	PUNCT
ajlm-1645	315	26	health	health	NOUN
ajlm-1645	315	27	equity	equity	NOUN
ajlm-1645	315	28	through	through	ADP
ajlm-1645	315	29	action	action	NOUN
ajlm-1645	315	30	on	on	ADP
ajlm-1645	315	31	the	the	DET
ajlm-1645	315	32	social	social	ADJ
ajlm-1645	315	33	determinants	determinant	NOUN
ajlm-1645	315	34	of	of	ADP
ajlm-1645	315	35	health	health	NOUN
ajlm-1645	315	36	.	.	PUNCT
ajlm-1645	316	1	lancet	lancet	PROPN
ajlm-1645	316	2	.	.	PUNCT
ajlm-1645	317	1	2008;372(9650):1661–1669	2008;372(9650):1661–1669	PROPN
ajlm-1645	317	2	.	.	PUNCT
ajlm-1645	318	1	https://doi.org/10.1016/s0140-6736(08)61690-6	https://doi.org/10.1016/s0140-6736(08)61690-6	VERB
ajlm-1645	318	2	ataguba	ataguba	PROPN
ajlm-1645	318	3	je	je	PROPN
ajlm-1645	318	4	,	,	PUNCT
ajlm-1645	318	5	akazili	akazili	PROPN
ajlm-1645	318	6	j	j	PROPN
ajlm-1645	318	7	,	,	PUNCT
ajlm-1645	318	8	mcintyre	mcintyre	PROPN
ajlm-1645	318	9	d.	d.	PROPN
ajlm-1645	318	10	socioeconomic	socioeconomic	ADV
ajlm-1645	318	11	-	-	PUNCT
ajlm-1645	318	12	related	relate	VERB
ajlm-1645	318	13	health	health	NOUN
ajlm-1645	318	14	inequality	inequality	NOUN
ajlm-1645	318	15	in	in	ADP
ajlm-1645	318	16	south	south	PROPN
ajlm-1645	318	17	africa	africa	PROPN
ajlm-1645	318	18	:	:	PUNCT
ajlm-1645	318	19	evidence	evidence	NOUN
ajlm-1645	318	20	from	from	ADP
ajlm-1645	318	21	general	general	ADJ
ajlm-1645	318	22	household	household	NOUN
ajlm-1645	318	23	surveys	survey	NOUN
ajlm-1645	318	24	.	.	PUNCT
ajlm-1645	319	1	int	int	NOUN
ajlm-1645	319	2	j	j	PROPN
ajlm-1645	319	3	equity	equity	NOUN
ajlm-1645	319	4	health	health	NOUN
ajlm-1645	319	5	.	.	PUNCT
ajlm-1645	320	1	2011;10(48	2011;10(48	NUM
ajlm-1645	320	2	):	):	PUNCT
ajlm-1645	320	3	https://doi.org/10.1186/1475-9276-10–48	https://doi.org/10.1186/1475-9276-10–48	PROPN
ajlm-1645	320	4	rios	rios	PROPN
ajlm-1645	320	5	a.	a.	PROPN
ajlm-1645	320	6	hiv	hiv	PROPN
ajlm-1645	320	7	-	-	PUNCT
ajlm-1645	320	8	related	relate	VERB
ajlm-1645	320	9	hematological	hematological	ADJ
ajlm-1645	320	10	malignancies	malignancy	NOUN
ajlm-1645	320	11	:	:	PUNCT
ajlm-1645	320	12	a	a	DET
ajlm-1645	320	13	concise	concise	ADJ
ajlm-1645	320	14	review	review	NOUN
ajlm-1645	320	15	.	.	PUNCT
ajlm-1645	321	1	clin	clin	PROPN
ajlm-1645	321	2	lymphoma	lymphoma	PROPN
ajlm-1645	321	3	myeloma	myeloma	PROPN
ajlm-1645	321	4	leuk	leuk	PROPN
ajlm-1645	321	5	.	.	PUNCT
ajlm-1645	322	1	2014;14	2014;14	NUM
ajlm-1645	322	2	:	:	PUNCT
ajlm-1645	322	3	s96	s96	NOUN
ajlm-1645	322	4	–	–	PUNCT
ajlm-1645	322	5	s103	s103	X
ajlm-1645	322	6	.	.	PUNCT
ajlm-1645	323	1	https://doi.org/10.1016/j.clml.2014.06.020	https://doi.org/10.1016/j.clml.2014.06.020	PROPN
ajlm-1645	323	2	conlan	conlan	VERB
ajlm-1645	323	3	mg	mg	PROPN
ajlm-1645	323	4	,	,	PUNCT
ajlm-1645	323	5	armitage	armitage	PROPN
ajlm-1645	323	6	jo	jo	PROPN
ajlm-1645	323	7	,	,	PUNCT
ajlm-1645	323	8	bast	bast	NOUN
ajlm-1645	323	9	m	m	PROPN
ajlm-1645	323	10	,	,	PUNCT
ajlm-1645	323	11	weisenburger	weisenburger	NOUN
ajlm-1645	323	12	dd	dd	NOUN
ajlm-1645	323	13	.	.	PUNCT
ajlm-1645	323	14	clinical	clinical	ADJ
ajlm-1645	323	15	significance	significance	NOUN
ajlm-1645	323	16	of	of	ADP
ajlm-1645	323	17	hematologic	hematologic	NOUN
ajlm-1645	323	18	parameters	parameter	NOUN
ajlm-1645	323	19	in	in	ADP
ajlm-1645	323	20	non	non	ADJ
ajlm-1645	323	21	-	-	ADJ
ajlm-1645	323	22	hodgkin	hodgkin	ADJ
ajlm-1645	323	23	’s	’s	PART
ajlm-1645	323	24	lymphoma	lymphoma	NOUN
ajlm-1645	323	25	at	at	ADP
ajlm-1645	323	26	diagnosis	diagnosis	NOUN
ajlm-1645	323	27	.	.	PUNCT
ajlm-1645	324	1	cancer	cancer	NOUN
ajlm-1645	324	2	.	.	PUNCT
ajlm-1645	325	1	1991;67(5):1389–1395	1991;67(5):1389–1395	PROPN
ajlm-1645	325	2	.	.	PUNCT
ajlm-1645	326	1	https://doi.org/10.1002/1097-0142(19910301)67:5<1389::aid-cncr2820670519>3.0.co;2-q	https://doi.org/10.1002/1097-0142(19910301)67:5<1389::aid-cncr2820670519>3.0.co;2-q	VERB
ajlm-1645	326	2	kanavos	kanavos	PROPN
ajlm-1645	326	3	p.	p.	PROPN
ajlm-1645	326	4	the	the	DET
ajlm-1645	326	5	rising	rise	VERB
ajlm-1645	326	6	burden	burden	NOUN
ajlm-1645	326	7	of	of	ADP
ajlm-1645	326	8	cancer	cancer	NOUN
ajlm-1645	326	9	in	in	ADP
ajlm-1645	326	10	the	the	DET
ajlm-1645	326	11	developing	develop	VERB
ajlm-1645	326	12	world	world	NOUN
ajlm-1645	326	13	.	.	PUNCT
ajlm-1645	327	1	ann	ann	PROPN
ajlm-1645	327	2	oncol	oncol	PROPN
ajlm-1645	327	3	.	.	PUNCT
ajlm-1645	328	1	2006;17(supplement	2006;17(supplement	PROPN
ajlm-1645	328	2	8):viii15	8):viii15	NOUN
ajlm-1645	328	3	–	–	PUNCT
ajlm-1645	328	4	viii23	viii23	NOUN
ajlm-1645	328	5	.	.	PUNCT
ajlm-1645	329	1	https://doi.org/10.1093/annonc/mdl983	https://doi.org/10.1093/annonc/mdl983	ADJ
ajlm-1645	329	2	tareen	tareen	NOUN
ajlm-1645	329	3	sm	sm	PROPN
ajlm-1645	329	4	,	,	PUNCT
ajlm-1645	329	5	bajwa	bajwa	PROPN
ajlm-1645	329	6	ma	ma	PROPN
ajlm-1645	329	7	,	,	PUNCT
ajlm-1645	329	8	tariq	tariq	PROPN
ajlm-1645	329	9	mm	mm	PROPN
ajlm-1645	329	10	,	,	PUNCT
ajlm-1645	329	11	babar	babar	PROPN
ajlm-1645	329	12	s	s	PROPN
ajlm-1645	329	13	,	,	PUNCT
ajlm-1645	329	14	tareen	tareen	NOUN
ajlm-1645	329	15	am	am	NOUN
ajlm-1645	329	16	.	.	PUNCT
ajlm-1645	330	1	pancytopenia	pancytopenia	NOUN
ajlm-1645	330	2	in	in	ADP
ajlm-1645	330	3	two	two	NUM
ajlm-1645	330	4	national	national	ADJ
ajlm-1645	330	5	ethnic	ethnic	ADJ
ajlm-1645	330	6	groups	group	NOUN
ajlm-1645	330	7	of	of	ADP
ajlm-1645	330	8	baluchistan	baluchistan	PROPN
ajlm-1645	330	9	.	.	PUNCT
ajlm-1645	331	1	j	j	PROPN
ajlm-1645	331	2	ayub	ayub	PROPN
ajlm-1645	331	3	med	med	PROPN
ajlm-1645	331	4	coll	coll	PROPN
ajlm-1645	331	5	abbottabad	abbottabad	PROPN
ajlm-1645	331	6	.	.	PUNCT
ajlm-1645	332	1	23(2):82–86	23(2):82–86	NUM
ajlm-1645	332	2	.	.	PUNCT
ajlm-1645	332	3	hamid	hamid	PROPN
ajlm-1645	332	4	ga	ga	PROPN
ajlm-1645	332	5	,	,	PUNCT
ajlm-1645	332	6	shukry	shukry	PROPN
ajlm-1645	332	7	sar	sar	PROPN
ajlm-1645	332	8	.	.	PROPN
ajlm-1645	332	9	patterns	pattern	NOUN
ajlm-1645	332	10	of	of	ADP
ajlm-1645	332	11	pancytopenia	pancytopenia	NOUN
ajlm-1645	332	12	in	in	ADP
ajlm-1645	332	13	yemen	yemen	PROPN
ajlm-1645	332	14	.	.	PUNCT
ajlm-1645	333	1	turk	turk	PROPN
ajlm-1645	333	2	j	j	PROPN
ajlm-1645	333	3	haematol	haematol	PROPN
ajlm-1645	333	4	.	.	PUNCT
ajlm-1645	334	1	2008;25(2):71–74	2008;25(2):71–74	X
ajlm-1645	334	2	.	.	PUNCT
ajlm-1645	334	3	azaad	azaad	PROPN
ajlm-1645	334	4	ma	ma	PROPN
ajlm-1645	334	5	,	,	PUNCT
ajlm-1645	334	6	li	li	PROPN
ajlm-1645	334	7	y	y	PROPN
ajlm-1645	334	8	,	,	PUNCT
ajlm-1645	334	9	zhang	zhang	PROPN
ajlm-1645	334	10	q	q	PROPN
ajlm-1645	334	11	,	,	PUNCT
ajlm-1645	334	12	wang	wang	PROPN
ajlm-1645	334	13	h.	h.	PROPN
ajlm-1645	334	14	detection	detection	PROPN
ajlm-1645	334	15	of	of	ADP
ajlm-1645	334	16	pancytopenia	pancytopenia	NOUN
ajlm-1645	334	17	associated	associate	VERB
ajlm-1645	334	18	with	with	ADP
ajlm-1645	334	19	clinical	clinical	ADJ
ajlm-1645	334	20	manifestation	manifestation	NOUN
ajlm-1645	334	21	and	and	CCONJ
ajlm-1645	334	22	their	their	PRON
ajlm-1645	334	23	final	final	ADJ
ajlm-1645	334	24	diagnosis	diagnosis	NOUN
ajlm-1645	334	25	.	.	PUNCT
ajlm-1645	335	1	open	open	ADJ
ajlm-1645	335	2	j	j	PROPN
ajlm-1645	335	3	blood	blood	NOUN
ajlm-1645	335	4	dis	dis	PROPN
ajlm-1645	335	5	.	.	PUNCT
ajlm-1645	336	1	2015;5(3):17–30	2015;5(3):17–30	NUM
ajlm-1645	336	2	.	.	PUNCT
ajlm-1645	337	1	https://doi.org/10.4236/ojbd.2015.53004	https://doi.org/10.4236/ojbd.2015.53004	PROPN
ajlm-1645	337	2	modjadji	modjadji	PROPN
ajlm-1645	337	3	s	s	PART
ajlm-1645	337	4	,	,	PUNCT
ajlm-1645	337	5	alberts	alberts	PROPN
ajlm-1645	337	6	m	m	PROPN
ajlm-1645	337	7	,	,	PUNCT
ajlm-1645	337	8	mamabolo	mamabolo	PROPN
ajlm-1645	337	9	r.	r.	PROPN
ajlm-1645	337	10	folate	folate	PROPN
ajlm-1645	337	11	and	and	CCONJ
ajlm-1645	337	12	iron	iron	NOUN
ajlm-1645	337	13	status	status	NOUN
ajlm-1645	337	14	of	of	ADP
ajlm-1645	337	15	south	south	ADJ
ajlm-1645	337	16	african	african	ADJ
ajlm-1645	337	17	non	non	ADJ
ajlm-1645	337	18	-	-	ADJ
ajlm-1645	337	19	pregnanat	pregnanat	ADJ
ajlm-1645	337	20	rural	rural	ADJ
ajlm-1645	337	21	women	woman	NOUN
ajlm-1645	337	22	of	of	ADP
ajlm-1645	337	23	childbearing	childbeare	VERB
ajlm-1645	337	24	age	age	NOUN
ajlm-1645	337	25	,	,	PUNCT
ajlm-1645	337	26	before	before	ADP
ajlm-1645	337	27	and	and	CCONJ
ajlm-1645	337	28	after	after	ADP
ajlm-1645	337	29	fortification	fortification	NOUN
ajlm-1645	337	30	of	of	ADP
ajlm-1645	337	31	foods	food	NOUN
ajlm-1645	337	32	.	.	PUNCT
ajlm-1645	338	1	s	s	PROPN
ajlm-1645	338	2	afr	afr	PROPN
ajlm-1645	338	3	j	j	PROPN
ajlm-1645	338	4	clin	clin	PROPN
ajlm-1645	338	5	nutr	nutr	PROPN
ajlm-1645	338	6	.	.	PUNCT
ajlm-1645	339	1	2008;20(3):89–95	2008;20(3):89–95	NUM
ajlm-1645	339	2	.	.	PUNCT
ajlm-1645	340	1	https://doi.org/10.1080/16070658.2007.11734132	https://doi.org/10.1080/16070658.2007.11734132	PUNCT
ajlm-1645	340	2	steyn	steyn	PROPN
ajlm-1645	340	3	np	np	PROPN
ajlm-1645	340	4	,	,	PUNCT
ajlm-1645	340	5	wolmarans	wolmarans	PROPN
ajlm-1645	340	6	p	p	X
ajlm-1645	340	7	,	,	PUNCT
ajlm-1645	340	8	nel	nel	PROPN
ajlm-1645	340	9	jh	jh	PROPN
ajlm-1645	340	10	,	,	PUNCT
ajlm-1645	340	11	bourne	bourne	PROPN
ajlm-1645	340	12	lt	lt	PROPN
ajlm-1645	340	13	.	.	PROPN
ajlm-1645	340	14	national	national	ADJ
ajlm-1645	340	15	fortification	fortification	NOUN
ajlm-1645	340	16	of	of	ADP
ajlm-1645	340	17	staple	staple	ADJ
ajlm-1645	340	18	foods	food	NOUN
ajlm-1645	340	19	can	can	AUX
ajlm-1645	340	20	make	make	VERB
ajlm-1645	340	21	a	a	DET
ajlm-1645	340	22	significant	significant	ADJ
ajlm-1645	340	23	contribution	contribution	NOUN
ajlm-1645	340	24	to	to	ADP
ajlm-1645	340	25	micronutrient	micronutrient	NOUN
ajlm-1645	340	26	intake	intake	NOUN
ajlm-1645	340	27	of	of	ADP
ajlm-1645	340	28	south	south	ADJ
ajlm-1645	340	29	african	african	ADJ
ajlm-1645	340	30	adults	adult	NOUN
ajlm-1645	340	31	.	.	PUNCT
ajlm-1645	341	1	public	public	ADJ
ajlm-1645	341	2	health	health	PROPN
ajlm-1645	341	3	nutr	nutr	PROPN
ajlm-1645	341	4	.	.	PUNCT
ajlm-1645	342	1	2008;11(3):307–313	2008;11(3):307–313	NUM
ajlm-1645	342	2	.	.	PUNCT
ajlm-1645	343	1	https://doi.org/10.1017/s136898000700033x	https://doi.org/10.1017/s136898000700033x	PROPN